Micron Document
<!DOCTYPE html>
<html class="client-nojs vector-feature-night-mode-disabled vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-sticky-header-enabled" lang="en" dir="ltr"><head>
<meta charset="UTF-8">
<title>Pregabalin</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<link rel="canonical" href="https://en.wikipedia.org/wiki/Pregabalin"> <link href="./mw/ext.cite.styles.css" rel="stylesheet" type="text/css">
<link href="./mw/skins.vector.icons.css" rel="stylesheet" type="text/css">
<link href="./mw/skins.vector.search.codex.styles.css" rel="stylesheet" type="text/css">
<link href="./mw/skins.vector.styles.css" rel="stylesheet" type="text/css">
<link href="./mw/user.styles.css" rel="stylesheet" type="text/css">
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" type="text/css" href="./mw/site.styles.css">
<link rel="stylesheet" type="text/css" href="./mw/noscript.css">
<link rel="stylesheet" type="text/css" href="./footer.css">
<link rel="stylesheet" type="text/css" href="./vector-2022.css">
</head>
<body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Pregabalin rootpage-Pregabalin skin-vector-2022 action-view">
<div class="mw-page-container">
<div class="mw-page-container-inner">
<div class="mw-content-container">
<main id="content" class="mw-body">
<header class="mw-body-header vector-page-titlebar">
<h1 id="firstHeading" class="firstHeading mw-first-heading">
<span id="openzim-page-title" class="mw-page-title-main"><span class="mw-page-title-main">Pregabalin</span></span>
</h1>
</header>
<a id="top"></a>
<div id="bodyContent" class="vector-body ve-init-mw-desktopArticleTarget-targetContainer" aria-labelledby="firstHeading" data-mw-ve-target-container="">
<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr">
<p class="mw-empty-elt">

</p>

<style data-mw-deduplicate="TemplateStyles:r1269284339">
/* start https://en.wikipedia.org/ */


@media screen{html.skin-theme-clientpref-night .mw-parser-output .dark_mode_safe img{background-color:var(--background-color-inverted,#f8f9fa)}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .dark_mode_safe img{background-color:var(--background-color-inverted,#f8f9fa)}}


/* end https://en.wikipedia.org/ */
</style>
<style data-mw-deduplicate="TemplateStyles:r1295905060">
/* start https://en.wikipedia.org/ */


.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}


/* end https://en.wikipedia.org/ */
</style><table class="infobox" style="border-spacing:2px;"><caption class="infobox-title"><span title="International nonproprietary name (INN): Pregabalin">Pregabalin</span></caption><tbody><tr><td colspan="2" class="infobox-image"><span class="skin-invert-image" typeof="mw:File"></span></td></tr><tr><td colspan="2" class="infobox-image"><span class="dark_mode_safe" typeof="mw:File"></span></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd;color:inherit;">Clinical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">Pronunciation</th><td class="infobox-data"><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt" lang="en-fonipa">/<span style="border-bottom:1px dotted"><span title="'p' in 'pie'">p</span><span title="'r' in 'rye'">r</span><span title="/i/: 'y' in 'happy'">i</span><span title="/ˈ/: primary stress follows">ˈ</span><span title="/ɡ/: 'g' in 'guy'">ɡ</span><span title="/æ/: 'a' in 'bad'">æ</span><span title="'b' in 'buy'">b</span><span title="/əl/: 'le' in 'bottle'">əl</span><span title="/ɪ/: 'i' in 'kit'">ɪ</span><span title="'n' in 'nigh'">n</span></span>/</span></span> </td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Drug_nomenclature#Trade_names" title="Drug nomenclature">Trade names</a></th><td class="infobox-data">Lyrica, others<sup id="cite_ref-www.drugs.com-2016_1-0" class="reference"><a href="#cite_note-www.drugs.com-2016-1"><span class="cite-bracket">[</span>1<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">Other names</th><td class="infobox-data">3-Isobutyl-GABA; (<i>S</i>)-3-Isobutyl-γ-aminobutyric acid; Isobutylgaba; CI-1008; PD-144723</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="Drugs.com" title="Drugs.com">Drugs.com</a></th><td class="infobox-data"><span title="www.drugs.com"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/pregabalin.html">Monograph</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="MedlinePlus" title="MedlinePlus">MedlinePlus</a></th><td class="infobox-data"><span title="medlineplus.gov"><a rel="nofollow" class="external text" href="https://medlineplus.gov/druginfo/meds/a605045.html">a605045</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">License data</a></th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1126788409">
/* start https://en.wikipedia.org/ */


.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}


/* end https://en.wikipedia.org/ */
</style><div class="plainlist">
<ul><li><small><abbr class="country-name" title="United States">US</abbr></small>&nbsp;<a href="DailyMed" title="DailyMed">DailyMed</a>:&nbsp;<span title="dailymed.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=Pregabalin">Pregabalin</a></span></li></ul></div>
</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Pregnancy_category" title="Pregnancy category">Pregnancy<br>category</a></th><td class="infobox-data"><div class="plainlist">
<ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small> D<sup id="cite_ref-Australian_Government_Pregnancy-2023_2-0" class="reference"><a href="#cite_note-Australian_Government_Pregnancy-2023-2"><span class="cite-bracket">[</span>2<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Australian_Government_Safety-2023_3-0" class="reference"><a href="#cite_note-Australian_Government_Safety-2023-3"><span class="cite-bracket">[</span>3<span class="cite-bracket">]</span></a></sup></li>
</ul>
</div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Substance_dependence" title="Substance dependence">Dependence<br>liability</a></th><td class="infobox-data"><a href="Physical_dependence" title="Physical dependence">Physical</a>: High<sup id="cite_ref-Sch2014_4-0" class="reference"><a href="#cite_note-Sch2014-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup><br><a href="Psychological_dependence" title="Psychological dependence">Psychological</a>: Moderate<sup id="cite_ref-Sch2014_4-1" class="reference"><a href="#cite_note-Sch2014-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Addiction" title="Addiction">Addiction<br>liability</a></th><td class="infobox-data">Low<sup id="cite_ref-Sch2014_4-2" class="reference"><a href="#cite_note-Sch2014-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> (but varying with dosage and route of administration)</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Route_of_administration" title="Route of administration">Routes of<br>administration</a></th><td class="infobox-data"><a href="Oral_administration" title="Oral administration">By mouth</a></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Drug_class" title="Drug class">Drug class</a></th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1129693374">
/* start https://en.wikipedia.org/ */


.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}


/* end https://en.wikipedia.org/ */
</style><div class="hlist"><ul><li><a href="Gabapentinoid" title="Gabapentinoid">Gabapentinoid</a></li><li><a href="Anticonvulsant" title="Anticonvulsant">Anticonvulsant</a></li><li><a href="GABA_analogue" title="GABA analogue">GABA analogue</a></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td class="infobox-data"><div class="plainlist"><ul><li><a href="ATC_code_N02" title="ATC code N02">N02BF02</a> (<span title="www.whocc.no"><a rel="nofollow" class="external text" href="https://www.whocc.no/atc_ddd_index/?code=N02BF02">WHO</a></span>) <a href="ATC_code_N02" title="ATC code N02">QN02BF02</a> (<span title="www.whocc.no/atcvet"><a rel="nofollow" class="external text" href="https://www.whocc.no/atcvet/atcvet_index/?code=QN02BF02">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd;color:inherit;">Legal status</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th><td class="infobox-data"><div class="plainlist">
<ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small> <a href="Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons#Schedule_4" title="Standard for the Uniform Scheduling of Medicines and Poisons">S4</a> (Prescription only)<sup id="cite_ref-Therapeutic_Goods_Administration_(TGA)-2022_5-0" class="reference"><a href="#cite_note-Therapeutic_Goods_Administration_(TGA)-2022-5"><span class="cite-bracket">[</span>5<span class="cite-bracket">]</span></a></sup></li>
<li><small><abbr class="country-name" title="Brazil">BR</abbr>:</small> <a href="Brazilian_Controlled_Drugs_and_Substances_Act#Class_C1" title="Brazilian Controlled Drugs and Substances Act">Class C1</a> (Other controlled substances)<sup id="cite_ref-Anvisa-2023_6-0" class="reference"><a href="#cite_note-Anvisa-2023-6"><span class="cite-bracket">[</span>6<span class="cite-bracket">]</span></a></sup></li>
<li><small><abbr class="country-name" title="Canada">CA</abbr></small>: <a href="Prescription_drug" title="Prescription drug"> ℞-only</a></li>
<li><small><abbr class="country-name" title="New Zealand">NZ</abbr></small>: Rx-only<sup id="cite_ref-Lyrica_Consumer_Medicine_Information-2023_7-0" class="reference"><a href="#cite_note-Lyrica_Consumer_Medicine_Information-2023-7"><span class="cite-bracket">[</span>7<span class="cite-bracket">]</span></a></sup></li>
<li><small><abbr class="country-name" title="United Kingdom">UK</abbr>:</small> <a href="Misuse_of_Drugs_Act_1971" title="Misuse of Drugs Act 1971">Class C</a><sup id="cite_ref-(emc)-2023_8-0" class="reference"><a href="#cite_note-(emc)-2023-8"><span class="cite-bracket">[</span>8<span class="cite-bracket">]</span></a></sup></li>
<li><small><abbr class="country-name" title="United States">US</abbr>:</small> <a href="Controlled_Substances_Act#Schedule_V_drugs" title="Controlled Substances Act">Schedule V</a><sup id="cite_ref-DailyMed-2020_9-0" class="reference"><a href="#cite_note-DailyMed-2020-9"><span class="cite-bracket">[</span>9<span class="cite-bracket">]</span></a></sup></li>
<li><small><abbr class="country-name" title="European Union">EU</abbr>:</small> Rx-only<sup id="cite_ref-Lyrica_EPAR_10-0" class="reference"><a href="#cite_note-Lyrica_EPAR-10"><span class="cite-bracket">[</span>10<span class="cite-bracket">]</span></a></sup></li>
<li>In&nbsp;general: ℞&nbsp;(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd;color:inherit;"><a href="Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Bioavailability" title="Bioavailability">Bioavailability</a></th><td class="infobox-data">Oral: ≥90%<sup id="cite_ref-EMA2013_11-0" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th><td class="infobox-data">&lt;1%<sup id="cite_ref-Bock2010_12-0" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Metabolite" title="Metabolite">Metabolites</a></th><td class="infobox-data">N-methylpregabalin<sup id="cite_ref-EMA2013_11-1" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Onset_of_action" title="Onset of action">Onset of action</a></th><td class="infobox-data">May occur within a week (pain)<sup id="cite_ref-AHFS2019_13-0" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Biological_half-life" title="Biological half-life">Elimination <span class="nowrap">half-life</span></a></th><td class="infobox-data">4.5–7 hours<sup id="cite_ref-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018_14-0" class="reference"><a href="#cite_note-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup> (mean 6.3 hours)<sup id="cite_ref-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018_14-1" class="reference"><a href="#cite_note-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018-14"><span class="cite-bracket">[</span>14<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid29261857_15-0" class="reference"><a href="#cite_note-pmid29261857-15"><span class="cite-bracket">[</span>15<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Pharmacodynamics#Duration_of_action" title="Pharmacodynamics">Duration of action</a></th><td class="infobox-data">8–12 hours <sup id="cite_ref-b403_16-0" class="reference"><a href="#cite_note-b403-16"><span class="cite-bracket">[</span>16<span class="cite-bracket">]</span></a></sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Excretion" title="Excretion">Excretion</a></th><td class="infobox-data"><a href="Kidney" title="Kidney">Kidney</a></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd;color:inherit;">Identifiers</th></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;">
<div style="line-height: 1.6em; font-weight: bold;"><div><a href="IUPAC_nomenclature_of_chemistry" title="IUPAC nomenclature of chemistry">IUPAC name</a></div></div>
<ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em;"><li style="line-height: inherit; margin: 0"><div style="font-size: 97%;">(3<i>S</i>)-3-(aminomethyl)-5-methylhexanoic acid</div></li></ul>
</div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="CAS_Registry_Number" title="CAS Registry Number">CAS Number</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="commonchemistry.cas.org"><a rel="nofollow" class="external text" href="https://commonchemistry.cas.org/detail?cas_rn=148553-50-8">148553-50-8</a></span><sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="PubChem#CID" title="PubChem">PubChem</a> <span style="font-weight:normal"><abbr title="Compound ID">CID</abbr></span></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="pubchem.ncbi.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/compound/5486971">5486971</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="DrugBank" title="DrugBank">DrugBank</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.drugbank.ca"><a rel="nofollow" class="external text" href="https://www.drugbank.ca/drugs/DB00230">DB00230</a></span><sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="ChemSpider" title="ChemSpider">ChemSpider</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.chemspider.com"><a rel="nofollow" class="external text" href="https://www.chemspider.com/Chemical-Structure.4589156.html">4589156</a></span><sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="precision.fda.gov"><a rel="nofollow" class="external text" href="https://precision.fda.gov/uniisearch/srs/unii/55JG375S6M">55JG375S6M</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="KEGG" title="KEGG">KEGG</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.kegg.jp"><a rel="nofollow" class="external text" href="https://www.kegg.jp/entry/D02716">D02716</a></span><sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="ChEBI" title="ChEBI">ChEBI</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:64356">CHEBI:64356</a></span><sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="ChEMBL" title="ChEMBL">ChEMBL</a></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembl/explore/compound/ChEMBL1059">ChEMBL1059</a></span><sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="CompTox_Chemicals_Dashboard" title="CompTox Chemicals Dashboard">CompTox Dashboard</a> <span style="font-weight:normal">(<abbr title="U.S. Environmental Protection Agency">EPA</abbr>)</span></th><td class="infobox-data"><div class="plainlist"><ul><li><span title="comptox.epa.gov"><a rel="nofollow" class="external text" href="https://comptox.epa.gov/dashboard/chemical/details/DTXSID1045950">DTXSID1045950</a> </span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="ECHA_InfoCard" class="mw-redirect" title="ECHA InfoCard"><span title="echa.europa.eu">ECHA InfoCard</span></a></th><td class="infobox-data"><a rel="nofollow" class="external text" href="https://echa.europa.eu/substance-information/-/substanceinfo/100.119.513">100.119.513</a> </td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd;color:inherit;">Chemical and physical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Chemical_formula" title="Chemical formula">Formula</a></th><td class="infobox-data"><span title="Carbon">C</span><sub>8</sub><span title="Hydrogen">H</span><sub>17</sub><span title="Nitrogen">N</span><span title="Oxygen">O</span><sub>2</sub></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="Molar_mass" title="Molar mass">Molar mass</a></th><td class="infobox-data"><span class="nowrap">159.229</span>&nbsp;g·mol<sup>−1</sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">3D model (<a href="JSmol" class="mw-redirect" title="JSmol">JSmol</a>)</th><td class="infobox-data"><div class="plainlist"><ul><li><span title="chemapps.stolaf.edu (3D interactive model)"><a rel="nofollow" class="external text" href="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29CC%28CC%28%3DO%29O%29CN">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;">
<div style="line-height: 1.6em; font-weight: bold;"><div><a href="Simplified_molecular-input_line-entry_system" class="mw-redirect" title="Simplified molecular-input line-entry system">SMILES</a></div></div>
<ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">CC(C)CC(CC(=O)O)CN</div></li></ul>
</div></td></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;">
<div style="line-height: 1.6em; font-weight: bold;"><div><a href="International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div></div>
<ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1<sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">Key:AYXYPKUFHZROOJ-ZETCQYMHSA-N<sup>&nbsp;<span typeof="mw:File"><span></span></span><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" class="infobox-below"><style data-mw-deduplicate="TemplateStyles:r886047488">
/* start https://en.wikipedia.org/ */


.mw-parser-output .nobold{font-weight:normal}


/* end https://en.wikipedia.org/ */
</style><span class="nobold">&nbsp;&nbsp;<span class="reflink nourlexpansion"><a class="external text external" href="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=457473985&amp;page2=Pregabalin">(verify)</a></span></span></td></tr></tbody></table>
<p><b>Pregabalin</b>, sold under the brand name <b>Lyrica</b> among others, is an <a href="Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>, <a href="Analgesic" title="Analgesic">analgesic</a>, and <a href="Anxiolytic" title="Anxiolytic">anxiolytic</a> amino acid medication used to treat <a href="Epilepsy" title="Epilepsy">epilepsy</a>, <a href="Neuropathic_pain" title="Neuropathic pain">neuropathic pain</a>, <a href="Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>, <a href="Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome</a>, <a href="Opioid_withdrawal" title="Opioid withdrawal">opioid withdrawal</a>, <a href="Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a> (GAD), and <a href="Shingles" title="Shingles">shingles</a>.<sup id="cite_ref-AHFS2019_13-1" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid25149863_17-0" class="reference"><a href="#cite_note-pmid25149863-17"><span class="cite-bracket">[</span>17<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28888061_18-0" class="reference"><a href="#cite_note-pmid28888061-18"><span class="cite-bracket">[</span>18<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span class="cite-bracket">[</span>19<span class="cite-bracket">]</span></a></sup> Pregabalin also has <a href="Allodynia" title="Allodynia">antiallodynic</a> properties.<sup id="cite_ref-Wyllie_2012_20-0" class="reference"><a href="#cite_note-Wyllie_2012-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Kirsch2013_21-0" class="reference"><a href="#cite_note-Kirsch2013-21"><span class="cite-bracket">[</span>21<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-SchatzbergNemeroff2009_22-0" class="reference"><a href="#cite_note-SchatzbergNemeroff2009-22"><span class="cite-bracket">[</span>22<span class="cite-bracket">]</span></a></sup> Its use in epilepsy is as an add-on therapy for <a href="Partial_seizure" class="mw-redirect" title="Partial seizure">partial seizures</a>.<sup id="cite_ref-AHFS2019_13-2" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup> When used before surgery, it reduces pain but results in greater sedation and visual disturbances.<sup id="cite_ref-pmid25209095_23-0" class="reference"><a href="#cite_note-pmid25209095-23"><span class="cite-bracket">[</span>23<span class="cite-bracket">]</span></a></sup> It is taken <a href="Oral_administration" title="Oral administration">by mouth</a>.<sup id="cite_ref-AHFS2019_13-3" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup>
</p><p>Common side effects can include <a href="Headache" title="Headache">headache</a>, <a href="Dizziness" title="Dizziness">dizziness</a>, <a href="Somnolence" title="Somnolence">sleepiness</a>, <a href="Euphoria" title="Euphoria">euphoria</a>, <a href="Confusion" title="Confusion">confusion</a>, trouble with memory, <a href="Ataxia" title="Ataxia">poor coordination</a>, <a href="Dry_mouth" class="mw-redirect" title="Dry mouth">dry mouth</a>, problems with vision, and <a href="Weight_gain" title="Weight gain">weight gain</a>.<sup id="cite_ref-AHFS2019_13-4" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BNF76_24-0" class="reference"><a href="#cite_note-BNF76-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup> Serious side effects may include <a href="Angioedema" title="Angioedema">angioedema</a> and kidney damage.<sup id="cite_ref-AHFS2019_13-5" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup> As with all other drugs approved by the FDA for treating epilepsy, the pregabalin labeling warns of an increased <a href="Suicide" title="Suicide">suicide</a> risk when combined with other drugs.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span class="cite-bracket">[</span>25<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AHFS2019_13-6" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup> When pregabalin is taken at high doses over a long period of time, addiction may occur, but if taken at <a href="Therapeutic_dose" class="mw-redirect" title="Therapeutic dose">usual doses</a> the risk is low.<sup id="cite_ref-Sch2014_4-3" class="reference"><a href="#cite_note-Sch2014-4"><span class="cite-bracket">[</span>4<span class="cite-bracket">]</span></a></sup> Use during pregnancy or breastfeeding is of unclear safety.<sup id="cite_ref-Preg2019_26-0" class="reference"><a href="#cite_note-Preg2019-26"><span class="cite-bracket">[</span>26<span class="cite-bracket">]</span></a></sup>
</p><p>It is a <a href="Gabapentinoid" title="Gabapentinoid">gabapentinoid</a> medication which is a class of drugs within the <a href="Chemical_derivative" class="mw-redirect" title="Chemical derivative">derivatives</a> of <a href="%CE%93-aminobutyric_acid" class="mw-redirect" title="Γ-aminobutyric acid">γ-aminobutyric acid</a> (<a href="GABA_analogue" title="GABA analogue">GABA analogues</a>), an <a href="Inhibitory_neurotransmitter" class="mw-redirect" title="Inhibitory neurotransmitter">inhibitory neurotransmitter</a>.<sup id="cite_ref-pmid27345098_27-0" class="reference"><a href="#cite_note-pmid27345098-27"><span class="cite-bracket">[</span>27<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17222465_28-0" class="reference"><a href="#cite_note-pmid17222465-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-WyllieCascino2012_29-0" class="reference"><a href="#cite_note-WyllieCascino2012-29"><span class="cite-bracket">[</span>29<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BenzonRathmell2013_30-0" class="reference"><a href="#cite_note-BenzonRathmell2013-30"><span class="cite-bracket">[</span>30<span class="cite-bracket">]</span></a></sup> Although pregabalin is inactive at <a href="GABA_receptor" title="GABA receptor">GABA receptors</a> and GABA <a href="Synapse" title="Synapse">synapses</a>, it acts by binding specifically to the α<sub>2</sub>δ-1 protein that was first described as an auxiliary subunit of <a href="Voltage-gated_calcium_channel" title="Voltage-gated calcium channel">voltage-gated</a> <a href="Calcium_channel" title="Calcium channel">calcium channels</a>.<sup id="cite_ref-AHFS2019_13-7" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Cal2016_31-0" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Uch2010_32-0" class="reference"><a href="#cite_note-Uch2010-32"><span class="cite-bracket">[</span>32<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin was approved for medical use in the United States in 2004.<sup id="cite_ref-AHFS2019_13-8" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup> In the US, pregabalin is a <a href="Controlled_Substances_Act#Schedule_V_drugs" title="Controlled Substances Act">Schedule V</a> controlled substance under the <a href="Controlled_Substances_Act_of_1970" class="mw-redirect" title="Controlled Substances Act of 1970">Controlled Substances Act of 1970</a>,<sup id="cite_ref-AHFS2019_13-9" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup> which means that the drug has low abuse potential compared to substances in Schedules I-IV, however, there is still a potential for misuse.<sup id="cite_ref-Is_Lyrica_a_Controlled_Substance-16_April_2024_33-0" class="reference"><a href="#cite_note-Is_Lyrica_a_Controlled_Substance-16_April_2024-33"><span class="cite-bracket">[</span>33<span class="cite-bracket">]</span></a></sup> It is available as a <a href="Generic_medication" class="mw-redirect" title="Generic medication">generic medication</a>.<sup id="cite_ref-BNF76_24-1" class="reference"><a href="#cite_note-BNF76-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Generic_Lyrica_Availability_34-0" class="reference"><a href="#cite_note-Generic_Lyrica_Availability-34"><span class="cite-bracket">[</span>34<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-FDA_approves_first_generics_of_Lyrica-2019_35-0" class="reference"><a href="#cite_note-FDA_approves_first_generics_of_Lyrica-2019-35"><span class="cite-bracket">[</span>35<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-USFDA-approval_36-0" class="reference"><a href="#cite_note-USFDA-approval-36"><span class="cite-bracket">[</span>36<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-USFDA-2023_37-0" class="reference"><a href="#cite_note-USFDA-2023-37"><span class="cite-bracket">[</span>37<span class="cite-bracket">]</span></a></sup> In 2022, it was the 91st most commonly prescribed medication in the United States, with more than 7<span class="nowrap">&nbsp;</span>million prescriptions.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span class="cite-bracket">[</span>38<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span class="cite-bracket">[</span>39<span class="cite-bracket">]</span></a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">
/* start https://en.wikipedia.org/ */


.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}


/* end https://en.wikipedia.org/ */
</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>
<div class="mw-heading mw-heading2"><h2 id="Medical_uses">Medical uses</h2></div>

<div class="mw-heading mw-heading3"><h3 id="Seizures">Seizures</h3></div>
<p>For drug-resistant focal epilepsy, pregabalin is useful as an add-on therapy to other treatments.<sup id="cite_ref-pmid35349176_40-0" class="reference"><a href="#cite_note-pmid35349176-40"><span class="cite-bracket">[</span>40<span class="cite-bracket">]</span></a></sup> Its use alone is less effective than some other seizure medications.<sup id="cite_ref-pmid23076957_41-0" class="reference"><a href="#cite_note-pmid23076957-41"><span class="cite-bracket">[</span>41<span class="cite-bracket">]</span></a></sup> It is unclear how it compares to <a href="Gabapentin" title="Gabapentin">gabapentin</a> for this use.<sup id="cite_ref-pmid23076957_41-1" class="reference"><a href="#cite_note-pmid23076957-41"><span class="cite-bracket">[</span>41<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Neuropathic_pain">Neuropathic pain</h3></div>
<p>The European Federation of Neurological Societies recommends pregabalin as a first-line agent for the treatment of pain associated with <a href="Diabetic_neuropathy" title="Diabetic neuropathy">diabetic neuropathy</a>, <a href="Post-herpetic_neuralgia" class="mw-redirect" title="Post-herpetic neuralgia">post-herpetic neuralgia</a>, and <a href="Central_neuropathic_pain" class="mw-redirect" title="Central neuropathic pain">central neuropathic pain</a>.<sup id="cite_ref-pmid20402746_42-0" class="reference"><a href="#cite_note-pmid20402746-42"><span class="cite-bracket">[</span>42<span class="cite-bracket">]</span></a></sup> A minority obtain substantial benefit, and a larger number obtain moderate benefit.<sup id="cite_ref-Derry_2019_43-0" class="reference"><a href="#cite_note-Derry_2019-43"><span class="cite-bracket">[</span>43<span class="cite-bracket">]</span></a></sup> It is given equal weight as <a href="Gabapentin" title="Gabapentin">gabapentin</a> and <a href="Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a> as a first-line agent, however, the latter are less expensive as of 2010.<sup id="cite_ref-pmid20705215_44-0" class="reference"><a href="#cite_note-pmid20705215-44"><span class="cite-bracket">[</span>44<span class="cite-bracket">]</span></a></sup> Pregabalin is as effective at relieving pain as <a href="Duloxetine" title="Duloxetine">duloxetine</a> and <a href="Amitriptyline" title="Amitriptyline">amitriptyline</a>. <a href="Combination_therapy" title="Combination therapy">Combination treatment</a> of pregabalin and amitriptyline or duloxetine offers additional pain relief for people whose pain is not adequately controlled with one medication and is safe.<sup id="cite_ref-NIHR_Evidence-2023_45-0" class="reference"><a href="#cite_note-NIHR_Evidence-2023-45"><span class="cite-bracket">[</span>45<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid36007534_46-0" class="reference"><a href="#cite_note-pmid36007534-46"><span class="cite-bracket">[</span>46<span class="cite-bracket">]</span></a></sup>
</p><p>Studies have shown that higher doses of pregabalin are associated with greater efficacy.<sup id="cite_ref-Freynhagen_Baron_Kawaguchi_Malik_pp._1–9_47-0" class="reference"><a href="#cite_note-Freynhagen_Baron_Kawaguchi_Malik_pp._1–9-47"><span class="cite-bracket">[</span>47<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin's use in cancer-associated neuropathic pain is controversial,<sup id="cite_ref-Bennett_1681–8_48-0" class="reference"><a href="#cite_note-Bennett_1681–8-48"><span class="cite-bracket">[</span>48<span class="cite-bracket">]</span></a></sup> though such use is common.<sup id="cite_ref-Howard-2017_49-0" class="reference"><a href="#cite_note-Howard-2017-49"><span class="cite-bracket">[</span>49<span class="cite-bracket">]</span></a></sup> It has been examined for the prevention of post-surgical chronic pain, but its utility for this purpose is controversial.<sup id="cite_ref-pmid22415535_50-0" class="reference"><a href="#cite_note-pmid22415535-50"><span class="cite-bracket">[</span>50<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid23881791_51-0" class="reference"><a href="#cite_note-pmid23881791-51"><span class="cite-bracket">[</span>51<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin is generally not regarded as efficacious in the treatment of acute pain.<sup id="cite_ref-Derry_2019_43-1" class="reference"><a href="#cite_note-Derry_2019-43"><span class="cite-bracket">[</span>43<span class="cite-bracket">]</span></a></sup> In trials examining the utility of pregabalin for the treatment of acute post-surgical pain, no effect on overall pain levels was observed, but people did require less morphine and had fewer opioid-related side effects.<sup id="cite_ref-pmid22415535_50-1" class="reference"><a href="#cite_note-pmid22415535-50"><span class="cite-bracket">[</span>50<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid27535436_52-0" class="reference"><a href="#cite_note-pmid27535436-52"><span class="cite-bracket">[</span>52<span class="cite-bracket">]</span></a></sup> Several possible mechanisms for pain improvement have been discussed.<sup id="cite_ref-pmid27069626_53-0" class="reference"><a href="#cite_note-pmid27069626-53"><span class="cite-bracket">[</span>53<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Anxiety_disorders">Anxiety disorders</h3></div>
<p>Pregabalin is effective for treatment of <a href="Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a>.<sup id="cite_ref-pmid30712879_54-0" class="reference"><a href="#cite_note-pmid30712879-54"><span class="cite-bracket">[</span>54<span class="cite-bracket">]</span></a></sup> It is also effective for the short- and long-term treatment of <a href="Social_anxiety_disorder" title="Social anxiety disorder">social anxiety disorder</a> and in reducing <a href="Preoperational_anxiety" title="Preoperational anxiety">preoperative anxiety</a>.<sup id="cite_ref-NIHR_Evidence-2022_55-0" class="reference"><a href="#cite_note-NIHR_Evidence-2022-55"><span class="cite-bracket">[</span>55<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Hong_2022_56-0" class="reference"><a href="#cite_note-Hong_2022-56"><span class="cite-bracket">[</span>56<span class="cite-bracket">]</span></a></sup> However, there is concern regarding pregabalin's off-label use due to the lack of strong scientific evidence for its efficacy in multiple conditions and its proven side effects.<sup id="cite_ref-pmid34819636_57-0" class="reference"><a href="#cite_note-pmid34819636-57"><span class="cite-bracket">[</span>57<span class="cite-bracket">]</span></a></sup>
</p><p>The World Federation of Biological Psychiatry recommends pregabalin as one of several first line agents for the treatment of generalized anxiety disorder, but recommends other agents such as those of the <a href="Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) class as first line treatment for <a href="Obsessive%E2%80%93compulsive_disorder" title="Obsessive–compulsive disorder">obsessive–compulsive disorder</a> (OCD) and <a href="Post-traumatic_stress_disorder" title="Post-traumatic stress disorder">post-traumatic stress disorder</a> (PTSD).<sup id="cite_ref-pmid22540422_58-0" class="reference"><a href="#cite_note-pmid22540422-58"><span class="cite-bracket">[</span>58<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid22395254_59-0" class="reference"><a href="#cite_note-pmid22395254-59"><span class="cite-bracket">[</span>59<span class="cite-bracket">]</span></a></sup> For PTSD, pregabalin as complementary treatment seems to be effective.<sup id="cite_ref-Hong_2022_56-1" class="reference"><a href="#cite_note-Hong_2022-56"><span class="cite-bracket">[</span>56<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading4"><h4 id="Generalized_anxiety_disorder">Generalized anxiety disorder</h4></div>
<p>Pregabalin has <a href="Anxiolytic" title="Anxiolytic">anxiolytic</a> effects similar to <a href="Benzodiazepines" class="mw-redirect" title="Benzodiazepines">benzodiazepines</a> with less risk of <a href="Substance_dependence" title="Substance dependence">dependence</a>.<sup id="cite_ref-pmid17940637_60-0" class="reference"><a href="#cite_note-pmid17940637-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup> The effects of pregabalin appear within one week of use,<sup id="cite_ref-Drugs.com-2021_61-0" class="reference"><a href="#cite_note-Drugs.com-2021-61"><span class="cite-bracket">[</span>61<span class="cite-bracket">]</span></a></sup> and are similar in effectiveness to <a href="Lorazepam" title="Lorazepam">lorazepam</a>, <a href="Alprazolam" title="Alprazolam">alprazolam</a>, and <a href="Bromazepam" title="Bromazepam">bromazepam</a>, but pregabalin has demonstrated superiority by producing more consistent therapeutic effects for <a href="Psychosomatic_medicine" title="Psychosomatic medicine">psychosomatic</a> anxiety symptoms.<sup id="cite_ref-pmid17610384_62-0" class="reference"><a href="#cite_note-pmid17610384-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> Long-term trials have shown continued effectiveness without the development of <a href="Drug_tolerance" title="Drug tolerance">tolerance</a>, and, in addition, unlike benzodiazepines, it has a beneficial effect on sleep and <a href="Sleep_architecture" class="mw-redirect" title="Sleep architecture">sleep architecture</a>, characterized by the enhancement of <a href="Slow-wave_sleep" title="Slow-wave sleep">slow-wave sleep</a>.<sup id="cite_ref-pmid17610384_62-1" class="reference"><a href="#cite_note-pmid17610384-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup> It produces less severe cognitive and psychomotor impairment compared to benzodiazepines.<sup id="cite_ref-pmid17610384_62-2" class="reference"><a href="#cite_note-pmid17610384-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17940637_60-1" class="reference"><a href="#cite_note-pmid17940637-60"><span class="cite-bracket">[</span>60<span class="cite-bracket">]</span></a></sup>
</p><p>A 2019 review found that pregabalin reduces symptoms, and was generally well tolerated.<sup id="cite_ref-pmid30712879_54-1" class="reference"><a href="#cite_note-pmid30712879-54"><span class="cite-bracket">[</span>54<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Other_uses">Other uses</h3></div>
<p>Although pregabalin is sometimes prescribed for people with <a href="Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, there is no evidence showing that it is effective.<sup id="cite_ref-Hong_2022_56-2" class="reference"><a href="#cite_note-Hong_2022-56"><span class="cite-bracket">[</span>56<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid34577534_63-0" class="reference"><a href="#cite_note-pmid34577534-63"><span class="cite-bracket">[</span>63<span class="cite-bracket">]</span></a></sup>
</p><p>There is no evidence and significant risk in using pregabalin for <a href="Sciatica" title="Sciatica">sciatica</a> and <a href="Low_back_pain" title="Low back pain">low back pain</a>.<sup id="cite_ref-pmid34637958_64-0" class="reference"><a href="#cite_note-pmid34637958-64"><span class="cite-bracket">[</span>64<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid28809936_65-0" class="reference"><a href="#cite_note-pmid28809936-65"><span class="cite-bracket">[</span>65<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Mannix-2018_66-0" class="reference"><a href="#cite_note-Mannix-2018-66"><span class="cite-bracket">[</span>66<span class="cite-bracket">]</span></a></sup> Evidence of benefit in <a href="Alcohol_withdrawal" class="mw-redirect" title="Alcohol withdrawal">alcohol withdrawal</a> as well as withdrawal from certain other drugs is limited as of 2016.<sup id="cite_ref-pmid27848217_67-0" class="reference"><a href="#cite_note-pmid27848217-67"><span class="cite-bracket">[</span>67<span class="cite-bracket">]</span></a></sup>
</p><p>There is no evidence for its use in the prevention of <a href="Migraine" title="Migraine">migraines</a> and gabapentin has also been found not to be useful.<sup id="cite_ref-pmid23797675_68-0" class="reference"><a href="#cite_note-pmid23797675-68"><span class="cite-bracket">[</span>68<span class="cite-bracket">]</span></a></sup>
</p><p>A 2025 review found possible benefits to sleep quality in patients with <a href="Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span class="cite-bracket">[</span>69<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Adverse_effects">Adverse effects</h2></div>
<p>Exposure to pregabalin is associated with weight gain, drowsiness, fatigue, dizziness, vertigo, leg swelling, disturbed vision, loss of coordination, and euphoria.<sup id="cite_ref-pmid30670513_70-0" class="reference"><a href="#cite_note-pmid30670513-70"><span class="cite-bracket">[</span>70<span class="cite-bracket">]</span></a></sup> It has an <a href="Adverse_effect" title="Adverse effect">adverse effect</a> profile similar to other <a href="Central_nervous_system" title="Central nervous system">central nervous system</a> (CNS) <a href="Central_nervous_system_depressant" class="mw-redirect" title="Central nervous system depressant">depressants</a>.<sup id="cite_ref-Federal_Register-2005_71-0" class="reference"><a href="#cite_note-Federal_Register-2005-71"><span class="cite-bracket">[</span>71<span class="cite-bracket">]</span></a></sup> Even though pregabalin is a <a href="Depressant" title="Depressant">depressant</a> and <a href="Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>, it can sometimes paradoxically induce <a href="Seizure" title="Seizure">seizures</a>, particularly in large <a href="Drug_overdose" title="Drug overdose">overdoses</a>.<sup id="cite_ref-Slocum-2018_72-0" class="reference"><a href="#cite_note-Slocum-2018-72"><span class="cite-bracket">[</span>72<span class="cite-bracket">]</span></a></sup> <a href="Adverse_drug_reaction" title="Adverse drug reaction">Adverse drug reactions</a> associated with the use of pregabalin include:<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span class="cite-bracket">[</span>73<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Pfizer_Australia_Pty_Ltd.-2006_74-0" class="reference"><a href="#cite_note-Pfizer_Australia_Pty_Ltd.-2006-74"><span class="cite-bracket">[</span>74<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AMH2006_75-0" class="reference"><a href="#cite_note-AMH2006-75"><span class="cite-bracket">[</span>75<span class="cite-bracket">]</span></a></sup>
</p>
<ul><li>Very common (&gt;10% of people with pregabalin): <a href="Dizziness" title="Dizziness">dizziness</a>, <a href="Drowsiness" class="mw-redirect" title="Drowsiness">drowsiness</a>.</li>
<li>Common (1–10% of people with pregabalin): peripheral <a href="Edema" title="Edema">edema</a>, <a href="Blurred_vision" title="Blurred vision">blurred vision</a>, <a href="Diplopia" title="Diplopia">diplopia</a>, <a href="Increased_appetite" class="mw-redirect" title="Increased appetite">increased appetite</a> and subsequent <a href="Weight_gain" title="Weight gain">weight gain</a>, <a href="Euphoria_(emotion)" class="mw-redirect" title="Euphoria (emotion)">euphoria</a>, <a href="Confusion" title="Confusion">confusion</a>, vivid <a href="Dream" title="Dream">dreams</a>, changes in libido (increase or decrease), <a href="Irritability" title="Irritability">irritability</a>, <a href="Ataxia" title="Ataxia">ataxia</a>, attention changes, <a href="Substance_intoxication" title="Substance intoxication">feeling high</a>, memory impairment, <a href="Tremor" title="Tremor">tremor</a>, <a href="Dysarthria" title="Dysarthria">dysarthria</a>, <a href="Paresthesia" title="Paresthesia">paresthesia</a>, <a href="Vertigo" title="Vertigo">vertigo</a>, <a href="Dry_mouth" class="mw-redirect" title="Dry mouth">dry mouth</a>, <a href="Constipation" title="Constipation">constipation</a>, <a href="Nausea" title="Nausea">nausea</a>, <a href="Vomiting" title="Vomiting">vomiting</a>, <a href="Flatulence" title="Flatulence">flatulence</a>, <a href="Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>, <a href="Fatigue" title="Fatigue">fatigue</a>, feelings of <a href="Drunkenness" class="mw-redirect" title="Drunkenness">drunkenness</a>, abnormal walking, <a href="Asthenia" class="mw-redirect" title="Asthenia">asthenia</a>, <a href="Nasopharyngitis" class="mw-redirect" title="Nasopharyngitis">nasopharyngitis</a>, increased <a href="Creatine_kinase" title="Creatine kinase">creatine kinase</a> level.</li>
<li>Infrequent (0.1–1% of people with pregabalin): <a href="Depression_(mood)" title="Depression (mood)">depression</a>, <a href="Lethargy" title="Lethargy">lethargy</a>, <a href="Agitation_(dementia)" title="Agitation (dementia)">agitation</a>, <a href="Anorgasmia" title="Anorgasmia">anorgasmia</a>, <a href="Hallucination" title="Hallucination">hallucinations</a>, <a href="Myoclonus" title="Myoclonus">myoclonus</a>, <a href="Hypoaesthesia" class="mw-redirect" title="Hypoaesthesia">hypoaesthesia</a>, <a href="Hyperaesthesia" class="mw-redirect" title="Hyperaesthesia">hyperaesthesia</a>, <a href="Tachycardia" title="Tachycardia">tachycardia</a>, <a href="Hypersalivation" title="Hypersalivation">hypersalivation</a>, <a href="Hypoglycaemia" class="mw-redirect" title="Hypoglycaemia">hypoglycaemia</a>, <a href="Excessive_sweating" class="mw-redirect" title="Excessive sweating">excessive sweating</a>, <a href="Flushing_(physiology)" title="Flushing (physiology)">flushing</a>, <a href="Rash" title="Rash">rash</a>, <a href="Muscle_cramp" class="mw-redirect" title="Muscle cramp">muscle cramp</a>, <a href="Myalgia" title="Myalgia">myalgia</a>, <a href="Arthralgia" title="Arthralgia">arthralgia</a>, <a href="Urinary_incontinence" title="Urinary incontinence">urinary incontinence</a>, <a href="Dysuria" title="Dysuria">dysuria</a>, <a href="Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a>, <a href="Kidney_calculus" class="mw-redirect" title="Kidney calculus">kidney calculus</a>.</li>
<li>Rare (&lt;0.1% of people with pregabalin): <a href="Neutropenia" title="Neutropenia">neutropenia</a>, first-degree <a href="Heart_block" title="Heart block">heart block</a>, <a href="Hypotension" title="Hypotension">hypotension</a>, <a href="Hypertension" title="Hypertension">hypertension</a>, <a href="Pancreatitis" title="Pancreatitis">pancreatitis</a>, <a href="Dysphagia" title="Dysphagia">dysphagia</a>, <a href="Oliguria" title="Oliguria">oliguria</a>, <a href="Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a>, <a href="Suicidal_ideation" title="Suicidal ideation">suicidal thoughts</a> or behavior.<sup id="cite_ref-USFDA-2011_76-0" class="reference"><a href="#cite_note-USFDA-2011-76"><span class="cite-bracket">[</span>76<span class="cite-bracket">]</span></a></sup></li></ul>
<p>Cases of recreational use, with associated adverse effects, have been reported.<sup id="cite_ref-Millar-2013_77-0" class="reference"><a href="#cite_note-Millar-2013-77"><span class="cite-bracket">[</span>77<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Withdrawal_symptoms">Withdrawal symptoms</h3></div>
<p>Following abrupt or rapid discontinuation of pregabalin, some people reported symptoms suggestive of <a href="Physical_dependence" title="Physical dependence">physical dependence</a>. The FDA determined that the <a href="Substance_dependence" title="Substance dependence">substance dependence</a> profile of pregabalin, as measured by a personal <a href="Drug_withdrawal" title="Drug withdrawal">physical withdrawal</a> checklist, was quantitatively less than <a href="Benzodiazepines" class="mw-redirect" title="Benzodiazepines">benzodiazepines</a>.<sup id="cite_ref-Federal_Register-2005_71-1" class="reference"><a href="#cite_note-Federal_Register-2005-71"><span class="cite-bracket">[</span>71<span class="cite-bracket">]</span></a></sup>
Even people who have discontinued short-term use of pregabalin have experienced <a href="Withdrawal_symptoms" class="mw-redirect" title="Withdrawal symptoms">withdrawal symptoms</a> including <a href="Insomnia" title="Insomnia">insomnia</a>, <a href="Headache" title="Headache">headache</a>, <a href="Heart_palpitations" class="mw-redirect" title="Heart palpitations">heart palpitations</a>, <a href="Nausea" title="Nausea">nausea</a>, <a href="Anxiety" title="Anxiety">anxiety</a>, <a href="Diarrhea" title="Diarrhea">diarrhea</a>, <a href="Flu_like_symptoms" class="mw-redirect" title="Flu like symptoms">flu-like symptoms</a>, <a href="Major_depression" class="mw-redirect" title="Major depression">major depression</a>, <a href="Pain" title="Pain">pain</a>, <a href="Seizure" title="Seizure">seizures</a>, <a href="Hyperhidrosis" title="Hyperhidrosis">excessive sweating</a>, <a href="Muscle_twitching" class="mw-redirect" title="Muscle twitching">muscle twitching</a>, and <a href="Dizziness" title="Dizziness">dizziness</a>.<sup id="cite_ref-medicines.org.uk-2020_78-0" class="reference"><a href="#cite_note-medicines.org.uk-2020-78"><span class="cite-bracket">[</span>78<span class="cite-bracket">]</span></a></sup>
</p><p>A tapered discontinuation is recommended to reduce the chances of withdrawal symptoms. Lyrica's US package insert recommends a taper period of at least one week.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span class="cite-bracket">[</span>79<span class="cite-bracket">]</span></a></sup> Best Practice Advocacy Centre New Zealand<sup id="cite_ref-80" class="reference"><a href="#cite_note-80"><span class="cite-bracket">[</span>80<span class="cite-bracket">]</span></a></sup> and NHS Somerset<sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span class="cite-bracket">[</span>81<span class="cite-bracket">]</span></a></sup> recommend a much slower withdrawal.
</p>
<div class="mw-heading mw-heading3"><h3 id="Pregnancy">Pregnancy</h3></div>
<p>It is unclear if it is safe for use in pregnancy with some studies showing potential harm.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82"><span class="cite-bracket">[</span>82<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Breathing">Breathing</h3></div>
<p>In December 2019, the US <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) warned about serious breathing issues for those taking <a href="Gabapentin" title="Gabapentin">gabapentin</a> or pregabalin when used with <a href="Central_nervous_system" title="Central nervous system">central nervous system</a> (CNS) <a href="Central_nervous_system_depressant" class="mw-redirect" title="Central nervous system depressant">depressants</a> or for those with lung problems.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-0" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems-PDF_84-0" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-PDF-84"><span class="cite-bracket">[</span>84<span class="cite-bracket">]</span></a></sup>
</p><p>The FDA required new warnings about the risk of respiratory depression to be added to the prescribing information of the gabapentinoids.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-1" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup> The FDA also required the drug manufacturers to conduct clinical trials to further evaluate their abuse potential, particularly in combination with opioids, because misuse and abuse of these products together is increasing, and co-use may increase the risk of respiratory depression.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-2" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup>
</p><p>Among 49 case reports submitted to the FDA over the five-year period from 2012 to 2017, twelve people died from <a href="Respiratory_depression" class="mw-redirect" title="Respiratory depression">respiratory depression</a> with gabapentinoids, all of whom had at least one risk factor.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-3" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup>
</p><p>The FDA reviewed the results of two randomized, double-blind, placebo-controlled clinical trials in healthy people, three observational studies, and several studies in animals.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-4" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup> One trial showed that using pregabalin alone and using it with an opioid pain reliever can depress breathing function.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-5" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup> The other trial showed gabapentin alone increased pauses in breathing during sleep.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-6" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup> The three observational studies at one academic medical center showed a relationship between gabapentinoids given before surgery and respiratory depression occurring after different kinds of surgeries.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-7" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup> The FDA also reviewed several animal studies that showed pregabalin alone and pregabalin plus opioids can depress respiratory function.<sup id="cite_ref-USFDA-2019-Serious-Breathing-Problems_83-8" class="reference"><a href="#cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="cite-bracket">[</span>83<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Abuse_potential">Abuse potential</h3></div>
<p>Pregabalin has potential for recreational use and abuse. It possesses a relatively wide <a href="Therapeutic_index" title="Therapeutic index">therapeutic index</a> and margin of safety compared to other central nervous system (CNS) depressants, and its effects may include <a href="Euphoria" title="Euphoria">euphoria</a>, <a href="Anxiolysis" class="mw-redirect" title="Anxiolysis">anxiolysis</a>, and <a href="Sedation" title="Sedation">sedation</a>.
</p><p>Although generally considered to have low abuse potential, reports describe pregabalin inducing sensations of euphoria, calmness, excitement, and a "high" comparable to that of <a href="Cannabis_(drug)" title="Cannabis (drug)">cannabis</a>. These effects may contribute to the development of <a href="Substance_dependence" title="Substance dependence">substance dependence</a>, and <a href="Drug_withdrawal" title="Drug withdrawal">withdrawal</a> symptoms can occur if the medication is stopped abruptly.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span class="cite-bracket">[</span>85<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid30726003_86-0" class="reference"><a href="#cite_note-pmid30726003-86"><span class="cite-bracket">[</span>86<span class="cite-bracket">]</span></a></sup>
</p><p>While pregabalin and cannabis share certain effects, such as CNS depressant and <a href="Orexigenic" class="mw-redirect" title="Orexigenic">orexigenic</a> (appetite-stimulating) properties, they differ significantly in their <a href="Pharmacodynamics" title="Pharmacodynamics">pharmacodynamics</a>. Cannabis is primarily an <a href="Anxiogenic" title="Anxiogenic">anxiogenic</a> substance with mild <a href="Psychedelic_drug" title="Psychedelic drug">psychedelic</a> effects, whereas pregabalin is an <a href="Anxiolytic" title="Anxiolytic">anxiolytic</a> agent associated with mild euphoria.<sup id="cite_ref-pmid33008420_87-0" class="reference"><a href="#cite_note-pmid33008420-87"><span class="cite-bracket">[</span>87<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26767525_88-0" class="reference"><a href="#cite_note-pmid26767525-88"><span class="cite-bracket">[</span>88<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Overdose">Overdose</h2></div>
<p>An <a href="Drug_overdose" title="Drug overdose">overdose</a> of pregabalin usually consists of severe <a href="Drowsiness" class="mw-redirect" title="Drowsiness">drowsiness</a>, severe <a href="Ataxia" title="Ataxia">ataxia</a>, <a href="Blurred_vision" title="Blurred vision">blurred vision</a>, <a href="Dysarthria" title="Dysarthria">slurred speech</a>, uncontrollable jerking motions (<a href="Myoclonus" title="Myoclonus">myoclonus</a>), and anxiety.<sup id="cite_ref-pmid30381161_89-0" class="reference"><a href="#cite_note-pmid30381161-89"><span class="cite-bracket">[</span>89<span class="cite-bracket">]</span></a></sup> In one case study, <a href="Macula" title="Macula">macular</a> detachment was reported with overdose<sup id="cite_ref-pmid30405948_90-0" class="reference"><a href="#cite_note-pmid30405948-90"><span class="cite-bracket">[</span>90<span class="cite-bracket">]</span></a></sup> Despite these symptoms an overdose is not usually fatal unless mixed with another CNS <a href="Central_nervous_system_depressant" class="mw-redirect" title="Central nervous system depressant">depressant</a>. Several people with <a href="Kidney_failure" title="Kidney failure">kidney failure</a> developed <a href="Myoclonus" title="Myoclonus">myoclonus</a> while receiving pregabalin, apparently as a result of the gradual accumulation of the drug. Acute overdosage may be manifested by <a href="Somnolence" title="Somnolence">drowsiness</a>, <a href="Tachycardia" title="Tachycardia">tachycardia</a>, and <a href="Hypertonia" title="Hypertonia">hypertonia</a>. Plasma, serum, or blood concentrations of pregabalin may be measured to monitor therapy or to confirm a diagnosis of poisoning in hospitalized people.<sup id="cite_ref-Murphy-2008_91-0" class="reference"><a href="#cite_note-Murphy-2008-91"><span class="cite-bracket">[</span>91<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19493601_92-0" class="reference"><a href="#cite_note-pmid19493601-92"><span class="cite-bracket">[</span>92<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Baselt-2008_93-0" class="reference"><a href="#cite_note-Baselt-2008-93"><span class="cite-bracket">[</span>93<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Interactions">Interactions</h2></div>
<p>No drug interactions have been demonstrated <i><a href="In_vivo" title="In vivo">in vivo</a></i>. However, the manufacturer notes potential pharmacological interactions with <a href="Opioid" title="Opioid">opioids</a>, <a href="Benzodiazepine" title="Benzodiazepine">benzodiazepines</a>, <a href="Barbiturate" title="Barbiturate">barbiturates</a>, <a href="Ethanol" title="Ethanol">ethanol</a> (<a href="Alcohol_(drug)" title="Alcohol (drug)">alcohol</a>), and other central nervous system depressants. Concurrent use of <a href="ACE_inhibitor" title="ACE inhibitor">ACE inhibitors</a> and pregabalin may increase the risk of <a href="Angioedema" title="Angioedema">angioedema</a>. Pregabalin may also enhance the fluid-retaining effects of certain antidiabetic agents, such as <a href="Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>.<sup id="cite_ref-Lexi-Drugs_[database_on_the_Internet-2007_94-0" class="reference"><a href="#cite_note-Lexi-Drugs_[database_on_the_Internet-2007-94"><span class="cite-bracket">[</span>94<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin may independently increase the risk of <a href="Angioedema" title="Angioedema">angioedema</a>, and this risk is further elevated when used in combination with other drugs known to increase the likelihood of angioedema. These include, but are not limited to, certain <a href="Calcium_channel_blocker" title="Calcium channel blocker">L-type calcium channel blockers</a>, ACE inhibitors, <a href="Angiotensin_II_receptor_blocker" title="Angiotensin II receptor blocker">angiotensin II receptor blockers</a>, and other agents that inhibit the <a href="Renin%E2%80%93angiotensin_system" title="Renin–angiotensin system">renin–angiotensin–aldosterone system</a>.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95"><span class="cite-bracket">[</span>95<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin can also cause rare but serious adverse effects,<sup id="cite_ref-pmid38635889_96-0" class="reference"><a href="#cite_note-pmid38635889-96"><span class="cite-bracket">[</span>96<span class="cite-bracket">]</span></a></sup> particularly when used in combination with other <a href="Central_nervous_system" title="Central nervous system">CNS</a> <a href="Depressant" title="Depressant">depressants</a>.<sup id="cite_ref-circular-0192018_97-0" class="reference"><a href="#cite_note-circular-0192018-97"><span class="cite-bracket">[</span>97<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span class="cite-bracket">[</span>98<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Pharmacology">Pharmacology</h2></div>
<div class="mw-heading mw-heading3"><h3 id="Mechanism_of_action">Mechanism of action</h3></div>
<style data-mw-deduplicate="TemplateStyles:r1236090951">
/* start https://en.wikipedia.org/ */


.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}


/* end https://en.wikipedia.org/ */
</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="Gabapentinoid" title="Gabapentinoid">Gabapentinoid</a></div>
<p>Pregabalin is a member of the <a href="Gabapentinoid" title="Gabapentinoid">gabapentinoid</a> <a href="Drug_class" title="Drug class">class</a>, also known as α<sub>2</sub>δ ligands. Despite being a <a href="Structural_analog" title="Structural analog">structural analog</a> of <a href="%CE%93-aminobutyric_acid" class="mw-redirect" title="Γ-aminobutyric acid">γ-aminobutyric acid</a> (GABA), pregabalin is inactive at <a href="GABA_receptor" title="GABA receptor">GABA receptors</a> and does not mimic GABA.<sup id="cite_ref-pmid27345098_27-1" class="reference"><a href="#cite_note-pmid27345098-27"><span class="cite-bracket">[</span>27<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17222465_28-1" class="reference"><a href="#cite_note-pmid17222465-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-WyllieCascino2012_29-1" class="reference"><a href="#cite_note-WyllieCascino2012-29"><span class="cite-bracket">[</span>29<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BenzonRathmell2013_30-1" class="reference"><a href="#cite_note-BenzonRathmell2013-30"><span class="cite-bracket">[</span>30<span class="cite-bracket">]</span></a></sup> Instead, its action involves binding to a specific site on the α<sub>2</sub>δ-1 protein and reducing the release of excitatory neurotransmitters in synapses.<sup id="cite_ref-Dooley-2007_99-0" class="reference"><a href="#cite_note-Dooley-2007-99"><span class="cite-bracket">[</span>99<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin does not directly block <a href="Calcium_channel_blocker" title="Calcium channel blocker">calcium channels</a> (it is not a <a href="Calcium_channel_blocker" title="Calcium channel blocker">calcium channel blocker</a>), as it does not bind to the ion conducting channel protein, called α1. However, <i><a href="In_vitro" title="In vitro">in vitro</a></i> studies show that pregabalin can reduce the normal traffic of calcium channels from intracellular sites (where they do not function) to membrane sites where they are functional.<sup id="cite_ref-AHFS2019_13-10" class="reference"><a href="#cite_note-AHFS2019-13"><span class="cite-bracket">[</span>13<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Cal2016_31-1" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup>
</p><p>While the mechanism of action of pregabalin is not definitively characterized, its action in animal models of pain, seizures and anxiety requires binding to the α<sub>2</sub>δ-1 protein.<sup id="cite_ref-Taylor-2020_100-0" class="reference"><a href="#cite_note-Taylor-2020-100"><span class="cite-bracket">[</span>100<span class="cite-bracket">]</span></a></sup> It has been found that this binding inhibits several actions of α2δ-1 and also inhibits the release of <a href="Excitatory_neurotransmitter" class="mw-redirect" title="Excitatory neurotransmitter">excitatory neurotransmitters</a>. These excitatory neurotransmitters include <a href="Glutamate" class="mw-redirect" title="Glutamate">glutamate</a>, <a href="Norepinephrine" title="Norepinephrine">norepinephrine</a> (noradrenaline), <a href="Serotonin" title="Serotonin">serotonin</a>, <a href="Dopamine" title="Dopamine">dopamine</a>, <a href="Substance_P" title="Substance P">substance P</a>, and <a href="Calcitonin_gene-related_peptide" title="Calcitonin gene-related peptide">calcitonin gene-related peptide</a>.<sup id="cite_ref-Dooley-2007_99-1" class="reference"><a href="#cite_note-Dooley-2007-99"><span class="cite-bracket">[</span>99<span class="cite-bracket">]</span></a></sup> By inhibiting the release of these neurotransmitters, pregabalin reduces excess activity of neuron networks, which helps alleviate symptoms and provides relief for patients experiencing pain, seizures, or other related symptoms.<sup id="cite_ref-pmid23009881_101-0" class="reference"><a href="#cite_note-pmid23009881-101"><span class="cite-bracket">[</span>101<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></div>


<p>There are two drug-binding α<sub>2</sub>δ subunits, <a href="CACNA2D1" title="CACNA2D1">α<sub>2</sub>δ-1</a> and <a href="CACNA2D2" title="CACNA2D2">α<sub>2</sub>δ-2</a>, and pregabalin shows similar <a href="Affinity_(pharmacology)" class="mw-redirect" title="Affinity (pharmacology)">affinity</a> for (and hence lack of <a href="Binding_selectivity" title="Binding selectivity">selectivity</a> between) these two sites.<sup id="cite_ref-Cal2016_31-2" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup> Pregabalin is selective in its binding to the α<sub>2</sub>δ VGCC subunits and does not bind significantly to other known drug receptors.<sup id="cite_ref-pmid16376147_102-0" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BenzonRathmell2013_30-2" class="reference"><a href="#cite_note-BenzonRathmell2013-30"><span class="cite-bracket">[</span>30<span class="cite-bracket">]</span></a></sup>
</p><p>Despite the fact that pregabalin is a <a href="GABA_analogue" title="GABA analogue">GABA analogue</a>,<sup id="cite_ref-pmid10189176_103-0" class="reference"><a href="#cite_note-pmid10189176-103"><span class="cite-bracket">[</span>103<span class="cite-bracket">]</span></a></sup> it does not bind to <a href="GABA_receptor" title="GABA receptor">GABA receptors</a>, does not convert into <a href="%CE%93-aminobutyric_acid" class="mw-redirect" title="Γ-aminobutyric acid"><abbr title="γ-aminobutyric acid">GABA</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip γ-aminobutyric acid</span> or another <a href="GABA_receptor_agonist" title="GABA receptor agonist">GABA receptor agonist</a> <i><a href="In_vivo" title="In vivo">in vivo</a></i>, and does not directly modulate GABA <a href="Neurotransmitter_transport" class="mw-redirect" title="Neurotransmitter transport">transport</a> or <a href="Metabolism" title="Metabolism">metabolism</a>.<sup id="cite_ref-Uch2010_32-1" class="reference"><a href="#cite_note-Uch2010-32"><span class="cite-bracket">[</span>32<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid16376147_102-1" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup> There is currently no evidence that the effects of pregabalin are mediated by any mechanism other than binding to the α<sub>2</sub>δ-1 protein.<sup id="cite_ref-pmid16376147_102-2" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid23642658_104-0" class="reference"><a href="#cite_note-pmid23642658-104"><span class="cite-bracket">[</span>104<span class="cite-bracket">]</span></a></sup> In accordance, inhibition of α<sub>2</sub>δ-1 proteins by pregabalin appears to be responsible for its <a href="Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>, <a href="Analgesic" title="Analgesic">analgesic</a>, and <a href="Anxiolytic" title="Anxiolytic">anxiolytic</a> effects in animal models.<sup id="cite_ref-pmid16376147_102-3" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid23642658_104-1" class="reference"><a href="#cite_note-pmid23642658-104"><span class="cite-bracket">[</span>104<span class="cite-bracket">]</span></a></sup>
</p><p>Recently, the α<sub>2</sub>δ-1 protein has been found (independent of calcium channels) to associate directly with certain <a href="NMDA_receptor" title="NMDA receptor">NMDA-type glutamate receptors</a>, some <a href="AMPA_receptor" title="AMPA receptor">AMPA-type glutamate receptors</a> and also with the extracellular matrix protein, <a href="Thrombospondin" title="Thrombospondin">thrombospondin</a>, and to modulate the function of these proteins.<sup id="cite_ref-Taylor-2020_100-1" class="reference"><a href="#cite_note-Taylor-2020-100"><span class="cite-bracket">[</span>100<span class="cite-bracket">]</span></a></sup> This has been proposed to contribute to the analgesic action of pregabalin animal models and in clinical use.
</p><p>The <a href="Endogenous" class="mw-redirect" title="Endogenous">endogenous</a> <a href="%CE%91-amino_acid" class="mw-redirect" title="Α-amino acid">α-amino acids</a> <a href="L-leucine" class="mw-redirect" title="L-leucine"><small>L</small>-leucine</a> and <a href="L-isoleucine" class="mw-redirect" title="L-isoleucine"><small>L</small>-isoleucine</a>, which closely resemble pregabalin and the other gabapentinoids in <a href="Chemical_structure" title="Chemical structure">chemical structure</a>, are apparent ligands of the α<sub>2</sub>δ VGCC subunit with similar affinity as the gabapentinoids (e.g., <a href="IC50" title="IC50">IC<sub>50</sub></a>=71&nbsp;nM for <small>L</small>-isoleucine), and are present in human <a href="Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a> at micromolar concentrations (e.g., 12.9&nbsp;μM for <small>L</small>-leucine, 4.8&nbsp;μM for <small>L</small>-isoleucine).<sup id="cite_ref-pmid17222465_28-2" class="reference"><a href="#cite_note-pmid17222465-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup> It has been theorized that they may be the endogenous ligands of the subunit and that they may <a href="Competitive_inhibition" title="Competitive inhibition">competitively antagonize</a> the effects of gabapentinoids.<sup id="cite_ref-pmid17222465_28-3" class="reference"><a href="#cite_note-pmid17222465-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17403543_105-0" class="reference"><a href="#cite_note-pmid17403543-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup> In accordance, while gabapentinoids like pregabalin and gabapentin have <a href="Nanomolar" class="mw-redirect" title="Nanomolar">nanomolar</a> affinities for the α<sub>2</sub>δ subunit, their potencies <i>in vivo</i> are in the low <a href="Micromolar" class="mw-redirect" title="Micromolar">micromolar</a> range, and competition for binding by endogenous <small>L</small>-amino acids has been said to likely be responsible for this discrepancy.<sup id="cite_ref-pmid23642658_104-2" class="reference"><a href="#cite_note-pmid23642658-104"><span class="cite-bracket">[</span>104<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin was found to possess 6-fold higher affinity than gabapentin for α<sub>2</sub>δ subunit-containing VGCCs in one study.<sup id="cite_ref-pmid21897498_106-0" class="reference"><a href="#cite_note-pmid21897498-106"><span class="cite-bracket">[</span>106<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-McMahon-2013_107-0" class="reference"><a href="#cite_note-McMahon-2013-107"><span class="cite-bracket">[</span>107<span class="cite-bracket">]</span></a></sup> However, another study found that pregabalin and gabapentin had similar affinities for the human recombinant α<sub>2</sub>δ-1 subunit (K<sub>i</sub>=32&nbsp;nM and 40&nbsp;nM, respectively).<sup id="cite_ref-pmid17126531_108-0" class="reference"><a href="#cite_note-pmid17126531-108"><span class="cite-bracket">[</span>108<span class="cite-bracket">]</span></a></sup> In any case, pregabalin is 2 to 4&nbsp;times more potent than gabapentin as an <a href="Analgesic" title="Analgesic">analgesic</a><sup id="cite_ref-pmid10189176_103-1" class="reference"><a href="#cite_note-pmid10189176-103"><span class="cite-bracket">[</span>103<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid12665421_109-0" class="reference"><a href="#cite_note-pmid12665421-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup> and, in animals, appears to be 3 to 10&nbsp;times more potent than gabapentin as an <a href="Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>.<sup id="cite_ref-pmid10189176_103-2" class="reference"><a href="#cite_note-pmid10189176-103"><span class="cite-bracket">[</span>103<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid12665421_109-1" class="reference"><a href="#cite_note-pmid12665421-109"><span class="cite-bracket">[</span>109<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></div>
<div class="mw-heading mw-heading4"><h4 id="Absorption">Absorption</h4></div>
<p>Pregabalin is <a href="Absorption_(pharmacokinetics)" class="mw-redirect" title="Absorption (pharmacokinetics)">absorbed</a> from the <a href="Intestine" class="mw-redirect" title="Intestine">intestines</a> by an <a href="Active_transport" title="Active transport">active transport</a> process mediated via the <a href="Large_neutral_amino_acid_transporter_1" class="mw-redirect" title="Large neutral amino acid transporter 1">large neutral amino acid transporter 1</a> (LAT1, SLC7A5), a transporter for <a href="Amino_acid" title="Amino acid">amino acids</a> such as <a href="L-leucine" class="mw-redirect" title="L-leucine"><small>L</small>-leucine</a> and <a href="L-phenylalanine" class="mw-redirect" title="L-phenylalanine"><small>L</small>-phenylalanine</a>.<sup id="cite_ref-Cal2016_31-3" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid16376147_102-4" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid23567998_110-0" class="reference"><a href="#cite_note-pmid23567998-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup> Very few (less than 10&nbsp;drugs) are known to be transported by this transporter.<sup id="cite_ref-pmid18656534_111-0" class="reference"><a href="#cite_note-pmid18656534-111"><span class="cite-bracket">[</span>111<span class="cite-bracket">]</span></a></sup> Unlike <a href="Gabapentin" title="Gabapentin">gabapentin</a>, which is transported solely by the LAT1,<sup id="cite_ref-pmid23567998_110-1" class="reference"><a href="#cite_note-pmid23567998-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Bock2010_12-1" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> pregabalin seems to be transported not only by the LAT1 but also by other carriers.<sup id="cite_ref-Cal2016_31-4" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup> The LAT1 is easily <a href="Enzyme_kinetics#General_principles" title="Enzyme kinetics">saturable</a>, so the <a href="Pharmacokinetics" title="Pharmacokinetics">pharmacokinetics</a> of gabapentin are dose-dependent, with diminished bioavailability and delayed peak levels at higher doses.<sup id="cite_ref-Cal2016_31-5" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup> In contrast, this is not the case for pregabalin, which shows linear pharmacokinetics and no saturation of absorption.<sup id="cite_ref-Cal2016_31-6" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup>
</p><p>The <a href="Oral_administration" title="Oral administration">oral</a> <a href="Bioavailability" title="Bioavailability">bioavailability</a> of pregabalin is greater than or equal to 90% across and beyond its entire clinical dose range (75 to 600&nbsp;mg/day).<sup id="cite_ref-Bock2010_12-2" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> Food does not significantly influence the oral bioavailability of pregabalin.<sup id="cite_ref-Bock2010_12-3" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> Pregabalin is rapidly absorbed when administered on an empty stomach, with a <a href="Tmax_(pharmacology)" class="mw-redirect" title="Tmax (pharmacology)">T<sub>max</sub></a> (time to <a href="Cmax_(pharmacology)" title="Cmax (pharmacology)">peak levels</a>) of generally less than or equal to 1&nbsp;hour at doses of 300&nbsp;mg or less.<sup id="cite_ref-Cal2016_31-7" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-EMA2013_11-2" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> However, food has been found to substantially delay the absorption of pregabalin and to significantly reduce peak levels without affecting the bioavailability of the drug; T<sub>max</sub> values for pregabalin of 0.6&nbsp;hours in a fasted state and 3.2&nbsp;hours in a fed state (5-fold difference), and the <a href="Cmax_(pharmacology)" title="Cmax (pharmacology)">C<sub>max</sub></a> is reduced by 25–31% in a fed versus fasted state.<sup id="cite_ref-Bock2010_12-4" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading4"><h4 id="Distribution">Distribution</h4></div>
<p>Pregabalin crosses the <a href="Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood–brain barrier</a> and enters the <a href="Central_nervous_system" title="Central nervous system">central nervous system</a>.<sup id="cite_ref-pmid16376147_102-5" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup> However, due to its low <a href="Lipophilicity" title="Lipophilicity">lipophilicity</a>,<sup id="cite_ref-Bock2010_12-5" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> pregabalin requires active transport across the blood–brain barrier.<sup id="cite_ref-pmid23567998_110-2" class="reference"><a href="#cite_note-pmid23567998-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid16376147_102-6" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26305616_112-0" class="reference"><a href="#cite_note-pmid26305616-112"><span class="cite-bracket">[</span>112<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19937841_113-0" class="reference"><a href="#cite_note-pmid19937841-113"><span class="cite-bracket">[</span>113<span class="cite-bracket">]</span></a></sup> The LAT1 is highly expressed at the blood–brain barrier<sup id="cite_ref-pmid10518579_114-0" class="reference"><a href="#cite_note-pmid10518579-114"><span class="cite-bracket">[</span>114<span class="cite-bracket">]</span></a></sup> and transports pregabalin across into the brain.<sup id="cite_ref-pmid23567998_110-3" class="reference"><a href="#cite_note-pmid23567998-110"><span class="cite-bracket">[</span>110<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid16376147_102-7" class="reference"><a href="#cite_note-pmid16376147-102"><span class="cite-bracket">[</span>102<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid26305616_112-1" class="reference"><a href="#cite_note-pmid26305616-112"><span class="cite-bracket">[</span>112<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid19937841_113-1" class="reference"><a href="#cite_note-pmid19937841-113"><span class="cite-bracket">[</span>113<span class="cite-bracket">]</span></a></sup> Pregabalin has been shown to cross the <a href="Placenta" title="Placenta">placenta</a> in rats and is present in the <a href="Breast_milk" title="Breast milk">milk</a> of <a href="Lactation" title="Lactation">lactating</a> rats.<sup id="cite_ref-EMA2013_11-3" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> In humans, the <a href="Volume_of_distribution" title="Volume of distribution">volume of distribution</a> of an orally administered dose of pregabalin is approximately 0.56&nbsp;L/kg.<sup id="cite_ref-EMA2013_11-4" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> Pregabalin is not significantly <a href="Plasma_protein_binding" title="Plasma protein binding">bound to plasma proteins</a> (&lt;1%).<sup id="cite_ref-Bock2010_12-6" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading4"><h4 id="Metabolism">Metabolism</h4></div>
<p>Pregabalin undergoes little or no <a href="Metabolism" title="Metabolism">metabolism</a>.<sup id="cite_ref-Bock2010_12-7" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Cal2016_31-8" class="reference"><a href="#cite_note-Cal2016-31"><span class="cite-bracket">[</span>31<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-ADTPD_115-0" class="reference"><a href="#cite_note-ADTPD-115"><span class="cite-bracket">[</span>115<span class="cite-bracket">]</span></a></sup> In experiments using <a href="Nuclear_medicine" title="Nuclear medicine">nuclear medicine</a> techniques, it was revealed that approximately 98% of the <a href="Radioactivity" class="mw-redirect" title="Radioactivity">radioactivity</a> recovered in the <a href="Urine" title="Urine">urine</a> was unchanged pregabalin.<sup id="cite_ref-EMA2013_11-5" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> The main metabolite is N-methylpregabalin.<sup id="cite_ref-EMA2013_11-6" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup>
</p><p>Pregabalin is generally safe in patients with liver <a href="Cirrhosis" title="Cirrhosis">cirrhosis</a>.<sup id="cite_ref-pmid37918778_116-0" class="reference"><a href="#cite_note-pmid37918778-116"><span class="cite-bracket">[</span>116<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading4"><h4 id="Elimination">Elimination</h4></div>
<p>Pregabalin is <a href="Elimination_(pharmacology)" title="Elimination (pharmacology)">eliminated</a> by the kidneys in the <a href="Urine" title="Urine">urine</a>, mainly in its unchanged form.<sup id="cite_ref-Bock2010_12-8" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-EMA2013_11-7" class="reference"><a href="#cite_note-EMA2013-11"><span class="cite-bracket">[</span>11<span class="cite-bracket">]</span></a></sup> It has a relatively short <a href="Elimination_half-life" class="mw-redirect" title="Elimination half-life">elimination half-life</a>, with a reported value of 6.3&nbsp;hours.<sup id="cite_ref-Bock2010_12-9" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> Because of its short elimination half-life, pregabalin is administered 2 to 3&nbsp;times per day to maintain therapeutic levels.<sup id="cite_ref-Bock2010_12-10" class="reference"><a href="#cite_note-Bock2010-12"><span class="cite-bracket">[</span>12<span class="cite-bracket">]</span></a></sup> The <a href="Renal_clearance" class="mw-redirect" title="Renal clearance">kidney clearance</a> of pregabalin is 73&nbsp;mL/minute.<sup id="cite_ref-DailyMed-2020_9-1" class="reference"><a href="#cite_note-DailyMed-2020-9"><span class="cite-bracket">[</span>9<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Chemistry">Chemistry</h2></div>
<p>Pregabalin is a <a href="GABA_analogue" title="GABA analogue">GABA analogue</a> that is a 3-substituted <a href="Chemical_derivative" class="mw-redirect" title="Chemical derivative">derivative</a> as well as a γ-amino acid.<sup id="cite_ref-Wyllie_2012_20-1" class="reference"><a href="#cite_note-Wyllie_2012-20"><span class="cite-bracket">[</span>20<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BenzonRathmell2013_30-3" class="reference"><a href="#cite_note-BenzonRathmell2013-30"><span class="cite-bracket">[</span>30<span class="cite-bracket">]</span></a></sup> Because of its chemical and pharmacological similarities to gabapentin, it is sometimes called a <a href="Gabapentinoid" title="Gabapentinoid">gabapentinoid</a> drug. Specifically, pregabalin is (<i>S</i>)-(+)-3-isobutyl-GABA.<sup id="cite_ref-pmid18221197_117-0" class="reference"><a href="#cite_note-pmid18221197-117"><span class="cite-bracket">[</span>117<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid11966555_118-0" class="reference"><a href="#cite_note-pmid11966555-118"><span class="cite-bracket">[</span>118<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-WhelessWillmore2009_119-0" class="reference"><a href="#cite_note-WhelessWillmore2009-119"><span class="cite-bracket">[</span>119<span class="cite-bracket">]</span></a></sup> Pregabalin also <a href="Structural_analog" title="Structural analog">closely resembles</a> the <a href="%CE%91-amino_acid" class="mw-redirect" title="Α-amino acid">α-amino acids</a> <a href="L-leucine" class="mw-redirect" title="L-leucine"><small>L</small>-leucine</a> and <a href="L-isoleucine" class="mw-redirect" title="L-isoleucine"><small>L</small>-isoleucine</a>, and this may be of greater relevance in relation to its <a href="Pharmacodynamics" title="Pharmacodynamics">pharmacodynamics</a> than its structural similarity to GABA.<sup id="cite_ref-pmid17222465_28-4" class="reference"><a href="#cite_note-pmid17222465-28"><span class="cite-bracket">[</span>28<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17403543_105-1" class="reference"><a href="#cite_note-pmid17403543-105"><span class="cite-bracket">[</span>105<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid18221197_117-1" class="reference"><a href="#cite_note-pmid18221197-117"><span class="cite-bracket">[</span>117<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Synthesis">Synthesis</h3></div>
<p><a href="Chemical_synthesis" title="Chemical synthesis">Chemical syntheses</a> of pregabalin have been described.<sup id="cite_ref-VardanyanHruby2016_120-0" class="reference"><a href="#cite_note-VardanyanHruby2016-120"><span class="cite-bracket">[</span>120<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-AndrushkoAndrushko2013_121-0" class="reference"><a href="#cite_note-AndrushkoAndrushko2013-121"><span class="cite-bracket">[</span>121<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="History">History</h2></div>
<p>Pregabalin was synthesized in 1990 as an <a href="Anticonvulsant" title="Anticonvulsant">anticonvulsant</a> that was developed as a successor to the related <a href="Gabapentin" title="Gabapentin">gabapentin</a>.<sup id="cite_ref-Kaye-2014_122-0" class="reference"><a href="#cite_note-Kaye-2014-122"><span class="cite-bracket">[</span>122<span class="cite-bracket">]</span></a></sup> It was first synthesized by <a href="Medicinal_chemist" class="mw-redirect" title="Medicinal chemist">medicinal chemist</a> <a href="Richard_Bruce_Silverman" title="Richard Bruce Silverman">Richard Bruce Silverman</a> at <a href="Northwestern_University" title="Northwestern University">Northwestern University</a> in <a href="Evanston%2C_Illinois" title="Evanston, Illinois">Evanston, Illinois</a>.<sup id="cite_ref-Lowe-2008_123-0" class="reference"><a href="#cite_note-Lowe-2008-123"><span class="cite-bracket">[</span>123<span class="cite-bracket">]</span></a></sup> During 1988 to 1990, Ryszard Andruszkiewicz, a visiting research fellow, synthesized a series of molecules requested by Silverman.<sup id="cite_ref-Andruszkiewicz_124-0" class="reference"><a href="#cite_note-Andruszkiewicz-124"><span class="cite-bracket">[</span>124<span class="cite-bracket">]</span></a></sup> Upon testing in mouse seizure models by collaborators at <a href="Parke-Davis" title="Parke-Davis">Parke-Davis Pharmaceuticals</a>,<sup id="cite_ref-125" class="reference"><a href="#cite_note-125"><span class="cite-bracket">[</span>125<span class="cite-bracket">]</span></a></sup> one looked particularly promising. In vitro, it activated <a href="L-glutamic_acid_decarboxylase" class="mw-redirect" title="L-glutamic acid decarboxylase">L-glutamic acid decarboxylase</a>, an enzyme, but this later proved to be unimportant to prevention of seizures. Silverman had originally hoped that the enzyme would increase the production of the inhibitory neurotransmitter GABA and block convulsions.<sup id="cite_ref-Merrill-2010_126-0" class="reference"><a href="#cite_note-Merrill-2010-126"><span class="cite-bracket">[</span>126<span class="cite-bracket">]</span></a></sup> After extensive development studies and clinical trials by Parke-Davis the drug was approved in the European Union in 2004. The US received FDA approval for use in treating <a href="Epilepsy" title="Epilepsy">epilepsy</a>, <a href="Diabetic" class="mw-redirect" title="Diabetic">diabetic</a> <a href="Neuropathic_pain" title="Neuropathic pain">neuropathic pain</a>, and <a href="Postherpetic_neuralgia" title="Postherpetic neuralgia">postherpetic neuralgia</a> in December 2004. Pregabalin then appeared on the US market under the brand name<i> Lyrica</i> in the fall of 2005.<sup id="cite_ref-pmid15959952_127-0" class="reference"><a href="#cite_note-pmid15959952-127"><span class="cite-bracket">[</span>127<span class="cite-bracket">]</span></a></sup> In 2017, the FDA approved pregabalin extended-release Lyrica CR for the management of neuropathic pain associated with diabetic peripheral neuropathy, and postherpetic neuralgia.<sup id="cite_ref-Seeking_Alpha-2017_128-0" class="reference"><a href="#cite_note-Seeking_Alpha-2017-128"><span class="cite-bracket">[</span>128<span class="cite-bracket">]</span></a></sup> However, unlike the <a href="Modified-release_dosage" title="Modified-release dosage">immediate release</a> formulation, Lyrica CR was not approved for the management of <a href="Fibromyalgia" title="Fibromyalgia">fibromyalgia</a> or as add-on therapy for adults with <a href="Partial_seizures" class="mw-redirect" title="Partial seizures">partial onset seizures</a>.<sup id="cite_ref-Reuters-2018_129-0" class="reference"><a href="#cite_note-Reuters-2018-129"><span class="cite-bracket">[</span>129<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-DailyMed-2020_9-2" class="reference"><a href="#cite_note-DailyMed-2020-9"><span class="cite-bracket">[</span>9<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Society_and_culture">Society and culture</h2></div>
<div class="mw-heading mw-heading3"><h3 id="Legal_status">Legal status</h3></div>
<ul><li>United States: During clinical trials a small number of users (~4%) reported <a href="Euphoria" title="Euphoria">euphoria</a> after use, which led to its control in the US.<sup id="cite_ref-Drugs.com-Lyrica-2016_130-0" class="reference"><a href="#cite_note-Drugs.com-Lyrica-2016-130"><span class="cite-bracket">[</span>130<span class="cite-bracket">]</span></a></sup> The <a href="Drug_Enforcement_Administration" title="Drug Enforcement Administration">Drug Enforcement Administration</a> (DEA) classified pregabalin as a <a href="Depressant" title="Depressant">depressant</a> and placed pregabalin, including its salts, and all products containing pregabalin into <a href="Controlled_Substances_Act#Schedule_V_drugs" title="Controlled Substances Act">Schedule V</a> of the <a href="Controlled_Substances_Act" title="Controlled Substances Act">Controlled Substances Act</a>.<sup id="cite_ref-DEA_Diversion_Control_Division-2005_131-0" class="reference"><a href="#cite_note-DEA_Diversion_Control_Division-2005-131"><span class="cite-bracket">[</span>131<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Federal_Register-2005_71-2" class="reference"><a href="#cite_note-Federal_Register-2005-71"><span class="cite-bracket">[</span>71<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-usdoj.gov-2015_132-0" class="reference"><a href="#cite_note-usdoj.gov-2015-132"><span class="cite-bracket">[</span>132<span class="cite-bracket">]</span></a></sup></li>
<li>Norway: Pregabalin is in prescription Schedule B, alongside <a href="Benzodiazepine" title="Benzodiazepine">benzodiazepines</a>.<sup id="cite_ref-Felleskatalogen-2015_133-0" class="reference"><a href="#cite_note-Felleskatalogen-2015-133"><span class="cite-bracket">[</span>133<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Chalabianloo_134-0" class="reference"><a href="#cite_note-Chalabianloo-134"><span class="cite-bracket">[</span>134<span class="cite-bracket">]</span></a></sup></li>
<li>United Kingdom: On January 14, 2016, the <a href="Advisory_Council_on_the_Misuse_of_Drugs" title="Advisory Council on the Misuse of Drugs">Advisory Council on the Misuse of Drugs</a> (ACMD) recommended that pregabalin, along with <a href="Gabapentin" title="Gabapentin">gabapentin</a>, be controlled under the <a href="Misuse_of_Drugs_Act_1971" title="Misuse of Drugs Act 1971">Misuse of Drugs Act 1971</a>.<sup id="cite_ref-GOV.UK-2016_135-0" class="reference"><a href="#cite_note-GOV.UK-2016-135"><span class="cite-bracket">[</span>135<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GOV.UK-2017_136-0" class="reference"><a href="#cite_note-GOV.UK-2017-136"><span class="cite-bracket">[</span>136<span class="cite-bracket">]</span></a></sup> In October 2018, it was announced that pregabalin would be reclassified as a Class C <a href="Controlled_substance" title="Controlled substance">controlled substance</a>, effective April 2019.<sup id="cite_ref-pmid30327316_137-0" class="reference"><a href="#cite_note-pmid30327316-137"><span class="cite-bracket">[</span>137<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GOV.UK-2018_138-0" class="reference"><a href="#cite_note-GOV.UK-2018-138"><span class="cite-bracket">[</span>138<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GOV.UK-2019_139-0" class="reference"><a href="#cite_note-GOV.UK-2019-139"><span class="cite-bracket">[</span>139<span class="cite-bracket">]</span></a></sup> As a Class C drug, pregabalin now requires a prescription in the UK,<sup id="cite_ref-GOV.UK-2018_138-1" class="reference"><a href="#cite_note-GOV.UK-2018-138"><span class="cite-bracket">[</span>138<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Controlled_Drug_Classes-2013_140-0" class="reference"><a href="#cite_note-Controlled_Drug_Classes-2013-140"><span class="cite-bracket">[</span>140<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-What_are_Class_C_Drugs-2022_141-0" class="reference"><a href="#cite_note-What_are_Class_C_Drugs-2022-141"><span class="cite-bracket">[</span>141<span class="cite-bracket">]</span></a></sup> and the prescription must clearly specify the dose.<sup id="cite_ref-circular-0192018_97-1" class="reference"><a href="#cite_note-circular-0192018-97"><span class="cite-bracket">[</span>97<span class="cite-bracket">]</span></a></sup></li></ul>
<p>In the United States, the FDA has approved pregabalin for <a href="Combination_therapy" title="Combination therapy">adjunctive therapy</a> for adults with partial onset <a href="Epileptic_seizure" class="mw-redirect" title="Epileptic seizure">seizures</a>, management of <a href="Postherpetic_neuralgia" title="Postherpetic neuralgia">postherpetic neuralgia</a> and <a href="Neuropathic_pain" title="Neuropathic pain">neuropathic pain</a> associated with <a href="Spinal_cord" title="Spinal cord">spinal cord</a> injury and <a href="Diabetic_neuropathy" title="Diabetic neuropathy">diabetic peripheral neuropathy</a>, and the treatment of <a href="Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>.<sup id="cite_ref-Off-label_142-0" class="reference"><a href="#cite_note-Off-label-142"><span class="cite-bracket">[</span>142<span class="cite-bracket">]</span></a></sup> Pregabalin has also been approved in the European Union, the United Kingdom, and Russia for treatment of <a href="Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a>.<sup id="cite_ref-Levy-2019_143-0" class="reference"><a href="#cite_note-Levy-2019-143"><span class="cite-bracket">[</span>143<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-pmid17610384_62-3" class="reference"><a href="#cite_note-pmid17610384-62"><span class="cite-bracket">[</span>62<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-GAD_144-0" class="reference"><a href="#cite_note-GAD-144"><span class="cite-bracket">[</span>144<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Economics">Economics</h3></div>
<p>Pregabalin is available as a <a href="Generic_medication" class="mw-redirect" title="Generic medication">generic medication</a> in a number of countries, including the United States as of July 2019.<sup id="cite_ref-BNF76_24-2" class="reference"><a href="#cite_note-BNF76-24"><span class="cite-bracket">[</span>24<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Generic_Lyrica_Availability_34-1" class="reference"><a href="#cite_note-Generic_Lyrica_Availability-34"><span class="cite-bracket">[</span>34<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Levy-2019_143-1" class="reference"><a href="#cite_note-Levy-2019-143"><span class="cite-bracket">[</span>143<span class="cite-bracket">]</span></a></sup> In the United States as of July 2019 the wholesale/pharmacy cost for generic pregabalin is US$0.17–0.22 per 150&nbsp;mg capsule.<sup id="cite_ref-46brooklyn_Research-2019_145-0" class="reference"><a href="#cite_note-46brooklyn_Research-2019-145"><span class="cite-bracket">[</span>145<span class="cite-bracket">]</span></a></sup>
</p><p>From 2008 until 2018, Pfizer engaged in extensive <a href="Direct-to-consumer_advertising" title="Direct-to-consumer advertising">direct-to-consumer advertising</a> campaigns to promote its branded product Lyrica for <a href="Fibromyalgia" title="Fibromyalgia">fibromyalgia</a> and diabetic nerve pain indications. In January 2016, the company spent a record amount, $24.6&nbsp;million for a single drug on TV ads, reaching global revenues of $14&nbsp;billion, more than half in the United States.<sup id="cite_ref-Bulik-2016_146-0" class="reference"><a href="#cite_note-Bulik-2016-146"><span class="cite-bracket">[</span>146<span class="cite-bracket">]</span></a></sup>
</p><p>Up until 2009, Pfizer promoted Lyrica for other uses that had not been approved by medical regulators. For Lyrica and three other drugs, Pfizer was fined a record amount of US$2.3 <a href="1%2C000%2C000%2C000" title="1,000,000,000">billion</a> by the Department of Justice,<sup id="cite_ref-NYT_Pfizer_Pays_147-0" class="reference"><a href="#cite_note-NYT_Pfizer_Pays-147"><span class="cite-bracket">[</span>147<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BBC-News-Prizer-Fraud-Fine-2009_148-0" class="reference"><a href="#cite_note-BBC-News-Prizer-Fraud-Fine-2009-148"><span class="cite-bracket">[</span>148<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-U.S._Securities_and_Exchange_Commission-2010_149-0" class="reference"><a href="#cite_note-U.S._Securities_and_Exchange_Commission-2010-149"><span class="cite-bracket">[</span>149<span class="cite-bracket">]</span></a></sup> after pleading guilty to advertising and branding "with the intent to defraud or mislead". Pfizer illegally promoted the drugs, with doctors "invited to consultant meetings, many in resort locations; attendees expenses were paid; they received a fee just for being there", according to prosecutor Michael Loucks.<sup id="cite_ref-NYT_Pfizer_Pays_147-1" class="reference"><a href="#cite_note-NYT_Pfizer_Pays-147"><span class="cite-bracket">[</span>147<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-BBC-News-Prizer-Fraud-Fine-2009_148-1" class="reference"><a href="#cite_note-BBC-News-Prizer-Fraud-Fine-2009-148"><span class="cite-bracket">[</span>148<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Intellectual_property">Intellectual property</h3></div>
<p>Professor Richard "Rick" Silverman of Northwestern University developed pregabalin there. The university holds a patent on it, exclusively licensed to Pfizer.<sup id="cite_ref-Jacoby-2008_150-0" class="reference"><a href="#cite_note-Jacoby-2008-150"><span class="cite-bracket">[</span>150<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-mw-2001_151-0" class="reference"><a href="#cite_note-mw-2001-151"><span class="cite-bracket">[</span>151<span class="cite-bracket">]</span></a></sup> That patent, along with others, was challenged by generic manufacturers and was upheld in 2014, giving Pfizer exclusivity for Lyrica in the US until 2018.<sup id="cite_ref-Decker-2014_152-0" class="reference"><a href="#cite_note-Decker-2014-152"><span class="cite-bracket">[</span>152<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-Decision-2020_153-0" class="reference"><a href="#cite_note-Decision-2020-153"><span class="cite-bracket">[</span>153<span class="cite-bracket">]</span></a></sup>
</p><p>Pfizer's main patent for Lyrica, for seizure disorders, in the UK expired in 2013. In November 2018, the <a href="Supreme_Court_of_the_United_Kingdom" title="Supreme Court of the United Kingdom">Supreme Court of the United Kingdom</a> ruled that <a href="Pfizer" title="Pfizer">Pfizer</a>'s second patent on the drug, for the treatment of pain, was invalid because there was a lack of evidence for the conditions it covered – central and peripheral neuropathic pain. From October 2015, GPs were forced to change people from generic pregabalin to branded until the second patent ran out in July 2017. This cost the NHS £502 million.<sup id="cite_ref-Pfizer-2018_154-0" class="reference"><a href="#cite_note-Pfizer-2018-154"><span class="cite-bracket">[</span>154<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Brand_names">Brand names</h3></div>
<p>As of October 2017, pregabalin is marketed under many brand names: Algerika, Alivax, Alyse, Alzain, Andogablin, Aprion, Averopreg, Axual, Balifibro, Brieka, Clasica, Convugabalin, Dapapalin, Dismedox, Dolgenal, Dolica, Dragonor, Ecubalin, Epica, Epiron, Gaba-P, Gabanext, Gabarol, Gabica, Gablin, Gablovac, Gabrika, Gavin, Gialtyn, Glonervya, Helimon, Hexgabalin, Irenypathic, Kabian, Kemirica, Kineptia, Lecaent, Lingabat, Linprel, Lyribastad, Lyric, Lyrica, Lyrineur, Lyrolin, Lyzalon, Martesia, Maxgalin, Mystika, Neuragabalin, Neugaba, Neurega, Neurica, Neuristan, Neurolin, Neurovan, Neurum, Newrica, Nuramed, Paden, Pagadin, Pagamax, Painica, Pevesca, PG, Plenica, Pragiola, Prebalin, Prebanal, Prebel, Prebictal, Prebien, Prefaxil, Pregaba, Pregabalin, Pregabalina, Pregabaline, Prégabaline, Pregabalinum, Pregabateg, Pregaben, Pregabid, Pregabin, Pregacent, Pregadel, Pregagamma, Pregalex, Pregalin, Pregalodos, Pregamid, Pregan, Preganerve, Pregastar, Pregatrend, Pregavalex, Pregdin Apex, Pregeb, Pregobin, Prejunate, Prelin, Preludyo, Prelyx, Premilin, Preneurolin, Prestat, Pretor, Priga, Provelyn, Regapen, Resenz, Rewisca, Serigabtin, Symra, Vronogabic, Xablin, and Xil.<sup id="cite_ref-brands_155-0" class="reference"><a href="#cite_note-brands-155"><span class="cite-bracket">[</span>155<span class="cite-bracket">]</span></a></sup>
</p><p>It is marketed as a <a href="Combination_drug" title="Combination drug">combination drug</a> with <a href="Mecobalamin" class="mw-redirect" title="Mecobalamin">mecobalamin</a> under the brand names Agemax-P, Alphamix-PG, Freenerve-P, Gaben, Macraberin-P, Mecoblend-P, Mecozen-PG, Meex-PG, Methylnuron-P, Nervolin, Nervopreg, Neurica-M, Neuroprime-PG, Neutron-OD, Nuroday-P, Nurodon-PG, Nuwin-P, Pecomin-PG, Prebel-M, Predic-GM, Pregacent-M, Pregamet, Preganerv-M, Pregeb-M OD, Pregmic, Prejunate Plus, Preneurolin Plus, Pretek-GM, Rejusite, Renerve-P, Safyvit-PR, Vitcobin-P, and Voltanerv with Methylcobalamin and ALA by Cogentrix Pharma.<sup id="cite_ref-brands_155-1" class="reference"><a href="#cite_note-brands-155"><span class="cite-bracket">[</span>155<span class="cite-bracket">]</span></a></sup>
</p><p>In the US, Lyrica is marketed by <a href="Viatris" title="Viatris">Viatris</a> after Upjohn was spun off from Pfizer.<sup id="cite_ref-156" class="reference"><a href="#cite_note-156"><span class="cite-bracket">[</span>156<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-157" class="reference"><a href="#cite_note-157"><span class="cite-bracket">[</span>157<span class="cite-bracket">]</span></a></sup><sup id="cite_ref-158" class="reference"><a href="#cite_note-158"><span class="cite-bracket">[</span>158<span class="cite-bracket">]</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="References">References</h2></div>
<style data-mw-deduplicate="TemplateStyles:r1239543626">
/* start https://en.wikipedia.org/ */


.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}


/* end https://en.wikipedia.org/ */
</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-www.drugs.com-2016-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-www.drugs.com-2016_1-0">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">
/* start https://en.wikipedia.org/ */


.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("./mw/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("./mw/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("./mw/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("./mw/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}


/* end https://en.wikipedia.org/ */
</style><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/pregabalin.html">"Pregabalin"</a>. <i>Drugs.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190828172817/https://www.drugs.com/international/pregabalin.html">Archived</a> from the original on August 28, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">November 7,</span> 2016</span>.</cite></span>
</li>
<li id="cite_note-Australian_Government_Pregnancy-2023-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-Australian_Government_Pregnancy-2023_2-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.tga.gov.au/news/safety-updates/avoid-prescribing-pregabalin-pregnancy-if-possible">"Avoid prescribing pregabalin in pregnancy if possible"</a>. Australian Department of Health and Aged Care. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230213035842/https://www.tga.gov.au/news/safety-updates/avoid-prescribing-pregabalin-pregnancy-if-possible">Archived</a> from the original on February 13, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">February 13,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-Australian_Government_Safety-2023-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-Australian_Government_Safety-2023_3-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.tga.gov.au/news/safety-updates/product-information-safety-updates-january-2023">"Product Information safety updates - January 2023"</a>. Australian Department of Health and Aged Care. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230213035847/https://www.tga.gov.au/news/safety-updates/product-information-safety-updates-january-2023">Archived</a> from the original on February 13, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">February 13,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-Sch2014-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sch2014_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sch2014_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sch2014_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Sch2014_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFSchifano2014" class="citation journal cs1">Schifano F (June 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-014-0164-4">"Misuse and abuse of pregabalin and gabapentin: cause for concern?"</a>. <i>CNS Drugs</i>. <b>28</b> (6): <span class="nowrap">491–</span>496. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-014-0164-4">10.1007/s40263-014-0164-4</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24760436">24760436</a>.</cite></span>
</li>
<li id="cite_note-Therapeutic_Goods_Administration_(TGA)-2022-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-Therapeutic_Goods_Administration_(TGA)-2022_5-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017">"Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017"</a>. <i>Therapeutic Goods Administration (TGA)</i>. June 21, 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230706023149/https://www.tga.gov.au/resources/publication/publications/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines-2017">Archived</a> from the original on July 6, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">March 30,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-Anvisa-2023-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Anvisa-2023_6-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFAnvisa2023" class="citation web cs1 cs1-prop-foreign-lang-source"><a href="Brazilian_Health_Regulatory_Agency" title="Brazilian Health Regulatory Agency">Anvisa</a> (March 31, 2023). <a rel="nofollow" class="external text" href="https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992">"RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial"</a> [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). <a href="Di%C3%A1rio_Oficial_da_Uni%C3%A3o" title="Diário Oficial da União">Diário Oficial da União</a> (published April 4, 2023). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992">Archived</a> from the original on August 3, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">August 16,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-Lyrica_Consumer_Medicine_Information-2023-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lyrica_Consumer_Medicine_Information-2023_7-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medsafe.govt.nz/consumers/cmi/l/lyrica.pdf">"Lyrica Consumer Medicine Information"</a> <span class="cs1-format">(PDF)</span>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20231204180154/https://www.medsafe.govt.nz/consumers/cmi/l/lyrica.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on December 4, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">December 4,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-(emc)-2023-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-(emc)-2023_8-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/emc/product/5539/smpc">"Lyrica Summary of Product Characteristics (SmPC)"</a>. <i>(emc)</i>. February 27, 2023. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20231221220209/https://www.medicines.org.uk/emc/product/5539/smpc">Archived</a> from the original on December 21, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-DailyMed-2020-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-DailyMed-2020_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DailyMed-2020_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-DailyMed-2020_9-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60185c88-ecfd-46f9-adb9-b97c6b00a553">"Lyrica- pregabalin capsule Lyrica- pregabalin solution"</a>. <i>DailyMed</i>. June 15, 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210925211707/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60185c88-ecfd-46f9-adb9-b97c6b00a553">Archived</a> from the original on September 25, 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-Lyrica_EPAR-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lyrica_EPAR_10-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ema.europa.eu/en/medicines/human/EPAR/lyrica">"Lyrica EPAR"</a>. <i><a href="European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA)</i>. July 6, 2004. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20231221220208/https://www.ema.europa.eu/en/medicines/human/EPAR/lyrica">Archived</a> from the original on December 21, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-EMA2013-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-EMA2013_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EMA2013_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EMA2013_11-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-EMA2013_11-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-EMA2013_11-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-EMA2013_11-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-EMA2013_11-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-EMA2013_11-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf">"Summary of product characteristics"</a> <span class="cs1-format">(PDF)</span>. <a href="European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA). March 6, 2013. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180916023926/http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on September 16, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">May 6,</span> 2013</span>.</cite></span>
</li>
<li id="cite_note-Bock2010-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bock2010_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bock2010_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Bock2010_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Bock2010_12-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Bock2010_12-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Bock2010_12-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Bock2010_12-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Bock2010_12-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Bock2010_12-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Bock2010_12-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Bock2010_12-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFBockbraderRadulovicPosvarStrand2010" class="citation journal cs1">Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, et&nbsp;al. (August 2010). "Clinical pharmacokinetics of pregabalin in healthy volunteers". <i>Journal of Clinical Pharmacology</i>. <b>50</b> (8): <span class="nowrap">941–</span>950. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F0091270009352087">10.1177/0091270009352087</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20147618">20147618</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:9905501">9905501</a>.</cite></span>
</li>
<li id="cite_note-AHFS2019-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-AHFS2019_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-AHFS2019_13-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/pregabalin.html">"Pregabalin"</a>. The American Society of Health-System Pharmacists. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191202155555/https://www.drugs.com/monograph/pregabalin.html">Archived</a> from the original on December 2, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">February 3,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Expert_Committee_on_Drug_Dependence_Forty-first_Meeting-2018_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFExpert_Committee_on_Drug_Dependence_Forty-first_Meeting2018" class="citation report cs1">Expert Committee on Drug Dependence Forty-first Meeting (November 2018). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201026155408/https://www.who.int/medicines/access/controlled-substances/Pregabalin_FINAL.pdf?ua=1">Critical Review Report: Pregabalin</a> <span class="cs1-format">(PDF)</span> (Report). Geneva: World Health Organization. Archived from <a rel="nofollow" class="external text" href="https://www.who.int/medicines/access/controlled-substances/Pregabalin_FINAL.pdf?ua=1">the original</a> <span class="cs1-format">(PDF)</span> on October 26, 2020.</cite></span>
</li>
<li id="cite_note-pmid29261857-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid29261857_15-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFCrossViswanathSherman2022" class="citation book cs1">Cross AL, Viswanath O, Sherman AI (July 19, 2022). "Pregabalin". <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK470341/"><i>StatPearls [Internet]</i></a>. Treasure Island (FL): StatPearls Publishing. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29261857">29261857</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220803171541/http://www.ncbi.nlm.nih.gov/books/NBK470341/">Archived</a> from the original on August 3, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2022</span> – via NCBI Bookshelf.</cite></span>
</li>
<li id="cite_note-b403-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-b403_16-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://bnf.nice.org.uk/drugs/pregabalin/#indications-and-dose">"BNF Pregabalin"</a>. NICE. November 16, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">June 19,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-pmid25149863-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25149863_17-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFFrampton2014" class="citation journal cs1">Frampton JE (September 2014). "Pregabalin: a review of its use in adults with generalized anxiety disorder". <i>CNS Drugs</i>. <b>28</b> (9): <span class="nowrap">835–</span>854. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-014-0192-0">10.1007/s40263-014-0192-0</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25149863">25149863</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5349255">5349255</a>.</cite></span>
</li>
<li id="cite_note-pmid28888061-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28888061_18-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFIftikharAlghothaniTrotti2017" class="citation journal cs1">Iftikhar IH, Alghothani L, Trotti LM (December 2017). "Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis". <i>European Journal of Neurology</i>. <b>24</b> (12): <span class="nowrap">1446–</span>1456. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fene.13449">10.1111/ene.13449</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28888061">28888061</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22262972">22262972</a>.</cite></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite id="CITEREFSchmaderDworkin2018" class="citation book cs1">Schmader K, Dworkin RH (January 1, 2018). "Chapter 28 - Herpes Zoster and Postherpetic Neuralgia". In Benzon HT, Raja SN, Liu SS, Fishman SM (eds.). <i>Essentials of Pain Medicine</i> (Fourth&nbsp;ed.). Elsevier. pp.&nbsp;233–240.e2. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fb978-0-323-40196-8.00028-0">10.1016/b978-0-323-40196-8.00028-0</a>. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-323-40196-8</bdi>.</cite></span>
</li>
<li id="cite_note-Wyllie_2012-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wyllie_2012_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wyllie_2012_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFWyllieCascinoGidalGoodkin2012" class="citation book cs1">Wyllie E, Cascino GD, Gidal BE, Goodkin HP (February 17, 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=j9t6Qg0kkuUC&amp;pg=RA1-PA423"><i>Wyllie's Treatment of Epilepsy: Principles and Practice</i></a>. Lippincott Williams &amp; Wilkins. p.&nbsp;423. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-1-4511-5348-4</bdi>.</cite></span>
</li>
<li id="cite_note-Kirsch2013-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kirsch2013_21-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFKirsch2013" class="citation book cs1">Kirsch D (October 10, 2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Gf9QAQAAQBAJ&amp;pg=PT241"><i>Sleep Medicine in Neurology</i></a>. John Wiley &amp; Sons. p.&nbsp;241. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-1-118-76417-6</bdi>.</cite></span>
</li>
<li id="cite_note-SchatzbergNemeroff2009-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-SchatzbergNemeroff2009_22-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFFryeMoore2009" class="citation book cs1">Frye M, Moore K (2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=Xx7iNGdV25IC&amp;pg=PA767">"Gabapentin and Pregabalin"</a>. In Schatzberg AF, Nemeroff CB (eds.). <i>The American Psychiatric Publishing Textbook of Psychopharmacology</i>. pp.&nbsp;<span class="nowrap">767–</span>77. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1176%2Fappi.books.9781585623860.as38">10.1176/appi.books.9781585623860.as38</a>. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-1-58562-309-9</bdi>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240227031427/https://books.google.com/books?id=Xx7iNGdV25IC&amp;pg=PA767#v=onepage&amp;q&amp;f=false">Archived</a> from the original on February 27, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">September 1,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-pmid25209095-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25209095_23-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMishrikyWaldronHabib2015" class="citation journal cs1">Mishriky BM, Waldron NH, Habib AS (January 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbja%2Faeu293">"Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis"</a>. <i>British Journal of Anaesthesia</i>. <b>114</b> (1): <span class="nowrap">10–</span>31. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbja%2Faeu293">10.1093/bja/aeu293</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25209095">25209095</a>.</cite></span>
</li>
<li id="cite_note-BNF76-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-BNF76_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BNF76_24-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BNF76_24-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation book cs1"><i>British National Formulary: BNF 76</i> (76&nbsp;ed.). Pharmaceutical Press. 2018. p.&nbsp;323. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>9780857113382</bdi>.</cite></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite id="CITEREFBrittonShih2010" class="citation journal cs1">Britton JW, Shih JJ (2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108698">"Antiepileptic drugs and suicidality"</a>. <i>Drug, Healthcare and Patient Safety</i>. <b>2</b>: <span class="nowrap">181–</span>189. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FDHPS.S13225">10.2147/DHPS.S13225</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108698">3108698</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21701630">21701630</a>.</cite></span>
</li>
<li id="cite_note-Preg2019-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-Preg2019_26-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/pregnancy/pregabalin.html">"Pregabalin Use During Pregnancy"</a>. <i>Drugs.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190321033634/https://www.drugs.com/pregnancy/pregabalin.html">Archived</a> from the original on March 21, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">February 4,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-pmid27345098-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid27345098_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid27345098_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFCalandreRico-VillademorosSlim2016" class="citation journal cs1">Calandre EP, Rico-Villademoros F, Slim M (2016). "Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". <i>Expert Rev Neurother</i>. <b>16</b> (11): <span class="nowrap">1263–</span>1277. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F14737175.2016.1202764">10.1080/14737175.2016.1202764</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27345098">27345098</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33200190">33200190</a>.</cite></span>
</li>
<li id="cite_note-pmid17222465-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17222465_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17222465_28-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17222465_28-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17222465_28-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17222465_28-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFDooleyTaylorDonevanFeltner2007" class="citation journal cs1">Dooley DJ, Taylor CP, Donevan S, Feltner D (2007). "Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission". <i>Trends Pharmacol. Sci</i>. <b>28</b> (2): <span class="nowrap">75–</span>82. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tips.2006.12.006">10.1016/j.tips.2006.12.006</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17222465">17222465</a>.</cite></span>
</li>
<li id="cite_note-WyllieCascino2012-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-WyllieCascino2012_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WyllieCascino2012_29-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFElaine_WyllieGregory_D._CascinoBarry_E._GidalHoward_P._Goodkin2012" class="citation book cs1"><a href="Elaine_Wyllie" title="Elaine Wyllie">Elaine Wyllie</a>, Gregory D. Cascino, Barry E. Gidal, Howard P. Goodkin (February 17, 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=j9t6Qg0kkuUC&amp;pg=RA1-PA423"><i>Wyllie's Treatment of Epilepsy: Principles and Practice</i></a>. Lippincott Williams &amp; Wilkins. p.&nbsp;423. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-1-4511-5348-4</bdi>.</cite></span>
</li>
<li id="cite_note-BenzonRathmell2013-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-BenzonRathmell2013_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BenzonRathmell2013_30-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BenzonRathmell2013_30-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-BenzonRathmell2013_30-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFHonorio_BenzonJames_P._RathmellChristopher_L._WuDennis_C._Turk2013" class="citation book cs1">Honorio Benzon, James P. Rathmell, Christopher L. Wu, Dennis C. Turk, Charles E. Argoff, Robert W Hurley (September 11, 2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=kfcDAQAAQBAJ&amp;pg=PA1006"><i>Practical Management of Pain</i></a>. Elsevier Health Sciences. p.&nbsp;1006. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-323-17080-2</bdi>.</cite></span>
</li>
<li id="cite_note-Cal2016-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cal2016_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cal2016_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cal2016_31-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Cal2016_31-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Cal2016_31-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Cal2016_31-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Cal2016_31-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Cal2016_31-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Cal2016_31-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFCalandreRico-VillademorosSlim2016" class="citation journal cs1">Calandre EP, Rico-Villademoros F, Slim M (November 2016). "Alpha<sub>2</sub>delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use". <i>Expert Review of Neurotherapeutics</i>. <b>16</b> (11): <span class="nowrap">1263–</span>1277. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F14737175.2016.1202764">10.1080/14737175.2016.1202764</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27345098">27345098</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:33200190">33200190</a>.</cite></span>
</li>
<li id="cite_note-Uch2010-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Uch2010_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Uch2010_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFUchitelDi_GuilmiUrbanoGonzalez-Inchauspe2010" class="citation journal cs1">Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C (2010). <a rel="nofollow" class="external text" href="https://doi.org/10.4161%2Fchan.4.6.12864">"Acute modulation of calcium currents and synaptic transmission by gabapentinoids"</a>. <i>Channels</i>. <b>4</b> (6): <span class="nowrap">490–</span>496. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.4161%2Fchan.4.6.12864">10.4161/chan.4.6.12864</a></span>. <a href="Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/11336%2F20897">11336/20897</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21150315">21150315</a>.</cite></span>
</li>
<li id="cite_note-Is_Lyrica_a_Controlled_Substance-16_April_2024-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-Is_Lyrica_a_Controlled_Substance-16_April_2024_33-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://recovered.org/prescription-drugs/pregabalin-lyrica/pregabalin-lyrica-controlled-substance">"Is Lyrica a Controlled Substance?"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240506185539/https://recovered.org/prescription-drugs/pregabalin-lyrica/pregabalin-lyrica-controlled-substance">Archived</a> from the original on May 6, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">May 6,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-Generic_Lyrica_Availability-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-Generic_Lyrica_Availability_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Generic_Lyrica_Availability_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/availability/generic-lyrica.html">"Generic Lyrica Availability"</a>. <i>Drugs.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190327101443/https://www.drugs.com/availability/generic-lyrica.html">Archived</a> from the original on March 27, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">February 4,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-FDA_approves_first_generics_of_Lyrica-2019-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_approves_first_generics_of_Lyrica-2019_35-0">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200609201441/https://www.fda.gov/news-events/press-announcements/fda-approves-first-generics-lyrica">"FDA approves first generics of Lyrica"</a>. <i>U.S. <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). September 11, 2019. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-generics-lyrica">the original</a> on June 9, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-USFDA-approval-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-USFDA-approval_36-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=213226">"Pregabalin ER: FDA-Approved Drugs"</a>. <i>U.S. <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210624200922/https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=213226">Archived</a> from the original on June 24, 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">June 19,</span> 2021</span>.</cite></span>
</li>
<li id="cite_note-USFDA-2023-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-USFDA-2023_37-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20230629233651/https://www.fda.gov/drugs/generic-drugs/competitive-generic-therapy-approvals">"Competitive Generic Therapy Approvals"</a>. <i>U.S. <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. June 29, 2023. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/drugs/generic-drugs/competitive-generic-therapy-approvals">the original</a> on June 29, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">June 29,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clincalc.com/DrugStats/Top300Drugs.aspx">"The Top 300 of 2022"</a>. <i>ClinCalc</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240830202410/https://clincalc.com/DrugStats/Top300Drugs.aspx">Archived</a> from the original on August 30, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">August 30,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clincalc.com/DrugStats/Drugs/Pregabalin">"Pregabalin Drug Usage Statistics, United States, 2013 - 2022"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">August 30,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-pmid35349176-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid35349176_40-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFPanebiancoBresnahanMarson2022" class="citation journal cs1">Panebianco M, Bresnahan R, Marson AG (March 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962962">"Pregabalin add-on for drug-resistant focal epilepsy"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>3</b> (3): CD005612. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD005612.pub5">10.1002/14651858.CD005612.pub5</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962962">8962962</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35349176">35349176</a>.</cite></span>
</li>
<li id="cite_note-pmid23076957-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid23076957_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid23076957_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFZhouZhengYuJia2012" class="citation journal cs1">Zhou Q, Zheng J, Yu L, Jia X (October 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11942706">"Pregabalin monotherapy for epilepsy"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2012</b> (10): CD009429. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD009429.pub2">10.1002/14651858.CD009429.pub2</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11942706">11942706</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23076957">23076957</a>.</cite></span>
</li>
<li id="cite_note-pmid20402746-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20402746_42-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFAttalCruccuBaronHaanpää2010" class="citation journal cs1">Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et&nbsp;al. (September 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1468-1331.2010.02999.x">"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision"</a>. <i>European Journal of Neurology</i>. <b>17</b> (9): 1113–1e88. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1468-1331.2010.02999.x">10.1111/j.1468-1331.2010.02999.x</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20402746">20402746</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14236933">14236933</a>.</cite></span>
</li>
<li id="cite_note-Derry_2019-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-Derry_2019_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Derry_2019_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFDerryBellStraubeWiffen2019" class="citation journal cs1">Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA (January 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353204">"Pregabalin for neuropathic pain in adults"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>1</b> (1): CD007076. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD007076.pub3">10.1002/14651858.CD007076.pub3</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353204">6353204</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30673120">30673120</a>.</cite></span>
</li>
<li id="cite_note-pmid20705215-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20705215_44-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFFinnerupSindrupJensen2010" class="citation journal cs1">Finnerup NB, Sindrup SH, Jensen TS (September 2010). "The evidence for pharmacological treatment of neuropathic pain". <i>Pain</i>. <b>150</b> (3): <span class="nowrap">573–</span>581. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pain.2010.06.019">10.1016/j.pain.2010.06.019</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20705215">20705215</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:29830155">29830155</a>.</cite></span>
</li>
<li id="cite_note-NIHR_Evidence-2023-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-NIHR_Evidence-2023_45-0">^</a></b></span> <span class="reference-text"><cite class="citation journal cs1"><span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://evidence.nihr.ac.uk/alert/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective/">"Combination therapy for painful diabetic neuropathy is safe and effective"</a></span>. <i>NIHR Evidence</i>. April 6, 2023. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3310%2Fnihrevidence_57470">10.3310/nihrevidence_57470</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:258013544">258013544</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20230428104720/https://evidence.nihr.ac.uk/alert/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective/">Archived</a> from the original on April 28, 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">April 28,</span> 2023</span>.</cite></span>
</li>
<li id="cite_note-pmid36007534-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid36007534_46-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFTesfayeSloanPetrieWhite2022" class="citation journal cs1">Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, et&nbsp;al. (August 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418415">"Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial"</a>. <i>Lancet</i>. <b>400</b> (10353): <span class="nowrap">680–</span>690. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2822%2901472-6">10.1016/s0140-6736(22)01472-6</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418415">9418415</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36007534">36007534</a>.</cite></span>
</li>
<li id="cite_note-Freynhagen_Baron_Kawaguchi_Malik_pp._1–9-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Freynhagen_Baron_Kawaguchi_Malik_pp._1–9_47-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFFreynhagenBaronKawaguchiMalik2021" class="citation journal cs1">Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, et&nbsp;al. (January 2021). <a rel="nofollow" class="external text" href="https://pure.au.dk/portal/files/274258964/00325481.2020.pdf">"Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration"</a> <span class="cs1-format">(PDF)</span>. <i>Postgraduate Medicine</i>. <b>133</b> (1). Informa UK Limited: <span class="nowrap">1–</span>9. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F00325481.2020.1857992">10.1080/00325481.2020.1857992</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33423590">33423590</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:231574963">231574963</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240227025752/https://pure.au.dk/ws/portalfiles/portal/274258964/00325481.2020.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on February 27, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">February 19,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-Bennett_1681–8-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bennett_1681–8_48-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBennettLairdvan_LitsenburgNimour2013" class="citation journal cs1">Bennett MI, Laird B, van Litsenburg C, Nimour M (November 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fpme.12212">"Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature"</a>. <i>Pain Medicine</i>. <b>14</b> (11): <span class="nowrap">1681–</span>1688. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fpme.12212">10.1111/pme.12212</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23915361">23915361</a>.</cite></span>
</li>
<li id="cite_note-Howard-2017-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Howard-2017_49-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFHoward2017" class="citation book cs1">Howard P (2017). <i>Palliative care formulary</i> (6&nbsp;ed.). Pharmaceutical press. p.&nbsp;Chapter 4 Central Nervous System. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-85711-348-1</bdi>.</cite></span>
</li>
<li id="cite_note-pmid22415535-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22415535_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22415535_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFClarkeBoninOrserEnglesakis2012" class="citation journal cs1">Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J (August 2012). "The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis". <i>Anesthesia and Analgesia</i>. <b>115</b> (2): <span class="nowrap">428–</span>442. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1213%2FANE.0b013e318249d36e">10.1213/ANE.0b013e318249d36e</a>. <a href="Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/10315%2F27968">10315/27968</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22415535">22415535</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:18933131">18933131</a>.</cite></span>
</li>
<li id="cite_note-pmid23881791-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23881791_51-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFChaparroSmithMooreWiffen2013" class="citation journal cs1">Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I (July 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481826">"Pharmacotherapy for the prevention of chronic pain after surgery in adults"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2021</b> (7): CD008307. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD008307.pub2">10.1002/14651858.CD008307.pub2</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481826">6481826</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23881791">23881791</a>.</cite></span>
</li>
<li id="cite_note-pmid27535436-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27535436_52-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFHamiltonStricklandPandit2016" class="citation journal cs1">Hamilton TW, Strickland LH, Pandit HG (August 2016). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://ora.ox.ac.uk/objects/uuid:cbe29197-14a9-47dc-b961-2ad3e24fd1c0">"A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty"</a></span>. <i>The Journal of Bone and Joint Surgery. American Volume</i>. <b>98</b> (16): <span class="nowrap">1340–</span>1350. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2106%2Fjbjs.15.01202">10.2106/jbjs.15.01202</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27535436">27535436</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200929012600/https://ora.ox.ac.uk/objects/uuid:cbe29197-14a9-47dc-b961-2ad3e24fd1c0">Archived</a> from the original on September 29, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">August 24,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-pmid27069626-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27069626_53-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFPatelDickenson2016" class="citation journal cs1">Patel R, Dickenson AH (April 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325">"Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain"</a>. <i>Pharmacology Research &amp; Perspectives</i>. <b>4</b> (2): e00205. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fprp2.205">10.1002/prp2.205</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804325">4804325</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27069626">27069626</a>.</cite></span>
</li>
<li id="cite_note-pmid30712879-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid30712879_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid30712879_54-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFSleeNazarethBondaronekLiu2019" class="citation journal cs1">Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N (February 2019). <a rel="nofollow" class="external text" href="https://discovery.ucl.ac.uk/id/eprint/10070219/1/Freemantle_Slee_GAD_Meta_Text%20R1_20180627%20clean.pdf">"Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis"</a> <span class="cs1-format">(PDF)</span>. <i>Lancet</i>. <b>393</b> (10173): <span class="nowrap">768–</span>777. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2818%2931793-8">10.1016/S0140-6736(18)31793-8</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30712879">30712879</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:72332967">72332967</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200313031825/https://discovery.ucl.ac.uk/id/eprint/10070219/1/Freemantle_Slee_GAD_Meta_Text%20R1_20180627%20clean.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on March 13, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">September 8,</span> 2020</span>.</cite>; <cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200309183455/https://discovery.ucl.ac.uk/id/eprint/10070219/7/Freemantle_Slee_GAD_Web_Appendix%20R1_20180627.pdf">"Supplemental Appendices"</a> <span class="cs1-format">(PDF)</span>. June 5, 2018. Archived from <a rel="nofollow" class="external text" href="https://discovery.ucl.ac.uk/id/eprint/10070219/7/Freemantle_Slee_GAD_Web_Appendix%20R1_20180627.pdf">the original</a> <span class="cs1-format">(PDF)</span> on March 9, 2020.</cite>; <cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20201017231136/https://discovery.ucl.ac.uk/id/eprint/10084194/3/Nazareth_Lancet%20Correspondence051019.pdf">"Authors' Reply"</a> <span class="cs1-format">(PDF)</span>. June 5, 2018. Archived from <a rel="nofollow" class="external text" href="https://discovery.ucl.ac.uk/id/eprint/10084194/3/Nazareth_Lancet%20Correspondence051019.pdf">the original</a> <span class="cs1-format">(PDF)</span> on October 17, 2020.</cite></span>
</li>
<li id="cite_note-NIHR_Evidence-2022-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-NIHR_Evidence-2022_55-0">^</a></b></span> <span class="reference-text"><cite class="citation journal cs1"><span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://evidence.nihr.ac.uk/alert/review-finds-little-evidence-support-gabapentinoid-use-bipolar-disorder-or-insomnia/">"Review finds little evidence to support gabapentinoid use in bipolar disorder or insomnia"</a></span>. <i>NIHR Evidence</i> (Plain English summary). National Institute for Health and Care Research. October 17, 2022. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3310%2Fnihrevidence_54173">10.3310/nihrevidence_54173</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:252983016">252983016</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221127080508/https://evidence.nihr.ac.uk/alert/review-finds-little-evidence-support-gabapentinoid-use-bipolar-disorder-or-insomnia/">Archived</a> from the original on November 27, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-Hong_2022-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hong_2022_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hong_2022_56-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Hong_2022_56-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFHongAtkinsonAl-JuffaliAwad2022" class="citation journal cs1">Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, et&nbsp;al. (March 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095464">"Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale"</a>. <i>Molecular Psychiatry</i>. <b>27</b> (3): <span class="nowrap">1339–</span>1349. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41380-021-01386-6">10.1038/s41380-021-01386-6</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095464">9095464</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34819636">34819636</a>.</cite></span>
</li>
<li id="cite_note-pmid34819636-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid34819636_57-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFHongAtkinsonAl-JuffaliAwad2022" class="citation journal cs1">Hong JS, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, et&nbsp;al. (March 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095464">"Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale"</a>. <i>Molecular Psychiatry</i>. <b>27</b> (3): <span class="nowrap">1339–</span>1349. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41380-021-01386-6">10.1038/s41380-021-01386-6</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095464">9095464</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34819636">34819636</a>.</cite></span>
</li>
<li id="cite_note-pmid22540422-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22540422_58-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBandelowSherBuneviciusHollander2012" class="citation journal cs1">Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, et&nbsp;al. (June 2012). <a rel="nofollow" class="external text" href="https://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Bandelow_et_al_01.pdf">"Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care"</a> <span class="cs1-format">(PDF)</span>. <i>International Journal of Psychiatry in Clinical Practice</i>. <b>16</b> (2): <span class="nowrap">77–</span>84. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F13651501.2012.667114">10.3109/13651501.2012.667114</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22540422">22540422</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:16253034">16253034</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180403134713/http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Bandelow_et_al_01.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on April 3, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">October 16,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-pmid22395254-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22395254_59-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFWenselPoweCates2012" class="citation journal cs1">Wensel TM, Powe KW, Cates ME (March 2012). "Pregabalin for the treatment of generalized anxiety disorder". <i>The Annals of Pharmacotherapy</i>. <b>46</b> (3): <span class="nowrap">424–</span>429. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1345%2Faph.1Q405">10.1345/aph.1Q405</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22395254">22395254</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26320851">26320851</a>.</cite></span>
</li>
<li id="cite_note-pmid17940637-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17940637_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17940637_60-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFOwen2007" class="citation journal cs1">Owen RT (September 2007). "Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety". <i>Drugs of Today</i>. <b>43</b> (9): <span class="nowrap">601–</span>610. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1358%2Fdot.2007.43.9.1133188">10.1358/dot.2007.43.9.1133188</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17940637">17940637</a>.</cite></span>
</li>
<li id="cite_note-Drugs.com-2021-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-Drugs.com-2021_61-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/medical-answers/long-lyrica-work-3558304/">"How long does it take for Lyrica to work?"</a>. <i>Drugs.com</i>. May 25, 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220218195925/https://www.drugs.com/medical-answers/long-lyrica-work-3558304/">Archived</a> from the original on February 18, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">February 18,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-pmid17610384-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17610384_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17610384_62-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17610384_62-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17610384_62-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFBandelowWedekindLeon2007" class="citation journal cs1">Bandelow B, Wedekind D, Leon T (July 2007). "Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention". <i>Expert Review of Neurotherapeutics</i>. <b>7</b> (7): <span class="nowrap">769–</span>781. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1586%2F14737175.7.7.769">10.1586/14737175.7.7.769</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17610384">17610384</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6229344">6229344</a>.</cite></span>
</li>
<li id="cite_note-pmid34577534-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid34577534_63-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFNgHanTeohYaow2021" class="citation journal cs1">Ng QX, Han MX, Teoh SE, Yaow CY, Lim YL, Chee KT (August 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469561">"A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder"</a>. <i>Pharmaceuticals</i>. <b>14</b> (9): 834. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fph14090834">10.3390/ph14090834</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469561">8469561</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34577534">34577534</a>.</cite></span>
</li>
<li id="cite_note-pmid34637958-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid34637958_64-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFGiménez-CamposPimenta-Fermisson-RamosDíaz-CambroneroCarbonell-Sanchís2022" class="citation journal cs1">Giménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI, Carbonell-Sanchís R, López-Briz E, Ruíz-García V (January 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515246">"A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain"</a>. <i>Atencion Primaria</i>. <b>54</b> (1). Elsevier BV: 102144. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.aprim.2021.102144">10.1016/j.aprim.2021.102144</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515246">8515246</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34637958">34637958</a>.</cite></span>
</li>
<li id="cite_note-pmid28809936-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid28809936_65-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFShanthannaGilronRajarathinamAlAmri2017" class="citation journal cs1">Shanthanna H, Gilron I, Rajarathinam M, AlAmri R, Kamath S, Thabane L, et&nbsp;al. (August 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428">"Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials"</a>. <i>PLOS Medicine</i>. <b>14</b> (8): e1002369. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pmed.1002369">10.1371/journal.pmed.1002369</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557428">5557428</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28809936">28809936</a>.</cite></span>
</li>
<li id="cite_note-Mannix-2018-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mannix-2018_66-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMannix2018" class="citation news cs1">Mannix L (December 18, 2018). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181218193541/https://www.canberratimes.com.au/national/victoria/this-popular-drug-is-linked-to-addiction-and-suicide-why-do-doctors-keep-prescribing-it-20181129-p50j1x.html">"This popular drug is linked to addiction and suicide. Why do doctors keep prescribing it?"</a>. <i><a href="The_Canberra_Times" title="The Canberra Times">The Canberra Times</a></i>. Archived from <a rel="nofollow" class="external text" href="https://www.canberratimes.com.au/national/victoria/this-popular-drug-is-linked-to-addiction-and-suicide-why-do-doctors-keep-prescribing-it-20181129-p50j1x.html">the original</a> on December 18, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">December 18,</span> 2018</span>.</cite></span>
</li>
<li id="cite_note-pmid27848217-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid27848217_67-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFFreynhagenBackonjaSchugLyndon2016" class="citation journal cs1">Freynhagen R, Backonja M, Schug S, Lyndon G, Parsons B, Watt S, et&nbsp;al. (December 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124051">"Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review"</a>. <i>CNS Drugs</i>. <b>30</b> (12): <span class="nowrap">1191–</span>1200. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-016-0390-z">10.1007/s40263-016-0390-z</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124051">5124051</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27848217">27848217</a>.</cite></span>
</li>
<li id="cite_note-pmid23797675-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23797675_68-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFLindeMullenersChronicleMcCrory2013" class="citation journal cs1">Linde M, Mulleners WM, Chronicle EP, McCrory DC (June 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858">"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>6</b> (6): CD010609. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD010609">10.1002/14651858.CD010609</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858">6599858</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23797675">23797675</a>.</cite></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite id="CITEREFPathakKelleherBrennanAmarnani2025" class="citation journal cs1">Pathak A, Kelleher EM, Brennan I, Amarnani R, Wall A, Murphy R, et&nbsp;al. (March 2025). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Frheumatology%2Fkeaf147">"Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis"</a>. <i>Rheumatology</i>: keaf147. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Frheumatology%2Fkeaf147">10.1093/rheumatology/keaf147</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/40084994">40084994</a>.</cite></span>
</li>
<li id="cite_note-pmid30670513-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30670513_70-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFOnakpoyaThomasLeeGoldacre2019" class="citation journal cs1">Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ (January 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347863">"Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials"</a>. <i>BMJ Open</i>. <b>9</b> (1): e023600. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmjopen-2018-023600">10.1136/bmjopen-2018-023600</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347863">6347863</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30670513">30670513</a>.</cite></span>
</li>
<li id="cite_note-Federal_Register-2005-71"><span class="mw-cite-backlink">^ <a href="#cite_ref-Federal_Register-2005_71-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Federal_Register-2005_71-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Federal_Register-2005_71-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.federalregister.gov/documents/2005/07/28/05-15036/schedules-of-controlled-substances-placement-of-pregabalin-into-schedule-v">"Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V"</a>. <i>Federal Register</i>. July 28, 2005. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210802131217/https://www.federalregister.gov/documents/2005/07/28/05-15036/schedules-of-controlled-substances-placement-of-pregabalin-into-schedule-v">Archived</a> from the original on August 2, 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-Slocum-2018-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-Slocum-2018_72-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSlocumSchultGorodetskyWiegand2018" class="citation journal cs1">Slocum GW, Schult RF, Gorodetsky RM, Wiegand TJ, Kamali M, Acquisto NM (January 1, 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F24734306.2018.1458465">"Pregabalin and paradoxical reaction of seizures in a large overdose"</a>. <i>Toxicology Communications</i>. <b>2</b> (1): <span class="nowrap">19–</span>20. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F24734306.2018.1458465">10.1080/24734306.2018.1458465</a></span>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:79760296">79760296</a>.</cite></span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><cite id="CITEREFSemelMurphyZlatevaCheung2010" class="citation journal cs1">Semel D, Murphy TK, Zlateva G, Cheung R, Emir B (November 2010). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988717">"Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies"</a>. <i>BMC Family Practice</i>. <b>11</b> (1): 85. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1186%2F1471-2296-11-85">10.1186/1471-2296-11-85</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988717">2988717</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21054853">21054853</a>.</cite></span>
</li>
<li id="cite_note-Pfizer_Australia_Pty_Ltd.-2006-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pfizer_Australia_Pty_Ltd.-2006_74-0">^</a></b></span> <span class="reference-text"><cite class="citation cs2"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20180313141049/https://www.pfizer.com.au/products/lyrica">"Lyrica (Australian Approved Product Information)"</a>, <i>Pfizer: The World's Largest Research-Based Pharmaceutical Company</i>, Pfizer Australia Pty Ltd., 2006, archived from <a rel="nofollow" class="external text" href="https://www.pfizer.com.au/products/lyrica">the original</a> on March 13, 2018</cite></span>
</li>
<li id="cite_note-AMH2006-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-AMH2006_75-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFRossi2006" class="citation book cs1">Rossi S, ed. (2006). <i>Australian Medicines Handbook, 2006</i>. Australian Medicines Handbook. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-9757919-2-9</bdi>.</cite></span>
</li>
<li id="cite_note-USFDA-2011-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-USFDA-2011_76-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110908154358/http://www.fda.gov/downloads/Drugs/DrugSafety/UCM152825.pdf">"Medication Guide (Pfizer Inc.)"</a> <span class="cs1-format">(PDF)</span>. U.S. <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). June 2011. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/downloads/Drugs/DrugSafety/UCM152825.pdf">the original</a> <span class="cs1-format">(PDF)</span> on September 8, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">November 6,</span> 2011</span>.</cite></span>
</li>
<li id="cite_note-Millar-2013-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-Millar-2013_77-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMillarSadasivanWeatherupLutton2013" class="citation journal cs1">Millar J, Sadasivan S, Weatherup N, Lutton S (September 7, 2013). "Lyrica Nights–Recreational Pregabalin Abuse in an Urban Emergency Department". <i>Emergency Medicine Journal</i>. <b>30</b> (10): 874.2–874. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Femermed-2013-203113.20">10.1136/emermed-2013-203113.20</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:73986091">73986091</a>.</cite></span>
</li>
<li id="cite_note-medicines.org.uk-2020-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-medicines.org.uk-2020_78-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/EMC/medicine/14651/SPC/Lyrica+Capsules/">"Lyrica Capsules"</a>. <i>medicines.org.uk</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201020191035/https://www.medicines.org.uk/EMC/medicine/14651/SPC/Lyrica+Capsules/">Archived</a> from the original on October 20, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 19,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200212033514/https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf">"LYRICA (pregabalin) Capsules &amp; Oral Solution, CV"</a> <span class="cs1-format">(PDF)</span>. <i>accessdata.fda.gov</i>. 2018. Archived from <a rel="nofollow" class="external text" href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf">the original</a> <span class="cs1-format">(PDF)</span> on February 12, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">February 26,</span> 2025</span>.</cite></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://bpac.org.nz/2024/deprescribing-gabapentin.aspx">"Deprescribing gabapentinoids - bpacnz"</a>. <i>bpac.org.nz</i>.</cite></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite id="CITEREFNHS_Somerset_Integrated_Care_Board" class="citation web cs1">NHS Somerset Integrated Care Board. <a rel="nofollow" class="external text" href="https://nhssomerset.nhs.uk/wp-content/uploads/sites/2/ICB-tapering-gabapentinoid-v1approved-2.docx">"Gabapentinoid suggested tapering regimes"</a>.</cite></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/pregnancy/pregabalin.html">"Pregabalin Pregnancy and Breastfeeding Warnings"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190321033634/https://www.drugs.com/pregnancy/pregabalin.html">Archived</a> from the original on March 21, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">August 29,</span> 2016</span>.</cite></span>
</li>
<li id="cite_note-USFDA-2019-Serious-Breathing-Problems-83"><span class="mw-cite-backlink">^ <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems_83-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20191222091828/https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin">"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems"</a>. <i>U.S. <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. December 19, 2019. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin">the original</a> on December 22, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2019</span>.</cite> <span class="noviewer" typeof="mw:File"><span></span></span> This article incorporates text from this source, which is in the <a href="Public_domain" title="Public domain">public domain</a>.</span>
</li>
<li id="cite_note-USFDA-2019-Serious-Breathing-Problems-PDF-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-USFDA-2019-Serious-Breathing-Problems-PDF_84-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/media/133681/download">"FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems"</a> <span class="cs1-format">(PDF)</span>. <i>U.S. <a href="Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. December 19, 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191222091828/https://www.fda.gov/media/133681/download">Archived</a> from the original on December 22, 2019.</cite> <span class="noviewer" typeof="mw:File"><span></span></span> This article incorporates text from this source, which is in the <a href="Public_domain" title="Public domain">public domain</a>.</span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/medical-answers/lyrica-controlled-substance-narcotic-3571636/">"Is Lyrica a controlled substance / Narcotic?"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240204164725/https://www.drugs.com/medical-answers/lyrica-controlled-substance-narcotic-3571636/">Archived</a> from the original on February 4, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">May 6,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-pmid30726003-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30726003_86-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFPreussKalavaKing2024" class="citation book cs1">Preuss CV, Kalava A, King KC (2024). <i>Prescription of Controlled Substances: Benefits and Risks</i>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30726003">30726003</a>.</cite></span>
</li>
<li id="cite_note-pmid33008420-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid33008420_87-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSharpeSinclairKramerde_Manincor2020" class="citation journal cs1">Sharpe L, Sinclair J, Kramer A, de Manincor M, Sarris J (October 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531079">"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties"</a>. <i>Journal of Translational Medicine</i>. <b>18</b> (1): 374. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12967-020-02518-2">10.1186/s12967-020-02518-2</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531079">7531079</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33008420">33008420</a>.</cite></span>
</li>
<li id="cite_note-pmid26767525-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid26767525_88-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSchjerningRosenzweigPottegårdDamkier2016" class="citation journal cs1">Schjerning O, Rosenzweig M, Pottegård A, Damkier P, Nielsen J (January 2016). "Abuse Potential of Pregabalin: A Systematic Review". <i>CNS Drugs</i>. <b>30</b> (1): <span class="nowrap">9–</span>25. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40263-015-0303-6">10.1007/s40263-015-0303-6</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26767525">26767525</a>.</cite></span>
</li>
<li id="cite_note-pmid30381161-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30381161_89-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFDesaiKherallahSzaboMarawar2019" class="citation journal cs1">Desai A, Kherallah Y, Szabo C, Marawar R (March 2019). "Gabapentin or pregabalin induced myoclonus: A case series and literature review". <i>Journal of Clinical Neuroscience</i>. <b>61</b>: <span class="nowrap">225–</span>234. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jocn.2018.09.019">10.1016/j.jocn.2018.09.019</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30381161">30381161</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:53165515">53165515</a>.</cite></span>
</li>
<li id="cite_note-pmid30405948-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30405948_90-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFTanyıldızKandemirManganTangılntız2018" class="citation journal cs1">Tanyıldız B, Kandemir B, Mangan MS, Tangılntız A, Göktaş E, Şimşek S (October 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216534">"Bilateral Serous Macular Detachment After Attempted Suicide with Pregabalin"</a>. <i>Turkish Journal of Ophthalmology</i>. <b>48</b> (5): <span class="nowrap">254–</span>257. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4274%2Ftjo.70923">10.4274/tjo.70923</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216534">6216534</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30405948">30405948</a>.</cite></span>
</li>
<li id="cite_note-Murphy-2008-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-Murphy-2008_91-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMurphyMosher2008" class="citation journal cs1">Murphy NG, Mosher L (2008). <a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F15563650802255033">"79. Severe myoclonus from pregabalin (Lyrica) due to chronic renal insufficiency"</a>. <i>Clinical Toxicology</i>. <b>46</b> (7): 604. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F15563650802255033">10.1080/15563650802255033</a></span>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:218857181">218857181</a>.</cite></span>
</li>
<li id="cite_note-pmid19493601-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19493601_92-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFYooMatalonHoffmanGoldfarb2009" class="citation journal cs1">Yoo L, Matalon D, Hoffman RS, Goldfarb DS (December 2009). <a rel="nofollow" class="external text" href="http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.955.4223&amp;rep=rep1&amp;type=pdf">"Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure"</a> <span class="cs1-format">(PDF)</span>. <i>American Journal of Kidney Diseases</i>. <b>54</b> (6): <span class="nowrap">1127–</span>1130. <a href="CiteSeerX_(identifier)" class="mw-redirect" title="CiteSeerX (identifier)">CiteSeerX</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.955.4223">10.1.1.955.4223</a></span>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.ajkd.2009.04.014">10.1053/j.ajkd.2009.04.014</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19493601">19493601</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220412003441/http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.955.4223&amp;rep=rep1&amp;type=pdf">Archived</a> from the original on April 12, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">October 19,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Baselt-2008-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-Baselt-2008_93-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBaselt2008" class="citation book cs1">Baselt RC (2008). <i>Disposition of Toxic Drugs and Chemicals in Man</i> (8th&nbsp;ed.). Biomedical Publications. pp.&nbsp;<span class="nowrap">1296–</span>1297. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-9626523-7-0</bdi>.</cite></span>
</li>
<li id="cite_note-Lexi-Drugs_[database_on_the_Internet-2007-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lexi-Drugs_[database_on_the_Internet-2007_94-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20201019225603/https://www.localhealthrx.com/drugs/pregabalin/">"Pregabalin"</a>. <i>Lexi-Drugs [database on the Internet</i>. Hudson (OH): Lexi-Comp, Inc. 2007. Archived from <a rel="nofollow" class="external text" href="https://www.localhealthrx.com/drugs/pregabalin/">the original</a> on October 19, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 29,</span> 2015</span>.</cite>.</span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medcentral.com/drugs/monograph/93954-305048/pregabalin-oral">"Pregabalin oral"</a>. <i>MedCentral</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 31,</span> 2025</span>.</cite></span>
</li>
<li id="cite_note-pmid38635889-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid38635889_96-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFZhangDuLuWu2024" class="citation journal cs1">Zhang M, Du K, Lu Y, Wu W, Yan H, Jiang Q, et&nbsp;al. (April 2024). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032052">"Pregabalin-induced delayed cutaneous hypersensitivity reaction occurring after 40 days of use: a case report"</a>. <i>The Journal of International Medical Research</i>. <b>52</b> (4): 3000605241245004. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F03000605241245004">10.1177/03000605241245004</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032052">11032052</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/38635889">38635889</a>.</cite></span>
</li>
<li id="cite_note-circular-0192018-97"><span class="mw-cite-backlink">^ <a href="#cite_ref-circular-0192018_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-circular-0192018_97-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gov.uk/government/publications/circular-0192018-control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971/control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971">"Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240221044657/https://www.gov.uk/government/publications/circular-0192018-control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971/control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971">Archived</a> from the original on February 21, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">February 21,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs">"Pregabalin and gabapentin to be controlled as class C drugs"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201112034051/https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs">Archived</a> from the original on November 12, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">April 2,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Dooley-2007-99"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dooley-2007_99-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dooley-2007_99-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFDooleyTaylorDonevanFeltner2007" class="citation journal cs1">Dooley DJ, Taylor CP, Donevan S, Feltner D (February 2007). "Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission". <i>Trends in Pharmacological Sciences</i>. <b>28</b> (2): <span class="nowrap">75–</span>82. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tips.2006.12.006">10.1016/j.tips.2006.12.006</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17222465">17222465</a>.</cite></span>
</li>
<li id="cite_note-Taylor-2020-100"><span class="mw-cite-backlink">^ <a href="#cite_ref-Taylor-2020_100-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Taylor-2020_100-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFTaylorHarris2020" class="citation journal cs1">Taylor CP, Harris EW (July 2020). "Analgesia with Gabapentin and Pregabalin May Involve <i>N</i>-Methyl-d-Aspartate Receptors, Neurexins, and Thrombospondins". <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>374</b> (1): <span class="nowrap">161–</span>174. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1124%2Fjpet.120.266056">10.1124/jpet.120.266056</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32321743">32321743</a>.</cite></span>
</li>
<li id="cite_note-pmid23009881-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23009881_101-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFHolsboer-TrachslerPrieto2013" class="citation journal cs1">Holsboer-Trachsler E, Prieto R (May 2013). "Effects of pregabalin on sleep in generalized anxiety disorder". <i>The International Journal of Neuropsychopharmacology</i>. <b>16</b> (4): <span class="nowrap">925–</span>936. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS1461145712000922">10.1017/S1461145712000922</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23009881">23009881</a>.</cite></span>
</li>
<li id="cite_note-pmid16376147-102"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16376147_102-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid16376147_102-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFSills2006" class="citation journal cs1">Sills GJ (February 2006). "The mechanisms of action of gabapentin and pregabalin". <i>Current Opinion in Pharmacology</i>. <b>6</b> (1): <span class="nowrap">108–</span>113. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.coph.2005.11.003">10.1016/j.coph.2005.11.003</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16376147">16376147</a>.</cite></span>
</li>
<li id="cite_note-pmid10189176-103"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid10189176_103-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid10189176_103-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid10189176_103-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFBryansWustrow1999" class="citation journal cs1">Bryans JS, Wustrow DJ (March 1999). "3-substituted GABA analogs with central nervous system activity: a review". <i>Medicinal Research Reviews</i>. <b>19</b> (2): <span class="nowrap">149–</span>177. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F%28SICI%291098-1128%28199903%2919%3A2%3C149%3A%3AAID-MED3%3E3.0.CO%3B2-B">10.1002/(SICI)1098-1128(199903)19:2&lt;149::AID-MED3&gt;3.0.CO;2-B</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10189176">10189176</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:38496241">38496241</a>.</cite></span>
</li>
<li id="cite_note-pmid23642658-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid23642658_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid23642658_104-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid23642658_104-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFStahlPorrecaTaylorCheung2013" class="citation journal cs1">Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A (June 2013). "The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?". <i>Trends in Pharmacological Sciences</i>. <b>34</b> (6): <span class="nowrap">332–</span>339. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tips.2013.04.001">10.1016/j.tips.2013.04.001</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23642658">23642658</a>.</cite></span>
</li>
<li id="cite_note-pmid17403543-105"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17403543_105-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17403543_105-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFDaviesHendrichVan_MinhWratten2007" class="citation journal cs1">Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC (May 2007). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Functional+biology+of+the+%CE%B12%CE%B4+subunits+of+voltage-gated+calcium+channels&amp;btnG=">"Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels"</a></span>. <i>Trends in Pharmacological Sciences</i>. <b>28</b> (5): <span class="nowrap">220–</span>228. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tips.2007.03.005">10.1016/j.tips.2007.03.005</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17403543">17403543</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201021072722/https://scholar.google.com/scholar?hl=en&amp;as_sdt=0,5&amp;q=Functional+biology+of+the+%CE%B12%CE%B4+subunits+of+voltage-gated+calcium+channels&amp;btnG=">Archived</a> from the original on October 21, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 19,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-pmid21897498-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21897498_106-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBaidyaAgarwalKhannaArora2011" class="citation journal cs1">Baidya DK, Agarwal A, Khanna P, Arora MK (July 2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161452">"Pregabalin in acute and chronic pain"</a>. <i>Journal of Anaesthesiology Clinical Pharmacology</i>. <b>27</b> (3): <span class="nowrap">307–</span>314. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.4103%2F0970-9185.83672">10.4103/0970-9185.83672</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161452">3161452</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21897498">21897498</a>.</cite></span>
</li>
<li id="cite_note-McMahon-2013-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-McMahon-2013_107-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMcMahon2013" class="citation book cs1">McMahon SB (2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=bNlvQJSqrB8C&amp;pg=PA515"><i>Wall and Melzack's textbook of pain</i></a> (6th&nbsp;ed.). Philadelphia, PA: Elsevier/Saunders. p.&nbsp;515. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>9780702040597</bdi>.</cite></span>
</li>
<li id="cite_note-pmid17126531-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17126531_108-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFTaylorAngelottiFauman2007" class="citation journal cs1">Taylor CP, Angelotti T, Fauman E (February 2007). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Pharmacology+and+mechanism+of+action+of+pregabalin%3A+The+calcium+channel+%CE%B12%E2%80%93%CE%B4+%28alpha2%E2%80%93delta%29+subunit+as+a+target+for+antiepileptic+drug+discovery&amp;btnG=">"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery"</a></span>. <i>Epilepsy Research</i>. <b>73</b> (2): <span class="nowrap">137–</span>150. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.eplepsyres.2006.09.008">10.1016/j.eplepsyres.2006.09.008</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17126531">17126531</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:54254671">54254671</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201023083313/https://scholar.google.com/scholar?hl=en&amp;as_sdt=0,5&amp;q=Pharmacology+and+mechanism+of+action+of+pregabalin:+The+calcium+channel+%CE%B12%E2%80%93%CE%B4+(alpha2%E2%80%93delta)+subunit+as+a+target+for+antiepileptic+drug+discovery&amp;btnG=">Archived</a> from the original on October 23, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 19,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-pmid12665421-109"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12665421_109-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12665421_109-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFLauria-HornerPohl2003" class="citation journal cs1">Lauria-Horner BA, Pohl RB (April 2003). "Pregabalin: a new anxiolytic". <i>Expert Opinion on Investigational Drugs</i>. <b>12</b> (4): <span class="nowrap">663–</span>672. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1517%2F13543784.12.4.663">10.1517/13543784.12.4.663</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12665421">12665421</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36137322">36137322</a>.</cite></span>
</li>
<li id="cite_note-pmid23567998-110"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid23567998_110-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid23567998_110-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid23567998_110-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid23567998_110-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFDickensWebbAntonyukGiannoudis2013" class="citation journal cs1">Dickens D, Webb SD, Antonyuk S, Giannoudis A, Owen A, Rädisch S, et&nbsp;al. (June 2013). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=+Transport+of+gabapentin+by+LAT1+%28SLC7A5%29+&amp;btnG=">"Transport of gabapentin by LAT1 (SLC7A5)"</a></span>. <i>Biochemical Pharmacology</i>. <b>85</b> (11): <span class="nowrap">1672–</span>1683. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bcp.2013.03.022">10.1016/j.bcp.2013.03.022</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23567998">23567998</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201021020947/https://scholar.google.com/scholar?hl=en&amp;as_sdt=0,5&amp;q=+Transport+of+gabapentin+by+LAT1+(SLC7A5)+&amp;btnG=">Archived</a> from the original on October 21, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 19,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-pmid18656534-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18656534_111-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFdel_AmoUrttiYliperttula2008" class="citation journal cs1">del Amo EM, Urtti A, Yliperttula M (October 2008). "Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2". <i>European Journal of Pharmaceutical Sciences</i>. <b>35</b> (3): <span class="nowrap">161–</span>174. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ejps.2008.06.015">10.1016/j.ejps.2008.06.015</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18656534">18656534</a>.</cite></span>
</li>
<li id="cite_note-pmid26305616-112"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid26305616_112-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid26305616_112-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFGeldenhuysMohammadAdkinsLockman2015" class="citation journal cs1">Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR (2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962">"Molecular determinants of blood-brain barrier permeation"</a>. <i>Therapeutic Delivery</i>. <b>6</b> (8): <span class="nowrap">961–</span>971. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4155%2Ftde.15.32">10.4155/tde.15.32</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675962">4675962</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26305616">26305616</a>.</cite></span>
</li>
<li id="cite_note-pmid19937841-113"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19937841_113-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19937841_113-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFMüller2009" class="citation journal cs1">Müller CE (November 2009). "Prodrug approaches for enhancing the bioavailability of drugs with low solubility". <i>Chemistry &amp; Biodiversity</i>. <b>6</b> (11): <span class="nowrap">2071–</span>2083. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fcbdv.200900114">10.1002/cbdv.200900114</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19937841">19937841</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32513471">32513471</a>.</cite></span>
</li>
<li id="cite_note-pmid10518579-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10518579_114-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBoadoLiNagayaZhang1999" class="citation journal cs1">Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (October 1999). <a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.96.21.12079">"Selective expression of the large neutral amino acid transporter at the blood-brain barrier"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>96</b> (21): <span class="nowrap">12079–</span>12084. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1999PNAS...9612079B">1999PNAS...9612079B</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.96.21.12079">10.1073/pnas.96.21.12079</a></span>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&nbsp;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18415">18415</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10518579">10518579</a>.</cite></span>
</li>
<li id="cite_note-ADTPD-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-ADTPD_115-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMcElroyKeckPost2008" class="citation book cs1"><a href="Susan_McElroy" title="Susan McElroy">McElroy SL</a>, Keck PE, Post RM, eds. (2008). <i>Antiepileptic Drugs to Treat Psychiatric Disorders</i>. INFRMA-HC. p.&nbsp;370. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-8493-8259-8</bdi>.</cite></span>
</li>
<li id="cite_note-pmid37918778-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid37918778_116-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMaBjörnssonChalasani2024" class="citation journal cs1">Ma J, Björnsson ES, Chalasani N (February 2024). "The Safe Use of Analgesics in Patients with Cirrhosis: A Narrative Review". <i>Am J Med</i>. <b>137</b> (2): <span class="nowrap">99–</span>106. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.amjmed.2023.10.022">10.1016/j.amjmed.2023.10.022</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/37918778">37918778</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:264888110">264888110</a>.</cite></span>
</li>
<li id="cite_note-pmid18221197-117"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18221197_117-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18221197_117-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFYogeeswariRagavendranSriram2006" class="citation journal cs1">Yogeeswari P, Ragavendran JV, Sriram D (January 2006). "An update on GABA analogs for CNS drug discovery". <i>Recent Patents on CNS Drug Discovery</i>. <b>1</b> (1): <span class="nowrap">113–</span>118. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F157488906775245291">10.2174/157488906775245291</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18221197">18221197</a>.</cite></span>
</li>
<li id="cite_note-pmid11966555-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11966555_118-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFRoseKam2002" class="citation journal cs1">Rose MA, Kam PC (May 2002). "Gabapentin: pharmacology and its use in pain management". <i>Anaesthesia</i>. <b>57</b> (5): <span class="nowrap">451–</span>462. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.0003-2409.2001.02399.x">10.1046/j.0003-2409.2001.02399.x</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11966555">11966555</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:27431734">27431734</a>.</cite></span>
</li>
<li id="cite_note-WhelessWillmore2009-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-WhelessWillmore2009_119-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFWhelessWillmoreBrumback2009" class="citation book cs1">Wheless JW, Willmore J, Brumback RA (2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=4W7UI-FPZmoC&amp;pg=PA302"><i>Advanced Therapy in Epilepsy</i></a>. PMPH-USA. p.&nbsp;302. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-1-60795-004-2</bdi>.</cite></span>
</li>
<li id="cite_note-VardanyanHruby2016-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-VardanyanHruby2016_120-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFVardanyanHruby2016" class="citation book cs1">Vardanyan R, Hruby V (January 7, 2016). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=A8oHBgAAQBAJ&amp;pg=PA158"><i>Synthesis of Best-Seller Drugs</i></a>. Elsevier Science. p.&nbsp;158. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-0-12-411524-8</bdi>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210829003809/https://books.google.com/books?id=A8oHBgAAQBAJ&amp;pg=PA158">Archived</a> from the original on August 29, 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">June 22,</span> 2018</span>.</cite></span>
</li>
<li id="cite_note-AndrushkoAndrushko2013-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-AndrushkoAndrushko2013_121-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFAndrushkoAndrushko2013" class="citation book cs1">Andrushko V, Andrushko N (August 16, 2013). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=jXFwAAAAQBAJ&amp;pg=PA869"><i>Stereoselective Synthesis of Drugs and Natural Products</i></a>. John Wiley &amp; Sons. p.&nbsp;869. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>978-1-118-62833-1</bdi>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210829205931/https://books.google.com/books?id=jXFwAAAAQBAJ&amp;pg=PA869">Archived</a> from the original on August 29, 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">June 22,</span> 2018</span>.</cite></span>
</li>
<li id="cite_note-Kaye-2014-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kaye-2014_122-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFKayeVadiveluUrman2014" class="citation book cs1">Kaye AD, Vadivelu N, Urman RD (2014). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=ms2lBQAAQBAJ&amp;pg=PA324"><i>Substance Abuse: Inpatient and Outpatient Management for Every Clinician</i></a>. Springer. p.&nbsp;324. <a href="ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&nbsp;<bdi>9781493919512</bdi>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220301084046/https://books.google.com/books?id=ms2lBQAAQBAJ&amp;pg=PA324">Archived</a> from the original on March 1, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">August 24,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Lowe-2008-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lowe-2008_123-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFLowe2008" class="citation web cs1"><a href="Derek_Lowe_(chemist)" title="Derek Lowe (chemist)">Lowe D</a> (March 25, 2008). <a rel="nofollow" class="external text" href="https://www.science.org/content/blog-post/getting-lyrica">"Getting to Lyrica"</a>. <i>In the Pipeline</i>. Science. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220827061356/https://www.science.org/content/blog-post/getting-lyrica">Archived</a> from the original on August 27, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">November 21,</span> 2015</span>.</cite></span>
</li>
<li id="cite_note-Andruszkiewicz-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-Andruszkiewicz_124-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFAndruszkiewiczSilverman1990" class="citation journal cs1">Andruszkiewicz R, Silverman RB (December 1990). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0021-9258%2818%2945702-X">"4-Amino-3-alkylbutanoic acids as substrates for gamma-aminobutyric acid aminotransferase"</a>. <i>The Journal of Biological Chemistry</i>. <b>265</b> (36): <span class="nowrap">22288–</span>22291. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0021-9258%2818%2945702-X">10.1016/S0021-9258(18)45702-X</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2266125">2266125</a>.</cite></span>
</li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><cite id="CITEREFSilvermanAndruszkiewiczNanavatiTaylor1991" class="citation journal cs1">Silverman RB, Andruszkiewicz R, Nanavati SM, Taylor CP, Vartanian MG (July 1991). "3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase". <i>Journal of Medicinal Chemistry</i>. <b>34</b> (7): <span class="nowrap">2295–</span>2298. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fjm00111a053">10.1021/jm00111a053</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/2067001">2067001</a>.</cite></span>
</li>
<li id="cite_note-Merrill-2010-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-Merrill-2010_126-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMerrill2010" class="citation news cs1">Merrill N (February 25, 2010). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160601194802/http://www.northbynorthwestern.com/story/silvermans-golden-drug-makes-him-nus-golden-ticket/">"Silverman's golden drug makes him NU's golden ticket"</a>. <i>North by Northwestern</i>. Archived from <a rel="nofollow" class="external text" href="http://www.northbynorthwestern.com/story/silvermans-golden-drug-makes-him-nus-golden-ticket/">the original</a> on June 1, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">May 19,</span> 2016</span>.</cite></span>
</li>
<li id="cite_note-pmid15959952-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15959952_127-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFDworkinKirkpatrick2005" class="citation journal cs1">Dworkin RH, Kirkpatrick P (June 2005). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Fresh+from+the+pipeline%3A+Pregabalin+2005&amp;btnG=">"Pregabalin"</a></span>. <i>Nature Reviews. Drug Discovery</i>. <b>4</b> (6): <span class="nowrap">455–</span>456. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrd1756">10.1038/nrd1756</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15959952">15959952</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:265702200">265702200</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201029175208/https://scholar.google.com/scholar?hl=en&amp;as_sdt=0,5&amp;q=Fresh+from+the+pipeline:+Pregabalin+2005&amp;btnG=">Archived</a> from the original on October 29, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Seeking_Alpha-2017-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-Seeking_Alpha-2017_128-0">^</a></b></span> <span class="reference-text"><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://seekingalpha.com/news/3300636-fda-approves-lyrica-cr-extended-release-tablets-cv">"FDA approves LYRICA CR extended-release tablets CV"</a>. <i>Seeking Alpha</i>. October 12, 2017. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220920163128/https://seekingalpha.com/news/3300636-fda-approves-lyrica-cr-extended-release-tablets-cv">Archived</a> from the original on September 20, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">September 16,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-Reuters-2018-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-Reuters-2018_129-0">^</a></b></span> <span class="reference-text"><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/brief-fda-approves-pfizers-lyrica-cr-ext/brief-fda-approves-pfizers-lyrica-cr-extended-release-tablets-cv-idUSASB0BMUS">"BRIEF-FDA approves Pfizer's Lyrica CR extended-release tablets CV"</a>. <i>Reuters</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181004021252/https://www.reuters.com/article/brief-fda-approves-pfizers-lyrica-cr-ext/brief-fda-approves-pfizers-lyrica-cr-extended-release-tablets-cv-idUSASB0BMUS">Archived</a> from the original on October 4, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">October 3,</span> 2018</span>.</cite></span>
</li>
<li id="cite_note-Drugs.com-Lyrica-2016-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-Drugs.com-Lyrica-2016_130-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/pro/lyrica.html">"Lyrica: Package Insert &amp; Prescribing Information"</a>. <i>Drugs.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170813014258/https://www.drugs.com/pro/lyrica.html">Archived</a> from the original on August 13, 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">August 18,</span> 2016</span>.</cite></span>
</li>
<li id="cite_note-DEA_Diversion_Control_Division-2005-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-DEA_Diversion_Control_Division-2005_131-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.deadiversion.usdoj.gov/fed_regs/rules/2005/fr0728.htm">"2005 - Placement of Pregabalin Into Schedule V"</a>. <i>DEA Diversion Control Division</i>. July 28, 2005. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220528181200/https://www.deadiversion.usdoj.gov/fed_regs/rules/2005/fr0728.htm">Archived</a> from the original on May 28, 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">August 27,</span> 2022</span>.</cite></span>
</li>
<li id="cite_note-usdoj.gov-2015-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-usdoj.gov-2015_132-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200903190235/https://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_15.htm">"Title 21 CFR – PART 1308 – Section 1308.15 Schedule V"</a>. <i>usdoj.gov</i>. Archived from <a rel="nofollow" class="external text" href="https://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_15.htm">the original</a> on September 3, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">September 27,</span> 2015</span>.</cite></span>
</li>
<li id="cite_note-Felleskatalogen-2015-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-Felleskatalogen-2015_133-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1 cs1-prop-foreign-lang-source"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20161223153207/https://www.felleskatalogen.no/medisin/lyrica-pfizer-561166">"Lyrica"</a>. <i>Felleskatalogen</i> (in Norwegian). May 7, 2015. Archived from <a rel="nofollow" class="external text" href="https://www.felleskatalogen.no/medisin/lyrica-pfizer-561166">the original</a> on December 23, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Chalabianloo-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chalabianloo_134-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFChalabianlooSchjøtt2009" class="citation journal cs1 cs1-prop-foreign-lang-source">Chalabianloo F, Schjøtt J (January 2009). <a rel="nofollow" class="external text" href="https://tidsskriftet.no/2009/01/legemidler-i-praksis/pregabalin-og-misbrukspotensial">"Pregabalin og misbrukspotensial"</a> [Pregabalin and its potential for abuse]. <i>Tidsskrift for den Norske Laegeforening</i> (in Norwegian). <b>129</b> (3): <span class="nowrap">186–</span>187. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.4045%2Ftidsskr.08.0047">10.4045/tidsskr.08.0047</a></span>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19180163">19180163</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201029162224/https://tidsskriftet.no/2009/01/legemidler-i-praksis/pregabalin-og-misbrukspotensial">Archived</a> from the original on October 29, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-GOV.UK-2016-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-GOV.UK-2016_135-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice_-_Pregabalin_and_gabapentin.pdf">"Re: Pregabalin and Gabapentin advice"</a> <span class="cs1-format">(PDF)</span>. <i>GOV.UK</i>. January 14, 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201108101040/https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice_-_Pregabalin_and_gabapentin.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on November 8, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">February 6,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-GOV.UK-2017-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-GOV.UK-2017_136-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gov.uk/government/consultations/pregabalin-and-gabapentin-proposal-to-schedule-under-the-misuse-of-drugs-regulations-2001">"Pregabalin and gabapentin: proposal to schedule under the Misuse of Drugs Regulations 2001"</a>. <i>GOV.UK</i>. November 10, 2017. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200103103115/https://www.gov.uk/government/consultations/pregabalin-and-gabapentin-proposal-to-schedule-under-the-misuse-of-drugs-regulations-2001">Archived</a> from the original on January 3, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">April 2,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-pmid30327316-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid30327316_137-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMayor2018" class="citation journal cs1">Mayor S (October 2018). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.bmj.com/content/363/bmj.k4364">"Pregabalin and gabapentin become controlled drugs to cut deaths from misuse"</a></span>. <i>BMJ</i>. <b>363</b>: k4364. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.k4364">10.1136/bmj.k4364</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30327316">30327316</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:53520780">53520780</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190809170709/https://www.bmj.com/content/363/bmj.k4364">Archived</a> from the original on August 9, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">February 6,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-GOV.UK-2018-138"><span class="mw-cite-backlink">^ <a href="#cite_ref-GOV.UK-2018_138-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GOV.UK-2018_138-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs">"Pregabalin and gabapentin to be controlled as Class C drugs"</a>. <i>GOV.UK</i>. October 15, 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201112034051/https://www.gov.uk/government/news/pregabalin-and-gabapentin-to-be-controlled-as-class-c-drugs">Archived</a> from the original on November 12, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">April 2,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-GOV.UK-2019-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-GOV.UK-2019_139-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gov.uk/government/publications/circular-0192018-control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971/control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971">"Control of pregabalin and gabapentin under the Misuse of Drugs Act 1971"</a>. <i>GOV.UK</i>. March 29, 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240221044657/https://www.gov.uk/government/publications/circular-0192018-control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971/control-of-pregabalin-and-gabapentin-under-the-misuse-of-drugs-act-1971">Archived</a> from the original on February 21, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">February 21,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-Controlled_Drug_Classes-2013-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-Controlled_Drug_Classes-2013_140-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.release.org.uk/law/classes">"Controlled Drug Classes"</a>. August 12, 2013. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240328102114/https://www.release.org.uk/law/classes">Archived</a> from the original on March 28, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">May 6,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-What_are_Class_C_Drugs-2022-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-What_are_Class_C_Drugs-2022_141-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://cpdonline.co.uk/knowledge-base/mental-health/what-are-class-c-drugs/">"What are Class C Drugs?"</a>. October 31, 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240506185542/https://cpdonline.co.uk/knowledge-base/mental-health/what-are-class-c-drugs/">Archived</a> from the original on May 6, 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">May 6,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-Off-label-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-Off-label_142-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120830023954/http://www.stopmedicarefraud.gov/pfizerfactsheet.html">"Pfizer to pay $2.3&nbsp;billion to resolve criminal and civil health care liability relating to fraudulent marketing and the payment of kickbacks"</a>. Stop Medicare Fraud, U.S. Departments of Health &amp; Human Services, and of Justice. Archived from <a rel="nofollow" class="external text" href="http://www.stopmedicarefraud.gov/pfizerfactsheet.html">the original</a> on August 30, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span>
</li>
<li id="cite_note-Levy-2019-143"><span class="mw-cite-backlink">^ <a href="#cite_ref-Levy-2019_143-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Levy-2019_143-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFLevy2019" class="citation cs2">Levy S (July 22, 2019), <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200805105514/https://drugstorenews.com/pharmacy/nine-generic-firms-get-fda-approval-for-generic-lyrica">"Nine generic firms get FDA approval for generic Lyrica."</a>, <i>Drug Store News</i>, archived from <a rel="nofollow" class="external text" href="https://www.drugstorenews.com/pharmacy/nine-generic-firms-get-fda-approval-for-generic-lyrica/">the original</a> on August 5, 2020</cite></span>
</li>
<li id="cite_note-GAD-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-GAD_144-0">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20070929121837/http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&amp;STORY=%2Fwww%2Fstory%2F03-27-2006%2F0004327379">"Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe"</a> (Press release). Archived from <a rel="nofollow" class="external text" href="http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&amp;STORY=/www/story/03-27-2006/0004327379">the original</a> on September 29, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">November 6,</span> 2011</span>.</cite></span>
</li>
<li id="cite_note-46brooklyn_Research-2019-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-46brooklyn_Research-2019_145-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.46brooklyn.com/news/2019/7/23/lyrica-goes-generic">"Generic Lyrica launches at 97% discount to brand version"</a>. <i>46brooklyn Research</i>. July 23, 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200716075241/https://www.46brooklyn.com/news/2019/7/23/lyrica-goes-generic">Archived</a> from the original on July 16, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">December 25,</span> 2019</span>.</cite></span>
</li>
<li id="cite_note-Bulik-2016-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bulik-2016_146-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBulik2016" class="citation news cs1">Bulik BS (March 2016). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201029161332/https://www.fiercepharma.com/marketing/abbvie-s-humira-pfizer-s-lyrica-kick-off-2016-hefty-tv-ad-spend">"AbbVie's Humira, Pfizer's Lyrica kick off 2016 with hefty TV ad spend"</a>. <i>FiercePharma</i>. Archived from <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/marketing/abbvie-s-humira-pfizer-s-lyrica-kick-off-2016-hefty-tv-ad-spend">the original</a> on October 29, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">March 5,</span> 2017</span>.</cite></span>
</li>
<li id="cite_note-NYT_Pfizer_Pays-147"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYT_Pfizer_Pays_147-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYT_Pfizer_Pays_147-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFHarris2009" class="citation news cs1">Harris G (September 2, 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/09/03/business/03health.html">"Pfizer Pays $2.3 Billion to Settle Marketing Case"</a>. <i><a href="The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200926003914/https://www.nytimes.com/2009/09/03/business/03health.html">Archived</a> from the original on September 26, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2017</span>.</cite></span>
</li>
<li id="cite_note-BBC-News-Prizer-Fraud-Fine-2009-148"><span class="mw-cite-backlink">^ <a href="#cite_ref-BBC-News-Prizer-Fraud-Fine-2009_148-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BBC-News-Prizer-Fraud-Fine-2009_148-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://news.bbc.co.uk/2/hi/business/8234533.stm">"Pfizer agrees record fraud fine"</a>. <i><a href="BBC_News" title="BBC News">BBC News</a></i>. September 2, 2009. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20090908011344/http://news.bbc.co.uk/2/hi/business/8234533.stm">Archived</a> from the original on September 8, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2017</span>.</cite></span>
</li>
<li id="cite_note-U.S._Securities_and_Exchange_Commission-2010-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-U.S._Securities_and_Exchange_Commission-2010_149-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/78003/000119312511048877/dex13.htm">"Portions of the Pfizer Inc. 2010 Financial Report"</a>. <i><a href="U.S._Securities_and_Exchange_Commission" class="mw-redirect" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a></i>. 2010. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190610193252/https://www.sec.gov/Archives/edgar/data/78003/000119312511048877/dex13.htm">Archived</a> from the original on June 10, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">December 21,</span> 2017</span>.</cite></span>
</li>
<li id="cite_note-Jacoby-2008-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jacoby-2008_150-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFJacoby2008" class="citation journal cs1">Jacoby M (2008). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://cen.acs.org/articles/86/i10/Financial-Windfall-Lyrica.html">"Financial Windfall from Lyrica"</a></span>. <i>Chemical &amp; Engineering News</i>. <b>86</b> (10): <span class="nowrap">56–</span>61. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fcen-v086n010.p056">10.1021/cen-v086n010.p056</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201026170423/https://cen.acs.org/articles/86/i10/Financial-Windfall-Lyrica.html">Archived</a> from the original on October 26, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-mw-2001-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-mw-2001_151-0">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1041539562">
/* start https://en.wikipedia.org/ */


.mw-parser-output .citation{word-wrap:break-word}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}


/* end https://en.wikipedia.org/ */
</style><span class="citation patent" id="CITEREFSilverman_RB,_Andruszkiewicz_R2001"><a rel="nofollow" class="external text" href="https://patents.google.com/patent/US6197819B1/en">US 6197819B1</a>, Silverman RB, Andruszkiewicz R, "Gamma amino butyric acid analogs and optical isomers", issued March 6, 2001, assigned to Northwestern University</span><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=6197819B1&amp;rft.cc=US&amp;rft.title=Gamma+amino+butyric+acid+analogs+and+optical+isomers&amp;rft.inventor=Silverman+RB%2C+Andruszkiewicz+R&amp;rft.assignee=Northwestern+University&amp;rft.date=March 6, 2001"><span style="display: none;">&nbsp;</span></span> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190321033355/https://patents.google.com/patent/US6197819B1/en">Archived</a> March 21, 2019, at the <a href="Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-Decker-2014-152"><span class="mw-cite-backlink"><b><a href="#cite_ref-Decker-2014_152-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFDecker2014" class="citation news cs1">Decker S (February 6, 2014). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018.html">"Pfizer Wins Ruling to Block Generic Lyrica Until 2018"</a>. <i>Bloomberg</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140208151103/https://www.bloomberg.com/news/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018.html">Archived</a> from the original on February 8, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Decision-2020-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-Decision-2020_153-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.finnegan.com/files/Publication/48de9f25-b22f-4d07-9c56-151fa117073b/Presentation/PublicationAttachment/67b8c48d-5c6b-48ef-b29d-160d7303d9fa/12-1576%202-6-14.pdf">"Decision: Pfizer Inc. (PFE) v. Teva Pharmaceuticals USA Inc., 12-1576, U.S. Court of Appeals for the Federal Circuit (Washington)"</a> <span class="cs1-format">(PDF)</span>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201029163458/https://www.finnegan.com/files/Publication/48de9f25-b22f-4d07-9c56-151fa117073b/Presentation/PublicationAttachment/67b8c48d-5c6b-48ef-b29d-160d7303d9fa/12-1576%202-6-14.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on October 29, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">October 26,</span> 2020</span>.</cite></span>
</li>
<li id="cite_note-Pfizer-2018-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pfizer-2018_154-0">^</a></b></span> <span class="reference-text"><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20181115195322/http://www.pulsetoday.co.uk/clinical/clinical-specialties/prescribing/pfizers-failed-pregabalin-patent-appeal-means-nhs-could-reclaim-502m/20037790.article">"Pfizer's failed pregabalin patent appeal means NHS could reclaim £502m"</a>. Pulse. November 14, 2018. Archived from <a rel="nofollow" class="external text" href="https://www.pulsetoday.co.uk/news/politics/pfizers-failed-pregabalin-patent-appeal-means-nhs-could-reclaim-502m/">the original</a> on November 15, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">May 17,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-brands-155"><span class="mw-cite-backlink">^ <a href="#cite_ref-brands_155-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-brands_155-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/international/pregabalin.html">"Pregabalin international brands"</a>. <i>Drugs.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190828172817/https://www.drugs.com/international/pregabalin.html">Archived</a> from the original on August 28, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2017</span>.</cite></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.businesswire.com/news/home/20201116005378/en/">"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan"</a>. Pfizer. November 16, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">June 17,</span> 2024</span> – via Business Wire.</cite></span>
</li>
<li id="cite_note-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-157">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.pfizer.com/products/product-detail/lyrica">"Lyrica"</a>. <i>Pfizer</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 17,</span> 2024</span>.</cite></span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.viatris.com/en/products/brands">"Brands"</a>. <i>Viatris</i>. November 16, 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">June 17,</span> 2024</span>.</cite></span>
</li>
</ol></div></div>
<div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1236075235">
/* start https://en.wikipedia.org/ */


.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}


/* end https://en.wikipedia.org/ */
</style></div><div role="navigation" class="navbox" aria-labelledby="Medical_uses110" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Medical_uses110" style="font-size:114%;margin:0 4em"><a href="Medicine" title="Medicine">Medical uses</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0;font-size:114%"><div style="padding:0px">
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Anticonvulsants_(N03)431" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r1239400231">
/* start https://en.wikipedia.org/ */


.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}


/* end https://en.wikipedia.org/ */
</style><div id="Anticonvulsants_(N03)431" style="font-size:114%;margin:0 4em"><a href="Anticonvulsant" title="Anticonvulsant">Anticonvulsants</a> (<a href="ATC_code_N03" title="ATC code N03">N03</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="GABAergic" title="GABAergic">GABAergics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="GABAA_receptor" title="GABAA receptor">GABA<sub>A</sub>R</a> <a href="Allosteric_modulator" title="Allosteric modulator">PAMs</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="Barbiturate" title="Barbiturate">Barbiturates</a>:</b> <a href="Barbexaclone" title="Barbexaclone">Barbexaclone</a></li>
<li><a href="Metharbital" title="Metharbital">Metharbital</a></li>
<li><a href="Methylphenobarbital" title="Methylphenobarbital">Methylphenobarbital</a></li>
<li><a href="Pentobarbital" title="Pentobarbital">Pentobarbital</a></li>
<li><a href="Phenobarbital" title="Phenobarbital">Phenobarbital</a><sup>#</sup></li>
<li><a href="Primidone" title="Primidone">Primidone</a>; <b><a href="Carbamate" title="Carbamate">Carbamates</a></b>: <a href="Cenobamate" title="Cenobamate">Cenobamate</a></li>
<li><a href="Felbamate" title="Felbamate">Felbamate</a>; <b><a href="Benzodiazepine" title="Benzodiazepine">Benzodiazepines</a></b>: <a href="Clobazam" title="Clobazam">Clobazam</a></li>
<li><a href="Clonazepam" title="Clonazepam">Clonazepam</a></li>
<li><a href="Clorazepate" title="Clorazepate">Clorazepate</a></li>
<li><a href="Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Lorazepam" title="Lorazepam">Lorazepam</a><sup>#</sup></li>
<li><a href="Midazolam" title="Midazolam">Midazolam</a></li>
<li><a href="Nimetazepam" title="Nimetazepam">Nimetazepam</a></li>
<li><a href="Nitrazepam" title="Nitrazepam">Nitrazepam</a></li>
<li><a href="Temazepam" title="Temazepam">Temazepam</a>; <b>Others:</b> <a href="Bromide" title="Bromide">Bromide</a> (<a href="Potassium_bromide" title="Potassium bromide">potassium bromide</a>, <a href="Sodium_bromide" title="Sodium bromide">sodium bromide</a>)</li>
<li><a href="Imepitoin" title="Imepitoin">Imepitoin</a></li>
<li><a href="Paraldehyde" title="Paraldehyde">Paraldehyde</a></li>
<li><a href="Stiripentol" title="Stiripentol">Stiripentol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="GABA_transaminase_inhibitor" title="GABA transaminase inhibitor">GABA-T inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="Fatty_acid" title="Fatty acid">Fatty acids</a> (and related):</b> <a href="Valproate" title="Valproate">Valproate</a></li>
<li><a href="Valpromide" title="Valpromide">Valpromide</a></li>
<li><a href="Valproate_pivoxil" title="Valproate pivoxil">Valproate pivoxil</a></li>
<li><a href="Vigabatrin" title="Vigabatrin">Vigabatrin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="GABA_receptor_agonist" title="GABA receptor agonist">GABAR agonists</a></b>: <a href="Progabide" title="Progabide">Progabide</a>; <b><a href="GABA_reuptake_inhibitor" title="GABA reuptake inhibitor">GAT-1 inhibitors</a>:</b> <a href="Tiagabine" title="Tiagabine">Tiagabine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Channel_modulator" title="Channel modulator">Channel<br>modulators</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Sodium_channel_blocker" title="Sodium channel blocker">Sodium blockers</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="Hydantoin" title="Hydantoin">Hydantoins</a>:</b> <a href="Ethotoin" title="Ethotoin">Ethotoin</a></li>
<li><a href="Fosphenytoin" title="Fosphenytoin">Fosphenytoin</a></li>
<li><a href="Mephenytoin" title="Mephenytoin">Mephenytoin</a></li>
<li><a href="Phenytoin" title="Phenytoin">Phenytoin</a><sup>#</sup>; <b><a href="Acylurea" title="Acylurea">Ureides</a>:</b> Acetylpheneturide</li>
<li><a href="Chlorphenacemide" title="Chlorphenacemide">Chlorphenacemide</a></li>
<li><a href="Phenacemide" title="Phenacemide">Phenacemide</a><sup>‡</sup></li>
<li><a href="Pheneturide" title="Pheneturide">Pheneturide</a>; <b><a href="Fatty_acid" title="Fatty acid">Fatty acids</a>:</b> <a href="Valproate" title="Valproate">Valproate</a></li>
<li><a href="Valpromide" title="Valpromide">Valpromide</a></li>
<li><a href="Valproate_pivoxil" title="Valproate pivoxil">Valproate pivoxil</a>; <b><a href="Carboxamide" class="mw-redirect" title="Carboxamide">Carboxamides</a>:</b></li>
<li><a href="Carbamazepine" title="Carbamazepine">Carbamazepine</a><sup>#</sup></li>
<li><a href="Eslicarbazepine_acetate" title="Eslicarbazepine acetate">Eslicarbazepine acetate</a></li>
<li><a href="Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a>; <b>Others:</b> <a href="Lacosamide" title="Lacosamide">Lacosamide</a></li>
<li><a href="Lamotrigine" title="Lamotrigine">Lamotrigine</a><sup>#</sup></li>
<li><a href="Rufinamide" title="Rufinamide">Rufinamide</a></li>
<li><a href="Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Calcium_channel_blocker" title="Calcium channel blocker">Calcium blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="2%2C4-Oxazolidinedione" title="2,4-Oxazolidinedione">Oxazolidinediones</a>:</b> <a href="Ethadione" title="Ethadione">Ethadione</a></li>
<li><a href="Paramethadione" title="Paramethadione">Paramethadione</a></li>
<li><a href="Trimethadione" title="Trimethadione">Trimethadione</a>; <b><a href="Succinimide" title="Succinimide">Succinimides</a></b>: <a href="Ethosuximide" title="Ethosuximide">Ethosuximide</a><sup>#</sup></li>
<li><a href="Mesuximide" title="Mesuximide">Mesuximide</a></li>
<li><a href="Phensuximide" title="Phensuximide">Phensuximide</a>; <b><a href="Gabapentinoid" title="Gabapentinoid">Gabapentinoids</a>:</b> <a href="Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li>; <b>Others:</b> <a href="Imepitoin" title="Imepitoin">Imepitoin</a></li>
<li><a href="Lamotrigine" title="Lamotrigine">Lamotrigine</a><sup>#</sup></li>
<li><a href="Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Potassium_channel_opener" title="Potassium channel opener">Potassium openers</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Retigabine" title="Retigabine">Retigabine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Carbonic_anhydrase_inhibitor" title="Carbonic anhydrase inhibitor">CA inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="Sulfonamide_(medicine)#Anticonvulsant" title="Sulfonamide (medicine)">Sulfonamides</a>:</b> <a href="Acetazolamide" title="Acetazolamide">Acetazolamide</a></li>
<li><a href="Ethoxzolamide" title="Ethoxzolamide">Ethoxzolamide</a></li>
<li><a href="Sultiame" title="Sultiame">Sultiame</a></li>
<li><a href="Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Albutoin" title="Albutoin">Albutoin</a></li>
<li><a href="Beclamide" title="Beclamide">Beclamide</a></li>
<li><a href="Brivaracetam" title="Brivaracetam">Brivaracetam</a></li>
<li><a href="Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li><a href="Carisbamate" title="Carisbamate">Carisbamate</a></li>
<li><a href="Etiracetam" title="Etiracetam">Etiracetam</a></li>
<li><a href="Fenfluramine" title="Fenfluramine">Fenfluramine</a></li>
<li><a href="Ganaxolone" title="Ganaxolone">Ganaxolone</a></li>
<li><a href="Levetiracetam" title="Levetiracetam">Levetiracetam</a></li>
<li><a href="Perampanel" title="Perampanel">Perampanel</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup><a href="WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Anxiolytics_(N05B)1664" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Anxiolytics_(N05B)1664" style="font-size:114%;margin:0 4em"><a href="Anxiolytic" title="Anxiolytic">Anxiolytics</a> (<a href="ATC_code_N05#N05B" title="ATC code N05">N05B</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="5-HT1A_receptor" title="5-HT1A receptor"><abbr title="5-HT1A receptor">5-HT<sub>1A</sub>R</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip 5-HT1A receptor</span> <a href="Agonist" title="Agonist">agonists</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Buspirone" title="Buspirone">Buspirone</a></li>
<li><a href="Gepirone" title="Gepirone">Gepirone</a></li>
<li><a href="Tandospirone" title="Tandospirone">Tandospirone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="GABAA_receptor" title="GABAA receptor"><abbr title="GABAA receptor">GABA<sub>A</sub>R</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip GABAA receptor</span> <a href="Positive_allosteric_modulators" class="mw-redirect" title="Positive allosteric modulators"><abbr title="positive allosteric modulators">PAMs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip positive allosteric modulators</span></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="Benzodiazepine" title="Benzodiazepine">Benzodiazepines</a>:</i> <a href="Adinazolam" title="Adinazolam">Adinazolam</a></li>
<li><a href="Alprazolam" title="Alprazolam">Alprazolam</a></li>
<li><a href="Bromazepam" title="Bromazepam">Bromazepam</a></li>
<li><a href="Camazepam" title="Camazepam">Camazepam</a></li>
<li><a href="Chlordiazepoxide" title="Chlordiazepoxide">Chlordiazepoxide</a></li>
<li><a href="Clobazam" title="Clobazam">Clobazam</a></li>
<li><a href="Clonazepam" title="Clonazepam">Clonazepam</a></li>
<li><a href="Clorazepate" title="Clorazepate">Clorazepate</a></li>
<li><a href="Clotiazepam" title="Clotiazepam">Clotiazepam</a></li>
<li><a href="Cloxazolam" title="Cloxazolam">Cloxazolam</a></li>
<li><a href="Diazepam" title="Diazepam">Diazepam</a><sup>#</sup></li>
<li><a href="Ethyl_loflazepate" title="Ethyl loflazepate">Ethyl loflazepate</a></li>
<li><a href="Etizolam" title="Etizolam">Etizolam</a></li>
<li><a href="Fludiazepam" title="Fludiazepam">Fludiazepam</a></li>
<li><a href="Halazepam" title="Halazepam">Halazepam</a></li>
<li><a href="Ketazolam" title="Ketazolam">Ketazolam</a></li>
<li><a href="Lorazepam" title="Lorazepam">Lorazepam</a><sup>#</sup></li>
<li><a href="Medazepam" title="Medazepam">Medazepam</a></li>
<li><a href="Nordazepam" title="Nordazepam">Nordazepam</a></li>
<li><a href="Oxazepam" title="Oxazepam">Oxazepam</a></li>
<li><a href="Pinazepam" title="Pinazepam">Pinazepam</a></li>
<li><a href="Prazepam" title="Prazepam">Prazepam</a>; <i>Others:</i> <a href="Alpidem" title="Alpidem">Alpidem</a><sup>‡</sup></li>
<li><a href="Barbiturate" title="Barbiturate">Barbiturates</a> (e.g., <a href="Phenobarbital" title="Phenobarbital">phenobarbital</a>)</li>
<li><a href="Carbamate" title="Carbamate">Carbamates</a> (e.g., <a href="Meprobamate" title="Meprobamate">meprobamate</a>)</li>
<li><a href="Carisoprodol" title="Carisoprodol">Carisoprodol</a></li>
<li><a href="Chlormezanone" title="Chlormezanone">Chlormezanone</a><sup>‡</sup></li>
<li><a href="Alcohol_(drug)" title="Alcohol (drug)">Ethanol (alcohol)</a></li>
<li><a href="Etifoxine" title="Etifoxine">Etifoxine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Gabapentinoid" title="Gabapentinoid">Gabapentinoids</a><br><span style="font-size:85%;">(<a href="Voltage-dependent_calcium_channel" class="mw-redirect" title="Voltage-dependent calcium channel"><abbr title="alpha2delta subunit">α<sub>2</sub>δ</abbr> <abbr title="voltage-dependent calcium channel">VDCC</abbr></a> <a href="Channel_blocker" title="Channel blocker">blockers</a>)</span></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li><a href="Gabapentin_enacarbil" title="Gabapentin enacarbil">Gabapentin enacarbil</a></li>
<li><a href="Phenibut" title="Phenibut">Phenibut</a></li>
</ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Antidepressant" title="Antidepressant">Antidepressants</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Selective_serotonin_reuptake_inhibitors" class="mw-redirect" title="Selective serotonin reuptake inhibitors"><abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Selective serotonin reuptake inhibitors</span> (e.g., <a href="Escitalopram" title="Escitalopram">escitalopram</a>)</li>
<li><a href="Serotonin-norepinephrine_reuptake_inhibitors" class="mw-redirect" title="Serotonin-norepinephrine reuptake inhibitors"><abbr title="Serotonin-norepinephrine reuptake inhibitors">SNRIs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Serotonin-norepinephrine reuptake inhibitors</span> (e.g., <a href="Duloxetine" title="Duloxetine">duloxetine</a>)</li>
<li><a href="Serotonin_antagonist_and_reuptake_inhibitors" class="mw-redirect" title="Serotonin antagonist and reuptake inhibitors"><abbr title="Serotonin antagonist and reuptake inhibitors">SARIs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Serotonin antagonist and reuptake inhibitors</span> (e.g., <a href="Trazodone" title="Trazodone">trazodone</a>)</li>
<li><a href="Tricyclic_antidepressants" class="mw-redirect" title="Tricyclic antidepressants"><abbr title="Tricyclic antidepressants">TCAs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Tricyclic antidepressants</span> (e.g., <a href="Clomipramine" title="Clomipramine">clomipramine</a><sup>#</sup>)</li>
<li><a href="Tetracyclic_antidepressants" class="mw-redirect" title="Tetracyclic antidepressants"><abbr title="Tetracyclic antidepressants">TeCAs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Tetracyclic antidepressants</span> (e.g., <a href="Mirtazapine" title="Mirtazapine">mirtazapine</a>)</li>
<li><a href="Monoamine_oxidase_inhibitors" class="mw-redirect" title="Monoamine oxidase inhibitors"><abbr title="Monoamine oxidase inhibitors">MAOIs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Monoamine oxidase inhibitors</span> (e.g., <a href="Phenelzine" title="Phenelzine">phenelzine</a>); <i>Others:</i> <a href="Agomelatine" title="Agomelatine">Agomelatine</a></li>
<li><a href="Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Tianeptine" title="Tianeptine">Tianeptine</a></li>
<li><a href="Vilazodone" title="Vilazodone">Vilazodone</a></li>
<li><a href="Vortioxetine" title="Vortioxetine">Vortioxetine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Sympatholytic" title="Sympatholytic">Sympatholytics</a><br><span style="font-size:85%;">(<a href="Antiadrenergic" class="mw-redirect" title="Antiadrenergic">Antiadrenergics</a>)</span></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Alpha-1_blocker" title="Alpha-1 blocker">Alpha-1 blockers</a> (e.g., <a href="Prazosin" title="Prazosin">prazosin</a>)</li>
<li><a href="Alpha-2_agonist" class="mw-redirect" title="Alpha-2 agonist">Alpha-2 agonists</a> (e.g., <a href="Clonidine" title="Clonidine">clonidine</a>, <a href="Dexmedetomidine" title="Dexmedetomidine">dexmedetomidine</a>, <a href="Guanfacine" title="Guanfacine">guanfacine</a>)</li>
<li><a href="Beta_blocker" title="Beta blocker">Beta blockers</a> (e.g., <a href="Propranolol" title="Propranolol">propranolol</a>, <a href="Atenolol" title="Atenolol">atenolol</a>, <a href="Betaxolol" title="Betaxolol">betaxolol</a>, <a href="Nadolol" title="Nadolol">nadolol</a>, <a href="Oxprenolol" title="Oxprenolol">oxprenolol</a>, <a href="Pindolol" title="Pindolol">pindolol</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Benzoctamine" title="Benzoctamine">Benzoctamine</a></li>
<li><a href="Cycloserine" title="Cycloserine">Cycloserine</a></li>
<li><a href="Fabomotizole" title="Fabomotizole">Fabomotizole</a></li>
<li><a href="Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li><a href="Lorpiprazole" title="Lorpiprazole">Lorpiprazole</a></li>
<li><a href="Mebicar" class="mw-redirect" title="Mebicar">Mebicar</a></li>
<li><a href="Mepiprazole" title="Mepiprazole">Mepiprazole</a></li>
<li><a href="Nicotine" title="Nicotine">Nicotine</a> (<a href="Tobacco" title="Tobacco">tobacco</a>)</li>
<li><a href="Opipramol" title="Opipramol">Opipramol</a></li>
<li><a href="Oxaflozane" title="Oxaflozane">Oxaflozane</a><sup>‡</sup></li>
<li><a href="Phenaglycodol" title="Phenaglycodol">Phenaglycodol</a></li>
<li><a href="Phenibut" title="Phenibut">Phenibut</a></li>
<li><a href="Picamilon" title="Picamilon">Picamilon</a></li>
<li><a href="Selank" title="Selank">Selank</a></li>
<li><a href="Tiagabine" title="Tiagabine">Tiagabine</a></li>
<li><a href="Tofisopam" title="Tofisopam">Tofisopam</a></li>
<li><a href="Validolum" class="mw-redirect" title="Validolum">Validolum</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist">
<ul><li><sup>#</sup><a href="WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Neuropathic_pain_and_fibromyalgia_pharmacotherapies131" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Neuropathic_pain_and_fibromyalgia_pharmacotherapies131" style="font-size:114%;margin:0 4em"><a href="Neuropathic_pain" title="Neuropathic pain">Neuropathic pain</a> and <a href="Fibromyalgia" title="Fibromyalgia">fibromyalgia</a> <a href="Pharmaceutical_drug" class="mw-redirect" title="Pharmaceutical drug">pharmacotherapies</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Monoaminergic" title="Monoaminergic">Monoaminergics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Serotonin%E2%80%93norepinephrine_reuptake_inhibitor" title="Serotonin–norepinephrine reuptake inhibitor"><abbr title="Serotonin–norepinephrine reuptake inhibitor">SNRIs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Serotonin–norepinephrine reuptake inhibitor</span> (e.g., <a href="Duloxetine" title="Duloxetine">duloxetine</a>, <a href="Milnacipran" title="Milnacipran">milnacipran</a>)</li>
<li><a href="Tricyclic_antidepressants" class="mw-redirect" title="Tricyclic antidepressants"><abbr title="Tricyclic antidepressants">TCAs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Tricyclic antidepressants</span> (e.g., <a href="Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Nortriptyline" title="Nortriptyline">nortriptyline</a>, <a href="Dosulepin" title="Dosulepin">dosulepin</a>)</li>
<li><a href="Opioid" title="Opioid">Opioid</a> <a href="Monoamine_reuptake_inhibitors" class="mw-redirect" title="Monoamine reuptake inhibitors"><abbr title="monoamine reuptake inhibitors">MRIs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip monoamine reuptake inhibitors</span> (e.g., <a href="Tapentadol" title="Tapentadol">tapentadol</a>, <a href="Tramadol" title="Tramadol">tramadol</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Ion_channel_blocker" class="mw-redirect" title="Ion channel blocker">Ion channel blockers</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Anticonvulsant" title="Anticonvulsant">Anticonvulsants</a> (e.g., <a href="Gabapentin" title="Gabapentin">gabapentin</a>, , <a href="Mirogabalin" title="Mirogabalin">mirogabalin</a>, <a href="Carbamazepine" title="Carbamazepine">carbamazepine</a>, <a href="Oxcarbazepine" title="Oxcarbazepine">oxcarbazepine</a>, <a href="Lacosamide" title="Lacosamide">lacosamide</a>, <a href="Lamotrigine" title="Lamotrigine">lamotrigine</a>)</li>
<li><a href="Local_anesthetic" title="Local anesthetic">Local anesthetics</a> (e.g., <a href="Lidocaine" title="Lidocaine">lidocaine</a>)</li>
<li><a href="Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li><a href="Tricyclic_antidepressants" class="mw-redirect" title="Tricyclic antidepressants"><abbr title="Tricyclic antidepressants">TCAs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Tricyclic antidepressants</span> (e.g., <a href="Amitriptyline" title="Amitriptyline">amitriptyline</a>, <a href="Nortriptyline" title="Nortriptyline">nortriptyline</a>, <a href="Desipramine" title="Desipramine">desipramine</a>)</li>
<li><a href="Ziconotide" title="Ziconotide">Ziconotide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Alpha_lipoic_acid" class="mw-redirect" title="Alpha lipoic acid">Alpha lipoic acid</a></li>
<li><a href="Benfotiamine" title="Benfotiamine">Benfotiamine</a></li>
<li><a href="Botulinum_toxin_A" class="mw-redirect" title="Botulinum toxin A">Botulinum toxin A</a></li>
<li><a href="Bupropion" title="Bupropion">Bupropion</a></li>
<li><a href="Cannabinoid" title="Cannabinoid">Cannabinoids</a> (e.g., <a href="Cannabis_(drug)" title="Cannabis (drug)">cannabis</a>, <a href="Dronabinol" title="Dronabinol">dronabinol</a>, <a href="Nabilone" title="Nabilone">nabilone</a>)</li>
<li><a href="NMDA_receptor_antagonist" title="NMDA receptor antagonist">NMDA receptor antagonists</a> (e.g., <a href="Ketamine" title="Ketamine">ketamine</a>, <a href="Dextromethorphan" title="Dextromethorphan">dextromethorphan</a>, <a href="Methadone" title="Methadone">methadone</a>)</li>
<li><a href="Opioid" title="Opioid">Opioids</a> (e.g., <a href="Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="Morphine" title="Morphine">morphine</a>, <a href="Oxycodone" title="Oxycodone">oxycodone</a>, <a href="Methadone" title="Methadone">methadone</a>, <a href="Buprenorphine" title="Buprenorphine">buprenorphine</a>, <a href="Tramadol" title="Tramadol">tramadol</a>, <a href="Tapentadol" title="Tapentadol">tapentadol</a>)</li>
<li><a href="Sodium_oxybate" title="Sodium oxybate">Sodium oxybate (<abbr title="γ-hydroxybutyric acid">GHB</abbr>)</a></li></ul>
</div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Recreational_uses128" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="background:#e8e8ff;background:#ccccff"><div id="Recreational_uses128" style="font-size:114%;margin:0 4em"><a href="Recreational_drug_use" title="Recreational drug use">Recreational uses</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0;font-size:114%"><div style="padding:0px">
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Euphoriants78" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Euphoriants78" style="font-size:114%;margin:0 4em"><a href="Euphoriant" class="mw-redirect" title="Euphoriant">Euphoriants</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="%CE%9C-Opioid_receptor" class="mw-redirect" title="Μ-Opioid receptor">μ-Opioid receptor</a> <a href="Agonist" title="Agonist">agonists</a> (<a href="Opioid" title="Opioid">opioids</a>) (e.g., <a href="Morphine" title="Morphine">morphine</a>, <a href="Heroin" title="Heroin">heroin</a>, <a href="Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="Oxycodone" title="Oxycodone">oxycodone</a>, <a href="Opium" title="Opium">opium</a>, <a href="Kratom" class="mw-redirect" title="Kratom">kratom</a>)</li>
<li><a href="Voltage-dependent_calcium_channel" class="mw-redirect" title="Voltage-dependent calcium channel">α<sub>2</sub>δ subunit</a>-containing <a href="Voltage-dependent_calcium_channel" class="mw-redirect" title="Voltage-dependent calcium channel">voltage-dependent calcium channels</a> <a href="Calcium_channel_blocker" title="Calcium channel blocker">blockers</a> (<a href="Gabapentinoid" title="Gabapentinoid">gabapentinoids</a>) (e.g., <a href="Gabapentin" title="Gabapentin">gabapentin</a>, , <a href="Phenibut" title="Phenibut">phenibut</a>)</li>
<li><a href="AMPA_receptor" title="AMPA receptor">AMPA receptor</a> <a href="Receptor_antagonist" title="Receptor antagonist">antagonists</a> (e.g., <a href="Perampanel" title="Perampanel">perampanel</a>)</li>
<li><a href="CB1_receptor" class="mw-redirect" title="CB1 receptor">CB<sub>1</sub> receptor</a> <a href="Agonist" title="Agonist">agonists</a> (<a href="Cannabinoid" title="Cannabinoid">cannabinoids</a>) (e.g., <a href="Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>, <a href="Cannabis_(drug)" title="Cannabis (drug)">cannabis</a>)</li>
<li><a href="Dopamine_agonist" title="Dopamine agonist">Dopamine receptor agonists</a> (e.g., <a href="Levodopa" title="Levodopa">levodopa</a>)</li>
<li><a href="Dopamine_releasing_agent" title="Dopamine releasing agent">Dopamine releasing agents</a> (e.g., <a href="Amphetamine" title="Amphetamine">amphetamine</a>, <a href="Methamphetamine" title="Methamphetamine">methamphetamine</a>, <a href="MDMA" title="MDMA">MDMA</a>, <a href="Mephedrone" title="Mephedrone">mephedrone</a>)</li>
<li><a href="Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">Dopamine reuptake inhibitors</a> (e.g., <a href="Cocaine" title="Cocaine">cocaine</a>, <a href="Methylphenidate" title="Methylphenidate">methylphenidate</a>)</li>
<li><a href="GABAA_receptor" title="GABAA receptor">GABA<sub>A</sub> receptor</a> <a href="Positive_allosteric_modulator" class="mw-redirect" title="Positive allosteric modulator">positive allosteric modulators</a> (e.g., <a href="Barbiturate" title="Barbiturate">barbiturates</a>, <a href="Benzodiazepine" title="Benzodiazepine">benzodiazepines</a>, <a href="Carbamate" title="Carbamate">carbamates</a>, <a href="Alcohol_(drug)" title="Alcohol (drug)">ethanol (alcohol)</a> (<a href="Alcoholic_drink" class="mw-redirect" title="Alcoholic drink">alcoholic drink</a>), <a href="Inhalant" title="Inhalant">inhalants</a>, <a href="Nonbenzodiazepine" title="Nonbenzodiazepine">nonbenzodiazepines</a>, <a href="Quinazolinone" title="Quinazolinone">quinazolinones</a>)</li>
<li><a href="Gamma-Hydroxybutyric_acid" class="mw-redirect" title="Gamma-Hydroxybutyric acid">GHB</a> (<a href="Sodium_oxybate" title="Sodium oxybate">sodium oxybate</a>) and <a href="Structural_analog" title="Structural analog">analogues</a></li>
<li><a href="Glucocorticoid" title="Glucocorticoid">Glucocorticoids (corticosteroids)</a> (e.g., <a href="Dexamethasone" title="Dexamethasone">dexamethasone</a>, <a href="Prednisone" title="Prednisone">prednisone</a>)</li>
<li><a href="Nicotinic_agonist" title="Nicotinic agonist">nACh receptor agonists</a> (e.g., <a href="Nicotine" title="Nicotine">nicotine</a>, <a href="Tobacco" title="Tobacco">tobacco</a>, <a href="Arecoline" title="Arecoline">arecoline</a>, <a href="Areca_nut" title="Areca nut">areca nut</a>)</li>
<li><a href="Nitric_oxide_donor" class="mw-redirect" title="Nitric oxide donor">Nitric oxide prodrugs</a> (e.g., <a href="Alkyl_nitrite" title="Alkyl nitrite">alkyl nitrites</a> (<a href="Poppers" title="Poppers">poppers</a>))</li>
<li><a href="NMDA_receptor_antagonist" title="NMDA receptor antagonist">NMDA receptor antagonists</a> (e.g., <a href="Dextromethorphan" title="Dextromethorphan">DXM</a>, <a href="Ketamine" title="Ketamine">ketamine</a>, <a href="Methoxetamine" title="Methoxetamine">methoxetamine</a>, <a href="Nitrous_oxide" title="Nitrous oxide">nitrous oxide</a>, <a href="Phencyclidine" title="Phencyclidine">phencyclidine</a>, <a href="Inhalant" title="Inhalant">inhalants</a>)</li>
<li><a href="Orexin_antagonist" title="Orexin antagonist">Orexin receptor antagonists</a> (e.g., <a href="Suvorexant" title="Suvorexant">suvorexant</a>)</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Recreational drug use</i></div></td></tr></tbody></table></div>
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Recreational_drug_use90" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;"><div id="Recreational_drug_use90" style="font-size:114%;margin:0 4em"><a href="Recreational_drug_use" title="Recreational drug use">Recreational drug use</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;;text-align:center;"><div id="Major_recreational_drugs90" style="font-size:114%;margin:0 4em">Major recreational drugs</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Depressant" title="Depressant">Depressants</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Barbiturate" title="Barbiturate">Barbiturates</a></li>
<li><a href="Benzodiazepine" title="Benzodiazepine">Benzodiazepines</a></li>
<li><a href="Carbamate" title="Carbamate">Carbamates</a></li>
<li><a href="Alcohol_(drug)" title="Alcohol (drug)">Ethanol (alcohol)</a>
<ul><li><a href="Alcoholic_beverage" title="Alcoholic beverage">Alcoholic beverage</a></li>
<li><a href="Beer" title="Beer">Beer</a></li>
<li><a href="Wine" title="Wine">Wine</a></li></ul></li>
<li><a href="Gabapentinoid" title="Gabapentinoid">Gabapentinoids</a></li>
<li><a href="Gamma-Hydroxybutyric_acid" class="mw-redirect" title="Gamma-Hydroxybutyric acid">GHB</a></li>
<li><a href="Inhalant" title="Inhalant">Inhalants</a>
<ul><li>Medical
<ul><li><a href="Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a> (<a href="Recreational_use_of_nitrous_oxide" title="Recreational use of nitrous oxide">recreational use</a>)</li></ul></li>
<li>Hazardous <a href="Solvent" title="Solvent">solvents</a>
<ul><li><a href="Adhesive#Contact" title="Adhesive">contact adhesives</a></li>
<li><a href="Gasoline" title="Gasoline">Gasoline</a></li>
<li><a href="Nail_polish#Nail_polish_remover" title="Nail polish">nail polish remover</a></li>
<li><a href="Paint_thinner" title="Paint thinner">Paint thinner</a></li></ul></li>
<li>Other
<ul><li><a href="Freon" title="Freon">Freon</a></li></ul></li></ul></li>
<li><a href="Kava" title="Kava">Kava</a></li>
<li><a href="Nonbenzodiazepine" title="Nonbenzodiazepine">Nonbenzodiazepines</a></li>
<li><a href="Quinazolinone" title="Quinazolinone">Quinazolinones</a>
<ul><li><a href="Methaqualone" title="Methaqualone">Quaaludes</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Opioid" title="Opioid">Opioids</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Buprenorphine" title="Buprenorphine">Buprenorphine</a>
<ul><li>Suboxone</li>
<li>Subutex</li></ul></li>
<li><a href="Codeine" title="Codeine">Codeine</a>
<ul><li><a href="Lean_(drug)" title="Lean (drug)">Lean</a></li></ul></li>
<li><a href="Desomorphine" title="Desomorphine">Desomorphine</a>
<ul><li>Krokodil</li></ul></li>
<li><a href="Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a>
<ul><li>Darvocet</li>
<li>Darvon</li></ul></li>
<li><a href="Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Heroin" title="Heroin">Diamorphine</a>
<ul><li>Heroin</li></ul></li>
<li><a href="Hydrocodone" title="Hydrocodone">Hydrocodone</a></li>
<li><a href="Hydromorphone" title="Hydromorphone">Hydromorphone</a>
<ul><li>Dilaudid</li></ul></li>
<li><a href="Methadone" title="Methadone">Methadone</a></li>
<li><a href="Mitragyna_speciosa" title="Mitragyna speciosa">Mitragyna speciosa</a>
<ul><li><a href="Kratom" class="mw-redirect" title="Kratom">Kratom</a></li></ul></li>
<li><a href="Morphine" title="Morphine">Morphine</a>
<ul><li><a href="Opium" title="Opium">Opium</a></li></ul></li>
<li><a href="Oxycodone" title="Oxycodone">Oxycodone</a>
<ul><li><a href="Oxycodone/paracetamol" title="Oxycodone/paracetamol">/paracetamol</a></li></ul></li>
<li><a href="Tramadol" title="Tramadol">Tramadol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Stimulant" title="Stimulant">Stimulants</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Amphetamine" title="Amphetamine">Amphetamine</a></li>
<li><a href="Arecoline" title="Arecoline">Arecoline</a>
<ul><li><a href="Areca" title="Areca">Areca</a></li></ul></li>
<li><a href="Paan" class="mw-redirect" title="Paan">Betel</a></li>
<li><a href="Caffeine" title="Caffeine">Caffeine</a>
<ul><li><a href="Coffee" title="Coffee">Coffee</a></li>
<li><a href="Energy_drink" title="Energy drink">Energy drinks</a></li>
<li><a href="Tea" title="Tea">Tea</a></li></ul></li>
<li><a href="Cathinone" title="Cathinone">Cathinone</a>
<ul><li><a href="Khat" title="Khat">Khat</a></li></ul></li>
<li><a href="Cocaine" title="Cocaine">Cocaine</a>
<ul><li><a href="Coca" title="Coca">Coca</a></li>
<li><a href="Cocaine_paste" title="Cocaine paste">Cocaine paste</a></li>
<li><a href="Crack_cocaine" title="Crack cocaine">Crack</a></li></ul></li>
<li><a href="Ephedrine" title="Ephedrine">Ephedrine</a>
<ul><li><a href="Ephedra_(medicine)" title="Ephedra (medicine)">Ephedra</a></li></ul></li>
<li><a href="Methylenedioxypyrovalerone" title="Methylenedioxypyrovalerone">MDPV</a></li>
<li><a href="Mephedrone" title="Mephedrone">Mephedrone</a></li>
<li><a href="Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><a href="Methylone" title="Methylone">Methylone</a></li>
<li><a href="Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Modafinil" title="Modafinil">Modafinil</a></li>
<li><a href="Nicotine" title="Nicotine">Nicotine</a>
<ul><li><a href="Nicotine_polacrilex" title="Nicotine polacrilex">Polacrilex</a></li>
<li><a href="Nicotine_salt" title="Nicotine salt">Salt</a></li>
<li><a href="Tobacco" title="Tobacco">Tobacco</a></li></ul></li>
<li><a href="Theobromine" title="Theobromine">Theobromine</a>
<ul><li><a href="Cocoa_bean" title="Cocoa bean">Cocoa</a></li>
<li><a href="Chocolate" title="Chocolate">Chocolate</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Empathogen%E2%80%93entactogen" class="mw-redirect" title="Empathogen–entactogen">Entactogens</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="2C_(psychedelics)" title="2C (psychedelics)">2C series</a></li>
<li><a href="6-APB" title="6-APB">6-APB</a>
<ul><li>Benzofury</li></ul></li>
<li><a href="Alpha-Methyltryptamine" class="mw-redirect" title="Alpha-Methyltryptamine">AMT</a></li>
<li><a href="3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA</a></li>
<li><a href="MDMA" title="MDMA">MDMA</a>
<ul><li><a href="MDMA#Forms" title="MDMA">Ecstasy</a></li>
<li><a href="MDMA#Forms" title="MDMA">Molly</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Hallucinogen" title="Hallucinogen">Hallucinogens</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Psychedelic_drug" title="Psychedelic drug">Psychedelics</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="2C-B" title="2C-B">2C-B</a></li>
<li><a href="25I-NBOMe" title="25I-NBOMe">25I-NBOMe</a></li>
<li><a href="4-AcO-DMT" title="4-AcO-DMT">4-AcO-DMT</a></li>
<li><a href="5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a>
<ul><li><a href="Colorado_River_toad" title="Colorado River toad">Psychoactive toads</a></li></ul></li>
<li><a href="Bufotenin" title="Bufotenin">Bufotenin</a>
<ul><li><a href="Anadenanthera_colubrina" title="Anadenanthera colubrina">Vilca</a></li>
<li><a href="Anadenanthera_peregrina" title="Anadenanthera peregrina">Yopo</a></li></ul></li>
<li><a href="N%2CN-Dimethyltryptamine" class="mw-redirect" title="N,N-Dimethyltryptamine">DMT</a>
<ul><li><a href="Ayahuasca" title="Ayahuasca">Ayahuasca</a></li></ul></li>
<li><a href="Ergine" title="Ergine">LSA</a> and <a href="Isoergine" title="Isoergine">iso-LSA</a>
<ul><li><a href="Morning_glory" title="Morning glory">Morning glory</a></li>
<li><a href="Ergot" title="Ergot">Ergot</a></li></ul></li>
<li><a href="LSD" title="LSD">LSD</a></li>
<li><a href="Mescaline" title="Mescaline">Mescaline</a>
<ul><li><a href="Echinopsis_peruviana" class="mw-redirect" title="Echinopsis peruviana">Peruvian torch</a></li>
<li><a href="Peyote" title="Peyote">Peyote</a></li>
<li><a href="Echinopsis_pachanoi" class="mw-redirect" title="Echinopsis pachanoi">San Pedro</a></li></ul></li>
<li><a href="Psilocybin" title="Psilocybin">Psilocybin</a> and <a href="Psilocin" title="Psilocin">psilocin</a>
<ul><li><a href="Psilocybin_mushroom" title="Psilocybin mushroom">Psilocybin mushrooms</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Dissociative" title="Dissociative">Dissociatives</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Dextromethorphan" title="Dextromethorphan">DXM</a> (<a href="Recreational_use_of_dextromethorphan" title="Recreational use of dextromethorphan">recreational use</a>)</li>
<li><a href="Inhalant" title="Inhalant">Inhalants</a>
<ul><li><a href="Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a> (<a href="Recreational_use_of_nitrous_oxide" title="Recreational use of nitrous oxide">recreational use</a>)</li></ul></li>
<li><a href="Ketamine" title="Ketamine">Ketamine</a></li>
<li><a href="Methoxetamine" title="Methoxetamine">MXE</a></li>
<li><a href="Phencyclidine" title="Phencyclidine">PCP</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Deliriant" title="Deliriant">Deliriants</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Atropine" title="Atropine">Atropine</a> and <a href="Scopolamine" title="Scopolamine">Scopolamine</a>
<ul><li><a href="Atropa_belladonna" class="mw-redirect" title="Atropa belladonna">Atropa belladonna</a></li>
<li><a href="Datura" title="Datura">Datura</a></li>
<li><a href="Hyoscyamus_niger" title="Hyoscyamus niger">Hyoscyamus niger</a></li>
<li><a href="Mandragora_officinarum" title="Mandragora officinarum">Mandragora officinarum</a></li></ul></li>
<li><a href="Dimenhydrinate" title="Dimenhydrinate">Dimenhydrinate</a></li>
<li><a href="Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Cannabinoid" title="Cannabinoid">Cannabinoids</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Tetrahydrocannabinol" title="Tetrahydrocannabinol">THC</a>
<ul><li><a href="Cannabis_(drug)" title="Cannabis (drug)">Cannabis (Marijuana)</a></li>
<li><a href="Hashish" title="Hashish">Hashish</a></li>
<li><a href="Hash_oil" title="Hash oil">Hash oil</a></li></ul></li>
<li><a href="Synthetic_cannabinoid" class="mw-redirect" title="Synthetic cannabinoid">Synthetic cannabinoids</a>
<ul><li><a href="JWH-018" title="JWH-018">JWH-018</a></li>
<li><a href="APICA_(synthetic_cannabinoid_drug)" title="APICA (synthetic cannabinoid drug)">APICA</a></li>
<li><a href="APINACA" title="APINACA">APINACA</a></li>
<li><a href="Spice_(drug)" class="mw-redirect" title="Spice (drug)">Spice</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Ibogaine" title="Ibogaine">Ibogaine</a>
<ul><li><i><a href="Tabernanthe_iboga" title="Tabernanthe iboga">Tabernanthe iboga</a></i></li></ul></li>
<li><a href="Muscimol" title="Muscimol">Muscimol</a>
<ul><li><i><a href="Amanita_muscaria" title="Amanita muscaria">Amanita muscaria</a></i></li></ul></li>
<li><a href="Oneirogen" title="Oneirogen">Oneirogens</a>
<ul><li><i><a href="Calea_ternifolia" title="Calea ternifolia">Calea zacatechichi</a></i></li>
<li><i><a href="Silene_undulata" title="Silene undulata">Silene capensis</a></i></li></ul></li>
<li><a href="Salvinorin_A" title="Salvinorin A">Salvinorin A</a>
<ul><li><i><a href="Salvia_divinorum" title="Salvia divinorum">Salvia divinorum</a></i></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;;text-align:center;"><div id="Drug_culture90" style="font-size:114%;margin:0 4em"><a href="Drug_culture" title="Drug culture">Drug culture</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Cannabis_culture" title="Cannabis culture">Cannabis culture</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="420_(cannabis_culture)" title="420 (cannabis culture)">420</a></li>
<li><a href="Cannabis_consumption" title="Cannabis consumption">Cannabis consumption</a></li>
<li><a href="Cannabis_cultivation" title="Cannabis cultivation">Cannabis cultivation</a></li>
<li><a href="Cannabis_edible" title="Cannabis edible">Cannabis edible</a></li>
<li><a href="Cannabis_rights" title="Cannabis rights">Cannabis rights</a></li>
<li><a href="List_of_cannabis_rights_leaders" title="List of cannabis rights leaders">Cannabis rights leaders</a></li>
<li><a href="List_of_cannabis_rights_organizations" title="List of cannabis rights organizations">List of cannabis rights organizations</a></li>
<li><a href="Cannabis_smoking" title="Cannabis smoking">Cannabis smoking</a></li>
<li><a href="Cannabis_Social_Club" title="Cannabis Social Club">Cannabis Social Club</a></li>
<li><a href="Cannabis_tea" title="Cannabis tea">Cannabis tea</a></li>
<li><a href="Vaporizer_(inhalation_device)#Cannabis_vaporizers" title="Vaporizer (inhalation device)">Cannabis vaping</a></li>
<li><a href="Head_shop" title="Head shop">Head shop</a></li>
<li><a href="Legal_history_of_cannabis_in_the_United_States" title="Legal history of cannabis in the United States">Legal history of cannabis in the United States</a></li>
<li><a href="Legality_of_cannabis" title="Legality of cannabis">Legality of cannabis</a></li>
<li><a href="Marijuana_Policy_Project" title="Marijuana Policy Project">Marijuana Policy Project</a></li>
<li><a href="Medical_cannabis" title="Medical cannabis">Medical cannabis</a></li>
<li><a href="National_Organization_for_the_Reform_of_Marijuana_Laws" title="National Organization for the Reform of Marijuana Laws">NORML</a></li>
<li><a href="Cannabis_and_religion" title="Cannabis and religion">Cannabis and religion</a></li>
<li><a href="Stoner_film" title="Stoner film">Stoner film</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Coffee_culture" title="Coffee culture">Coffee culture</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Break_(work)#Coffee_break" title="Break (work)">Coffee break</a></li>
<li><a href="Coffeehouse" title="Coffeehouse">Coffeehouse</a></li>
<li><a href="Latte_art" title="Latte art">Latte art</a></li>
<li><a href="Teahouse" title="Teahouse">Teahouse</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Drinking_culture" title="Drinking culture">Drinking culture</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Bartender" title="Bartender">Bartending</a></li>
<li><a href="Beer#Beer_and_society" title="Beer">Beer culture</a></li>
<li><a href="Beer_festival" title="Beer festival">Beer festival</a></li>
<li><a href="Binge_drinking" title="Binge drinking">Binge drinking</a></li>
<li><a href="Diethyl_ether#Recreational_use" title="Diethyl ether">Diethyl ether</a></li>
<li><a href="Drinking_game" title="Drinking game">Drinking games</a></li>
<li><a href="Drinking_song" title="Drinking song">Drinking song</a></li>
<li><a href="Happy_hour" title="Happy hour">Happy hour</a></li>
<li><a href="Hip_flask" title="Hip flask">Hip flask</a></li>
<li><a href="Nightclub" title="Nightclub">Nightclub</a></li>
<li><a href="Oktoberfest" title="Oktoberfest">Oktoberfest</a></li>
<li><a href="Pub" title="Pub">Pub</a></li>
<li><a href="Pub_crawl" title="Pub crawl">Pub crawl</a></li>
<li><a href="Sommelier" title="Sommelier">Sommelier</a></li>
<li><a href="Bar_(establishment)" title="Bar (establishment)">Sports bar</a></li>
<li><a href="Tailgate_party" title="Tailgate party">Tailgate party</a></li>
<li><a href="Wine_bar" title="Wine bar">Wine bar</a></li>
<li><a href="Wine_tasting" title="Wine tasting">Wine tasting</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Psychedelia" title="Psychedelia">Psychedelia</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Psychonautics" title="Psychonautics">Psychonautics</a></li>
<li><a href="Psychedelic_art" title="Psychedelic art">Art</a></li>
<li><a href="Psychedelic_drug" title="Psychedelic drug">Drug</a></li>
<li><a href="Psychedelic_era" title="Psychedelic era">Era</a></li>
<li><a href="Psychedelic_experience" title="Psychedelic experience">Experience</a></li>
<li><a href="Psychedelic_literature" class="mw-redirect" title="Psychedelic literature">Literature</a></li>
<li><a href="Psychedelic_music" title="Psychedelic music">Music</a></li>
<li><a href="Psychedelic_microdosing" title="Psychedelic microdosing">Microdosing</a></li>
<li><a href="Smart_shop" title="Smart shop">Smart shop</a></li>
<li><a href="Psychedelic_therapy" title="Psychedelic therapy">Therapy</a></li>
<li><a href="Trip_report" title="Trip report">Trip report</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Smoking#Society_and_culture" title="Smoking">Smoking culture</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Cigarette_card" title="Cigarette card">Cigarette card</a></li>
<li><a href="Fashion_cigarettes" title="Fashion cigarettes">Fashion cigarettes</a></li>
<li><a href="Cloud-chasing" title="Cloud-chasing">Cloud-chasing</a></li>
<li><a href="Loosie" title="Loosie">Loosie</a></li>
<li><a href="Smokeasy" title="Smokeasy">Smokeasy</a></li>
<li><a href="Smoking_fetishism" title="Smoking fetishism">Smoking fetishism</a></li>
<li><a href="Tobacco_smoking" title="Tobacco smoking">Tobacco smoking</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Chasing_the_dragon" title="Chasing the dragon">Chasing the dragon</a></li>
<li><a href="Club_drug" title="Club drug">Club drug</a></li>
<li><a href="Counterculture_of_the_1960s" title="Counterculture of the 1960s">Counterculture of the 1960s</a></li>
<li><a href="Dance_party" title="Dance party">Dance party</a></li>
<li><a href="Drug_paraphernalia" title="Drug paraphernalia">Drug paraphernalia</a></li>
<li><a href="Recreational_drug_tourism" title="Recreational drug tourism">Drug tourism</a></li>
<li><a href="Entheogen" title="Entheogen">Entheogen</a></li>
<li><a href="Hippie" title="Hippie">Hippie</a></li>
<li><a href="Needle_sharing" title="Needle sharing">Needle sharing</a></li>
<li><a href="Nootropic" title="Nootropic">Nootropic</a></li>
<li><a href="Party_and_play" title="Party and play">Party and play</a></li>
<li><a href="Poly_drug_use" class="mw-redirect" title="Poly drug use">Poly drug use</a></li>
<li><a href="Rave" title="Rave">Rave</a></li>
<li><a href="Religion_and_drugs" title="Religion and drugs">Religion and drugs</a></li>
<li><a href="Self-medication" title="Self-medication">Self-medication</a></li>
<li><a href="Sex_and_drugs" title="Sex and drugs">Sex and drugs</a></li>
<li><a href="Urban_legends_about_drugs" title="Urban legends about drugs">Urban legends about drugs</a></li>
<li><a href="Whoonga" title="Whoonga">Whoonga</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;;text-align:center;"><div id="Legality_of_drug_use90" style="font-size:114%;margin:0 4em">Legality of drug use</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">International</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="United_Nations_drug_control_conventions" class="mw-redirect" title="United Nations drug control conventions">International drug control conventions</a>
<ul><li><a href="Single_Convention_on_Narcotic_Drugs" title="Single Convention on Narcotic Drugs">1961 Narcotic Drugs</a></li>
<li><a href="Convention_on_Psychotropic_Substances" title="Convention on Psychotropic Substances">1971 Psychotropic Substances</a></li>
<li><a href="United_Nations_Convention_Against_Illicit_Traffic_in_Narcotic_Drugs_and_Psychotropic_Substances" title="United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances">1988 Drug Trafficking</a></li></ul></li>
<li>Other treaties addressing drugs
<ul><li><a href="United_Nations_Convention_on_the_Law_of_the_Sea" title="United Nations Convention on the Law of the Sea">Law of the Sea Convention</a></li>
<li><a href="International_Convention_Against_Doping_in_Sport" title="International Convention Against Doping in Sport">Convention Against Doping</a></li>
<li><a href="Council_of_the_European_Union_decisions_on_designer_drugs" title="Council of the European Union decisions on designer drugs">Council of the European Union decisions on designer drugs</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">State level</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Drug_policy" title="Drug policy">Drug policy</a>
<ul><li><a href="Decriminalization" title="Decriminalization">Decriminalization</a></li>
<li><a href="Legalization" title="Legalization">Legalization</a></li>
<li><a href="Prohibition_of_drugs" class="mw-redirect" title="Prohibition of drugs">Prohibition</a></li>
<li><a href="Regulation" title="Regulation">Regulation</a></li>
<li><a href="Supply_reduction" title="Supply reduction">Supply reduction</a></li></ul></li>
<li><a href="Drug_policy_reform" class="mw-redirect" title="Drug policy reform">Policy reform</a>
<ul><li><a href="Demand_reduction" title="Demand reduction">Demand reduction</a></li>
<li><a href="Drug_Policy_Alliance" title="Drug Policy Alliance">Drug Policy Alliance</a></li>
<li><a href="Harm_reduction" title="Harm reduction">Harm reduction</a></li>
<li><a href="Law_Enforcement_Action_Partnership" title="Law Enforcement Action Partnership">Law Enforcement Action Partnership</a></li>
<li><a href="Drug_liberalization" title="Drug liberalization">Liberalization</a>
<ul><li><a href="Latin_American_drug_legalization" title="Latin American drug legalization">Latin America</a></li></ul></li>
<li><a href="Students_for_Sensible_Drug_Policy" title="Students for Sensible Drug Policy">Students for Sensible Drug Policy</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Drug policy<br> by country</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Drug_policy#Australia" title="Drug policy">Australia</a></li>
<li><a href="Drug_policy_of_Canada" title="Drug policy of Canada">Canada</a></li>
<li><a href="Drug_policy_of_China" title="Drug policy of China">China</a></li>
<li><a href="Drug_policy_of_the_Czech_Republic" class="mw-redirect" title="Drug policy of the Czech Republic">Czech Republic</a></li>
<li><a href="Drug_policy#Germany" title="Drug policy">Germany</a></li>
<li><a href="Drug_policy_of_India" title="Drug policy of India">India</a></li>
<li><a href="Drug_policy_of_Laos" title="Drug policy of Laos">Laos</a></li>
<li><a href="Drug_policy_of_the_Netherlands" title="Drug policy of the Netherlands">Netherlands</a></li>
<li><a href="Drug_policy_of_the_Philippines" title="Drug policy of the Philippines">Philippines</a></li>
<li><a href="Drug_policy_of_Poland" title="Drug policy of Poland">Poland</a></li>
<li><a href="Drug_policy_of_Portugal" title="Drug policy of Portugal">Portugal</a></li>
<li><a href="Drug_policy_of_Romania" title="Drug policy of Romania">Romania</a></li>
<li><a href="Drug_policy_of_Slovakia" title="Drug policy of Slovakia">Slovakia</a></li>
<li><a href="Drug_policy_of_South_Korea" title="Drug policy of South Korea">South Korea</a></li>
<li><a href="Drug_policy_of_the_Soviet_Union" title="Drug policy of the Soviet Union">Soviet Union</a></li>
<li><a href="Drug_policy_of_Sweden" title="Drug policy of Sweden">Sweden</a></li>
<li><a href="Drug_policy#Switzerland" title="Drug policy">Switzerland</a></li>
<li><a href="Federal_drug_policy_of_the_United_States" title="Federal drug policy of the United States">United States</a>
<ul><li><a href="Just_Say_No" title="Just Say No">Just Say No</a></li>
<li><a href="Office_of_National_Drug_Control_Policy" title="Office of National Drug Control Policy">Office of National Drug Control Policy</a></li>
<li><a href="School_district_drug_policies" title="School district drug policies">School district drug policies</a></li>
<li><a href="Drug_policy_of_California" title="Drug policy of California">California</a></li>
<li><a href="Cannabis_in_Colorado" title="Cannabis in Colorado">Colorado</a></li>
<li><a href="Drug_policy_of_Maryland" title="Drug policy of Maryland">Maryland</a></li>
<li><a href="Drug_policy_of_Oregon" title="Drug policy of Oregon">Oregon</a></li>
<li><a href="Drug_policy_of_Virginia" title="Drug policy of Virginia">Virginia</a></li></ul></li>
<li><a href="Drug_policy_of_the_United_Kingdom" title="Drug policy of the United Kingdom">United Kingdom</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Drug legality</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Alcohol_law" title="Alcohol law">Alcohol legality</a></li>
<li><a href="Anabolic_steroid#Legal_status" title="Anabolic steroid">Anabolic steroid legality</a></li>
<li><a href="Legality_of_cannabis" title="Legality of cannabis">Cannabis legality</a></li>
<li><a href="Legal_status_of_cocaine" title="Legal status of cocaine">Cocaine legality</a></li>
<li><a href="Legal_status_of_methamphetamine" title="Legal status of methamphetamine">Methamphetamine legality</a></li>
<li><a href="Psilocybin_decriminalization_in_the_United_States" title="Psilocybin decriminalization in the United States">Psilocybin decriminalization in the U.S.</a></li>
<li><a href="Legal_status_of_psilocybin_mushrooms" title="Legal status of psilocybin mushrooms">Psilocybin mushrooms legality</a></li>
<li><a href="Legal_status_of_Salvia_divinorum" title="Legal status of Salvia divinorum">Salvia legality</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Arguments_for_and_against_drug_prohibition" title="Arguments for and against drug prohibition">Arguments for and against drug prohibition</a></li>
<li><a href="Cannabis_rights" title="Cannabis rights">Cannabis rights</a></li>
<li><a href="Capital_punishment_for_drug_trafficking" title="Capital punishment for drug trafficking">Capital punishment for drug trafficking</a></li>
<li><a href="Cognitive_liberty" title="Cognitive liberty">Cognitive liberty</a></li>
<li><a href="Designer_drug" title="Designer drug">Designer drug</a></li>
<li><a href="Drug_court" title="Drug court">Drug court</a></li>
<li><a href="Drug_possession" class="mw-redirect" title="Drug possession">Drug possession</a></li>
<li><a href="Drug_test" title="Drug test">Drug test</a></li>
<li><a href="Informant" title="Informant">Narc</a></li>
<li><a href="Politics_of_drug_abuse" title="Politics of drug abuse">Politics of drug abuse</a></li>
<li><a href="War_on_drugs" title="War on drugs">War on drugs</a>
<ul><li><a href="Mexican_drug_war" title="Mexican drug war">Mexican drug war</a></li>
<li><a href="Plan_Colombia" title="Plan Colombia">Plan Colombia</a></li>
<li><a href="Philippine_drug_war" title="Philippine drug war">Philippine drug war</a></li></ul></li>
<li><a href="Zero_tolerance" title="Zero tolerance">Zero tolerance</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2" style="text-align:center;;text-align:center;"><div id="Other90" style="font-size:114%;margin:0 4em">Other</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Drug<br> production<br> and trade</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug<br> production</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Coca_production_in_Colombia" title="Coca production in Colombia">Coca production in Colombia</a></li>
<li><a href="Drug_precursors" title="Drug precursors">Drug precursors</a></li>
<li><a href="Opium_production_in_Afghanistan" title="Opium production in Afghanistan">Opium production in Afghanistan</a></li>
<li><a href="Rolling_meth_lab" title="Rolling meth lab">Rolling meth lab</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Drug trade</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Illegal_drug_trade" title="Illegal drug trade">Illegal drug trade</a>
<ul><li><a href="Illegal_drug_trade_in_Afghanistan" class="mw-redirect" title="Illegal drug trade in Afghanistan">Afghanistan</a></li>
<li><a href="Illegal_drug_trade_in_Aruba" title="Illegal drug trade in Aruba">Aruba</a></li>
<li><a href="Illegal_drug_trade_in_Australia" class="mw-redirect" title="Illegal drug trade in Australia">Australia</a></li>
<li><a href="Illegal_drug_trade_in_Bangladesh" class="mw-redirect" title="Illegal drug trade in Bangladesh">Bangladesh</a></li>
<li><a href="Illegal_drug_trade_in_Belize" class="mw-redirect" title="Illegal drug trade in Belize">Belize</a></li>
<li><a href="Illegal_drug_trade_in_Benin" class="mw-redirect" title="Illegal drug trade in Benin">Benin</a></li>
<li><a href="Illegal_drug_trade_in_Bhutan" class="mw-redirect" title="Illegal drug trade in Bhutan">Bhutan</a></li>
<li><a href="Illegal_drug_trade_in_Bolivia" class="mw-redirect" title="Illegal drug trade in Bolivia">Bolivia</a></li>
<li><a href="Illegal_drug_trade_in_Brazil" class="mw-redirect" title="Illegal drug trade in Brazil">Brazil</a></li>
<li><a href="Illegal_drug_trade_in_Burma" class="mw-redirect" title="Illegal drug trade in Burma">Burma</a></li>
<li><a href="Drugs_in_Cambodia" title="Drugs in Cambodia">Cambodia</a></li>
<li><a href="Illegal_drug_trade_in_Chile" class="mw-redirect" title="Illegal drug trade in Chile">Chile</a></li>
<li><a href="Illegal_drug_trade_in_China" title="Illegal drug trade in China">China</a></li>
<li><a href="Illegal_drug_trade_in_Colombia" title="Illegal drug trade in Colombia">Colombia</a></li>
<li><a href="Illegal_drug_trade_in_Costa_Rica" class="mw-redirect" title="Illegal drug trade in Costa Rica">Costa Rica</a></li>
<li><a href="Illegal_drug_trade_in_Cuba" class="mw-redirect" title="Illegal drug trade in Cuba">Cuba</a></li>
<li><a href="Illegal_drug_trade_in_Cyprus" class="mw-redirect" title="Illegal drug trade in Cyprus">Cyprus</a></li>
<li><a href="Illegal_drug_trade_in_the_Dominican_Republic" class="mw-redirect" title="Illegal drug trade in the Dominican Republic">Dominican Republic</a></li>
<li><a href="Illegal_drug_trade_in_El_Salvador" title="Illegal drug trade in El Salvador">El Salvador</a></li>
<li><a href="Illegal_drug_trade_in_Estonia" class="mw-redirect" title="Illegal drug trade in Estonia">Estonia</a></li>
<li><a href="Illegal_drug_trade_in_Finland" class="mw-redirect" title="Illegal drug trade in Finland">Finland</a></li>
<li><a href="Illegal_drug_trade_in_Germany" class="mw-redirect" title="Illegal drug trade in Germany">Germany</a></li>
<li><a href="Illegal_drug_trade_in_Haiti" title="Illegal drug trade in Haiti">Haiti</a></li>
<li><a href="Illegal_drug_trade_in_Honduras" class="mw-redirect" title="Illegal drug trade in Honduras">Honduras</a></li>
<li><a href="Illegal_drug_trade_in_India" class="mw-redirect" title="Illegal drug trade in India">India</a></li>
<li><a href="Illegal_drug_trade_in_the_Indian_Ocean_region" title="Illegal drug trade in the Indian Ocean region">Indian Ocean region</a></li>
<li><a href="Illegal_drug_trade_in_Iran" class="mw-redirect" title="Illegal drug trade in Iran">Iran</a></li>
<li><a href="Illegal_drug_trade_in_Italy" class="mw-redirect" title="Illegal drug trade in Italy">Italy</a></li>
<li><a href="Illegal_drug_trade_in_Japan" title="Illegal drug trade in Japan">Japan</a></li>
<li><a href="Illegal_drug_trade_in_Kenya" class="mw-redirect" title="Illegal drug trade in Kenya">Kenya</a></li>
<li><a href="Illegal_drug_trade_in_Kosovo" class="mw-redirect" title="Illegal drug trade in Kosovo">Kosovo</a></li>
<li><a href="Illegal_drug_trade_in_Kyrgyzstan" class="mw-redirect" title="Illegal drug trade in Kyrgyzstan">Kyrgyzstan</a></li>
<li><a href="Illegal_drug_trade_in_Laos" class="mw-redirect" title="Illegal drug trade in Laos">Laos</a></li>
<li><a href="Illegal_drug_trade_in_Latin_America" title="Illegal drug trade in Latin America">Latin America</a></li>
<li><a href="Illegal_drug_trade_in_Latvia" class="mw-redirect" title="Illegal drug trade in Latvia">Latvia</a></li>
<li><a href="Illegal_drug_trade_in_Malaysia" class="mw-redirect" title="Illegal drug trade in Malaysia">Malaysia</a></li>
<li><a href="Drug_trafficking_in_Mauritius" title="Drug trafficking in Mauritius">Mauritius</a></li>
<li><a href="Illegal_drug_trade_in_Moldova" class="mw-redirect" title="Illegal drug trade in Moldova">Moldova</a></li>
<li><a href="Illegal_drug_trade_in_Nigeria" class="mw-redirect" title="Illegal drug trade in Nigeria">Nigeria</a></li>
<li><a href="Illegal_drug_trade_in_Norway" class="mw-redirect" title="Illegal drug trade in Norway">Norway</a></li>
<li><a href="Illegal_drug_trade_in_Oman" class="mw-redirect" title="Illegal drug trade in Oman">Oman</a></li>
<li><a href="Illegal_drug_trade_in_Panama" title="Illegal drug trade in Panama">Panama</a></li>
<li><a href="Illegal_drug_trade_in_Papua_New_Guinea" class="mw-redirect" title="Illegal drug trade in Papua New Guinea">Papua New Guinea</a></li>
<li><a href="Illegal_drug_trade_in_Paraguay" title="Illegal drug trade in Paraguay">Paraguay</a></li>
<li><a href="Illegal_drug_trade_in_the_Philippines" title="Illegal drug trade in the Philippines">Philippines</a></li>
<li><a href="Illegal_drug_trade_in_Poland" class="mw-redirect" title="Illegal drug trade in Poland">Poland</a></li>
<li><a href="Illegal_drug_trade_in_Portugal" class="mw-redirect" title="Illegal drug trade in Portugal">Portugal</a></li>
<li><a href="Illegal_drug_trade_in_Puerto_Rico" title="Illegal drug trade in Puerto Rico">Puerto Rico</a></li>
<li><a href="Illegal_drug_trade_in_Russia" class="mw-redirect" title="Illegal drug trade in Russia">Russia</a></li>
<li><a href="Illegal_drug_trade_in_Saint_Kitts_and_Nevis" class="mw-redirect" title="Illegal drug trade in Saint Kitts and Nevis">Saint Kitts and Nevis</a></li>
<li><a href="Illegal_drug_trade_in_Seychelles" title="Illegal drug trade in Seychelles">Seychelles</a></li>
<li><a href="Illegal_drug_trade_in_Slovakia" class="mw-redirect" title="Illegal drug trade in Slovakia">Slovakia</a></li>
<li><a href="Illegal_drug_trade_in_South_Africa" class="mw-redirect" title="Illegal drug trade in South Africa">South Africa</a></li>
<li><a href="Illegal_drug_trade_in_South_Korea" class="mw-redirect" title="Illegal drug trade in South Korea">South Korea</a></li>
<li><a href="Illegal_drug_trade_in_Spain" class="mw-redirect" title="Illegal drug trade in Spain">Spain</a></li>
<li><a href="Illegal_drug_trade_in_Suriname" class="mw-redirect" title="Illegal drug trade in Suriname">Suriname</a></li>
<li><a href="Illegal_drug_trade_in_Switzerland" class="mw-redirect" title="Illegal drug trade in Switzerland">Switzerland</a></li>
<li><a href="Illegal_drug_trade_in_Taiwan" class="mw-redirect" title="Illegal drug trade in Taiwan">Taiwan</a></li>
<li><a href="Illegal_drug_trade_in_Thailand" class="mw-redirect" title="Illegal drug trade in Thailand">Thailand</a></li>
<li><a href="Illegal_drug_trade_in_Turkey" title="Illegal drug trade in Turkey">Turkey</a></li>
<li><a href="Illegal_drug_trade_in_the_Turks_and_Caicos_Islands" title="Illegal drug trade in the Turks and Caicos Islands">Turks and Caicos Islands</a></li>
<li><a href="Illegal_drug_trade_in_the_United_Arab_Emirates" class="mw-redirect" title="Illegal drug trade in the United Arab Emirates">United Arab Emirates</a></li>
<li><a href="Illegal_drug_trade_in_the_United_States" title="Illegal drug trade in the United States">United States</a></li>
<li><a href="Illegal_drug_trade_in_Venezuela" title="Illegal drug trade in Venezuela">Venezuela</a></li></ul></li>
<li><a href="Darknet_market" title="Darknet market">Darknet market</a></li>
<li><a href="Pharmaceutical_distribution" title="Pharmaceutical distribution">Pharmaceutical distribution</a>
<ul><li><a href="Beer_shop" class="mw-redirect" title="Beer shop">Beer shop</a></li>
<li><a href="Cannabis_shop" class="mw-redirect" title="Cannabis shop">Cannabis shop</a></li>
<li><a href="Liquor_store" title="Liquor store">Liquor store</a></li>
<li><a href="Liquor_license" title="Liquor license">Liquor license</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Issues with<br>drug use</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Substance_abuse" title="Substance abuse">Abuse</a></li>
<li><a href="Addiction" title="Addiction">Addiction</a></li>
<li><a href="Date_rape_drug" title="Date rape drug">Date rape drug</a></li>
<li><a href="Substance_dependence" title="Substance dependence">Dependence</a></li>
<li><a href="Driving_under_the_influence" title="Driving under the influence">Driving impaired</a></li>
<li><a href="Drug_harmfulness" class="mw-redirect" title="Drug harmfulness">Drug harmfulness</a>
<ul><li><a href="Effects_of_cannabis" title="Effects of cannabis">Effects of cannabis</a></li></ul></li>
<li><a href="Drug-related_crime" title="Drug-related crime">Drug-related crime</a></li>
<li><a href="Fetal_alcohol_spectrum_disorder" title="Fetal alcohol spectrum disorder">Fetal alcohol spectrum disorder</a></li>
<li><a href="Long-term_effects_of_cannabis" title="Long-term effects of cannabis">Long-term effects of cannabis</a></li>
<li><a href="Neurotoxicity" title="Neurotoxicity">Neurotoxicity</a></li>
<li><a href="Drug_overdose" title="Drug overdose">Overdose</a></li>
<li><a href="Passive_smoking" title="Passive smoking">Passive smoking</a>
<ul><li>of tobacco or other substances</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Harm reduction</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Drug_checking" title="Drug checking">Drug checking</a></li>
<li><a href="Drug_legalization" class="mw-redirect" title="Drug legalization">Drug legalization</a></li>
<li><a href="Drug_rehabilitation" title="Drug rehabilitation">Drug rehabilitation</a></li>
<li><a href="Needle_and_syringe_programmes" title="Needle and syringe programmes">Needle and syringe programmes</a></li>
<li><a href="Opioid_replacement_therapy" class="mw-redirect" title="Opioid replacement therapy">Opioid replacement therapy</a></li>
<li><a href="Pharmacovigilance" title="Pharmacovigilance">Pharmacovigilance</a></li>
<li><a href="Reagent_testing" title="Reagent testing">Reagent testing</a></li>
<li><a href="Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Regulation of therapeutic goods</a></li>
<li><a href="Responsible_drug_use" title="Responsible drug use">Responsible drug use</a></li>
<li><a href="Substance_abuse_prevention" title="Substance abuse prevention">Substance abuse prevention</a></li>
<li><a href="Supervised_injection_site" title="Supervised injection site">Supervised injection site</a></li>
<li><a href="Trip_killer" title="Trip killer">Trip killer</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Countries by <br> drug use</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="List_of_countries_by_alcohol_consumption_per_capita" title="List of countries by alcohol consumption per capita">Alcohol consumption</a></li>
<li><a href="List_of_countries_by_prevalence_of_cocaine_use" title="List of countries by prevalence of cocaine use">Cocaine use</a></li>
<li>Cannabis
<ul><li><a href="Annual_cannabis_use_by_country" class="mw-redirect" title="Annual cannabis use by country">Annual use</a></li>
<li><a href="Adult_lifetime_cannabis_use_by_country" title="Adult lifetime cannabis use by country">Lifetime use</a></li></ul></li>
<li><a href="List_of_countries_by_prevalence_of_opiates_use" title="List of countries by prevalence of opiates use">Opiates use</a></li>
<li><a href="List_of_countries_by_tobacco_consumption" class="mw-redirect" title="List of countries by tobacco consumption">Tobacco consumption</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div></div></td></tr></tbody></table></div>
<div class="navbox-styles"></div><div role="navigation" class="navbox" aria-labelledby="Ion_channel_modulators357" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Ion_channel_modulators357" style="font-size:114%;margin:0 4em"><a href="Channel_modulator" title="Channel modulator">Ion channel modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Calcium_channel" title="Calcium channel">Calcium</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="VDCCsTooltip_Voltage-dependent_calcium_channels424" scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Voltage-dependent_calcium_channels" class="mw-redirect" title="Voltage-dependent calcium channels"><abbr title="Voltage-dependent calcium channels">VDCCs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Voltage-dependent calcium channels</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Calcium_channel_blocker" title="Calcium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="L-type_calcium_channel" title="L-type calcium channel">L-type-selective</a>:</b> <i><a href="Dihydropyridine" class="mw-redirect" title="Dihydropyridine">Dihydropyridines</a>:</i> <a href="Amlodipine" title="Amlodipine">Amlodipine</a> (<a href="Telmisartan/amlodipine/indapamide" title="Telmisartan/amlodipine/indapamide">+telmisartan and indapamide</a>)</li>
<li><a href="Aranidipine" title="Aranidipine">Aranidipine</a></li>
<li><a href="Azelnidipine" title="Azelnidipine">Azelnidipine</a></li>
<li><a href="Barnidipine" title="Barnidipine">Barnidipine</a></li>
<li><a href="Clevidipine" title="Clevidipine">Clevidipine</a></li>
<li>Cronidipine</li>
<li><a href="Darodipine" title="Darodipine">Darodipine</a></li>
<li>Dexniguldipine</li>
<li>Elgodipine</li>
<li>Elnadipine</li>
<li><a href="Felodipine" title="Felodipine">Felodipine</a></li>
<li>Flordipine</li>
<li>Furnidipine</li>
<li>Iganidipine</li>
<li><a href="Isradipine" title="Isradipine">Isradipine</a></li>
<li><a href="Lacidipine" title="Lacidipine">Lacidipine</a></li>
<li>Lemildipine</li>
<li><a href="Lercanidipine" title="Lercanidipine">Lercanidipine</a></li>
<li><a href="Levamlodipine" title="Levamlodipine">Levamlodipine</a></li>
<li>Levniguldipine</li>
<li><a href="Manidipine" title="Manidipine">Manidipine</a></li>
<li><a href="Barnidipine" title="Barnidipine">Mepirodipine</a></li>
<li>Mesudipine</li>
<li><a href="Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li><a href="Niguldipine" title="Niguldipine">Niguldipine</a></li>
<li><a href="Niludipine" title="Niludipine">Niludipine</a></li>
<li><a href="Nilvadipine" title="Nilvadipine">Nilvadipine</a></li>
<li><a href="Nimodipine" title="Nimodipine">Nimodipine</a></li>
<li><a href="Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li><a href="Nitrendipine" title="Nitrendipine">Nitrendipine</a></li>
<li>Olradipine</li>
<li><a href="Oxodipine" title="Oxodipine">Oxodipine</a></li>
<li>Palonidipine</li>
<li><a href="Pranidipine" title="Pranidipine">Pranidipine</a></li>
<li><a href="Riodipine" title="Riodipine">Ryodipine (riodipine)</a></li>
<li>Sagandipine</li>
<li>Sornidipine</li>
<li>Teludipine</li>
<li>Tiamdipine</li>
<li>Trombodipine</li>
<li>Vatanidipine; <i><a href="Diltiazem" title="Diltiazem">Diltiazem</a> derivatives:</i> <a href="Clentiazem" title="Clentiazem">Clentiazem</a></li>
<li><a href="Diltiazem" title="Diltiazem">Diltiazem</a></li>
<li>Iprotiazem</li>
<li>Nictiazem</li>
<li>Siratiazem; <i><a href="Arylalkylamine" title="Arylalkylamine">Phenylalkylamines</a>:</i> <a href="Anipamil" title="Anipamil">Anipamil</a></li>
<li>Dagapamil</li>
<li><a href="Devapamil" title="Devapamil">Devapamil</a></li>
<li>Dexverapamil</li>
<li><a href="Emopamil" title="Emopamil">Emopamil</a></li>
<li>Etripamil</li>
<li><a href="Falipamil" title="Falipamil">Falipamil</a></li>
<li><a href="Gallopamil" title="Gallopamil">Gallopamil</a></li>
<li>Levemopamil</li>
<li>Nexopamil</li>
<li><a href="Norverapamil" title="Norverapamil">Norverapamil</a></li>
<li>Ronipamil</li>
<li><a href="Tiapamil" title="Tiapamil">Tiapamil</a></li>
<li><a href="Verapamil" title="Verapamil">Verapamil</a>; <i>Others:</i> <a href="AH-1058" title="AH-1058">AH-1058</a></li>
<li>Brinazarone</li>
<li><a href="Budiodarone" title="Budiodarone">Budiodarone</a></li>
<li><a href="Celivarone" title="Celivarone">Celivarone</a></li>
<li><a href="Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Dronedarone" title="Dronedarone">Dronedarone</a></li>
<li><a href="Fantofarone" title="Fantofarone">Fantofarone</a></li>
<li>SR-33805</li>
<li><a href="Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li></ul>
<ul><li><b><a href="N-type_calcium_channel" title="N-type calcium channel">N-type-selective</a>:</b> <a href="%CE%A9-Conotoxin" class="mw-redirect" title="Ω-Conotoxin">ω-Conotoxins</a></li>
<li>ω-Conotoxin GVIA</li>
<li><a href="Caroverine" title="Caroverine">Caroverine</a></li>
<li>Huwentoxin XVI</li>
<li><a href="Leconotide" title="Leconotide">Leconotide (ω-conotoxin CVID)</a></li>
<li>PD-173212</li>
<li><a href="Ralfinamide" title="Ralfinamide">Ralfinamide</a></li>
<li><a href="Safinamide" title="Safinamide">Safinamide</a></li>
<li>Z160</li>
<li><a href="Ziconotide" title="Ziconotide">Ziconotide (ω-conotoxin MVIIA)</a></li></ul>
<ul><li><b><a href="P-type_calcium_channel" title="P-type calcium channel">P-type-selective</a>:</b> ω-Agatoxin IVA</li>
<li>ω-Agatoxin IVB</li></ul>
<ul><li><b><a href="R-type_calcium_channel" title="R-type calcium channel">R-type-selective</a>:</b> <a href="SNX-482" title="SNX-482">SNX-482</a></li></ul>
<ul><li><b><a href="T-type_calcium_channel" title="T-type calcium channel">T-type-selective</a>:</b> ABT-639</li>
<li>ML-218</li>
<li><a href="Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li>NNC 55-0396</li>
<li>ProTx I</li>
<li>Z944</li>
<li><a href="Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
<ul><li><b>Non-selective:</b> ω-Agatoxin TK</li>
<li>ω-Conotoxin MVIIC</li>
<li><a href="Benidipine" title="Benidipine">Benidipine</a></li>
<li><a href="Bepridil" title="Bepridil">Bepridil</a></li>
<li><a href="Cilnidipine" title="Cilnidipine">Cilnidipine</a></li>
<li><a href="Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li><a href="Dotarizine" title="Dotarizine">Dotarizine</a></li>
<li><a href="Efonidipine" title="Efonidipine">Efonidipine</a></li>
<li><a href="Flunarizine" title="Flunarizine">Flunarizine</a></li>
<li><a href="Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Levetiracetam" title="Levetiracetam">Levetiracetam</a></li>
<li><a href="Lomerizine" title="Lomerizine">Lomerizine</a></li>
<li><a href="Loperamide" title="Loperamide">Loperamide</a></li>
<li><a href="Mibefradil" title="Mibefradil">Mibefradil</a></li>
<li>NP078585</li>
<li><a href="Ruthenium_red" title="Ruthenium red">Ruthenium red</a></li>
<li><a href="TROX-1" title="TROX-1">TROX-1</a></li></ul>
<ul><li><b><a href="Voltage-dependent_calcium_channel" class="mw-redirect" title="Voltage-dependent calcium channel">α<sub>2</sub>δ subunit</a>-selective (<a href="Gabapentinoid" title="Gabapentinoid">gabapentinoids</a>):</b> <a href="4-Methylpregabalin" title="4-Methylpregabalin">4-Methylpregabalin</a></li>
<li><a href="Arbaclofen" title="Arbaclofen">Arbaclofen</a></li>
<li><a href="Arbaclofen_placarbil" title="Arbaclofen placarbil">Arbaclofen placarbil</a></li>
<li><a href="Atagabalin" title="Atagabalin">Atagabalin</a></li>
<li><a href="Baclofen" title="Baclofen">Baclofen</a></li>
<li><a href="Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li><a href="Gabapentin_enacarbil" title="Gabapentin enacarbil">Gabapentin enacarbil</a></li>
<li><a href="Imagabalin" title="Imagabalin">Imagabalin</a></li>
<li><a href="Mirogabalin" title="Mirogabalin">Mirogabalin</a></li>
<li>PD-200,347</li>
<li><a href="PD-217%2C014" title="PD-217,014">PD-217,014</a></li>
<li>PD-299,685</li>
<li><a href="Phenibut" title="Phenibut">Phenibut</a></li>
</ul>
<ul><li><b>Others/unsorted:</b> <a href="Bencyclane" title="Bencyclane">Bencyclane</a></li>
<li><a href="Berbamine" title="Berbamine">Berbamine</a></li>
<li><a href="Bevantolol" title="Bevantolol">Bevantolol</a></li>
<li><a href="Canadine" title="Canadine">Canadine</a></li>
<li><a href="Carboxyamidotriazole" title="Carboxyamidotriazole">Carboxyamidotriazole</a></li>
<li><a href="Cycleanine" title="Cycleanine">Cycleanine</a></li>
<li><a href="Dauricine" title="Dauricine">Dauricine</a></li>
<li><a href="Dimeditiapramine" class="mw-redirect" title="Dimeditiapramine">Dimeditiapramine</a></li>
<li><a href="Diproteverine" title="Diproteverine">Diproteverine</a></li>
<li><a href="Enpiperate" title="Enpiperate">Enpiperate</a></li>
<li><a href="Eperisone" title="Eperisone">Eperisone</a></li>
<li>Elpetrigine</li>
<li><a href="Ethadione" title="Ethadione">Ethadione</a></li>
<li><a href="Alcohol_(drug)" title="Alcohol (drug)">Ethanol (alcohol)</a></li>
<li><a href="Ethosuximide" title="Ethosuximide">Ethosuximide</a></li>
<li><a href="Fasudil" title="Fasudil">Fasudil</a></li>
<li><a href="Fendiline" title="Fendiline">Fendiline</a></li>
<li><a href="Fostedil" title="Fostedil">Fostedil</a></li>
<li><a href="Imepitoin" title="Imepitoin">Imepitoin</a></li>
<li><a href="JTV-519" title="JTV-519">JTV-519</a></li>
<li><a href="Lidoflazine" title="Lidoflazine">Lidoflazine</a></li>
<li><a href="Magnesium" title="Magnesium">Magnesium</a></li>
<li><a href="Manoalide" title="Manoalide">Manoalide</a></li>
<li><a href="Mesuximide" title="Mesuximide">Mesuximide</a></li>
<li><a href="Monatepil" title="Monatepil">Monatepil</a></li>
<li><a href="Naftopidil" title="Naftopidil">Naftopidil</a></li>
<li><a href="Ochratoxin_A" title="Ochratoxin A">Ochratoxin A</a></li>
<li><a href="Osthol" title="Osthol">Osthol</a></li>
<li><a href="Otilonium_bromide" title="Otilonium bromide">Otilonium bromide</a></li>
<li><a href="Paramethadione" title="Paramethadione">Paramethadione</a></li>
<li><a href="Phensuximide" title="Phensuximide">Phensuximide</a></li>
<li><a href="Pinaverium_bromide" title="Pinaverium bromide">Pinaverium bromide</a></li>
<li><a href="Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li><a href="Rhynchophylline" title="Rhynchophylline">Rhynchophylline</a></li>
<li><a href="Sesamodil" title="Sesamodil">Sesamodil</a></li>
<li><a href="Silperisone" title="Silperisone">Silperisone</a></li>
<li>Sipatrigine</li>
<li><a href="Terodiline" title="Terodiline">Terodiline</a></li>
<li><a href="Tetrandrine" title="Tetrandrine">Tetrandrine</a></li>
<li><a href="Tolperisone" title="Tolperisone">Tolperisone</a></li>
<li><a href="Trimethadione" title="Trimethadione">Trimethadione</a></li>
<li><a href="Valperinol" title="Valperinol">Valperinol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Calcium_channel_opener" title="Calcium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="L-type_calcium_channel" title="L-type calcium channel">L-type-selective</a>:</b> <a href="Bay_K8644" title="Bay K8644">Bay K8644</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Potassium_channel" title="Potassium channel">Potassium</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Voltage-gated_potassium_channels" class="mw-redirect" title="Voltage-gated potassium channels"><abbr title="Voltage-gated potassium channels">VGKCs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Voltage-gated potassium channels</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_blocker" title="Potassium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="3%2C4-Diaminopyridine" class="mw-redirect" title="3,4-Diaminopyridine">3,4-Diaminopyridine (amifampridine)</a></li>
<li><a href="4-Aminopyridine" title="4-Aminopyridine">4-Aminopyridine (fampridine/dalfampridine)</a></li>
<li>Adekalant</li>
<li><a href="Almokalant" title="Almokalant">Almokalant</a></li>
<li><a href="Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Azimilide" title="Azimilide">Azimilide</a></li>
<li><a href="Bretylium" title="Bretylium">Bretylium</a></li>
<li><a href="Bunaftine" title="Bunaftine">Bunaftine</a></li>
<li><a href="Charybdotoxin" title="Charybdotoxin">Charybdotoxin</a></li>
<li>Clamikalant</li>
<li><a href="Conotoxin" title="Conotoxin">Conotoxins</a></li>
<li>Dalazatide</li>
<li><a href="Dendrotoxin" title="Dendrotoxin">Dendrotoxin</a></li>
<li><a href="Dofetilide" title="Dofetilide">Dofetilide</a></li>
<li><a href="Dronedarone" title="Dronedarone">Dronedarone</a></li>
<li><a href="E-4031" title="E-4031">E-4031</a></li>
<li><a href="Hanatoxin" title="Hanatoxin">Hanatoxin</a></li>
<li><a href="HgeTx1" title="HgeTx1">HgeTx1</a></li>
<li><a href="HsTx1" title="HsTx1">HsTx1</a></li>
<li><a href="Ibutilide" title="Ibutilide">Ibutilide</a></li>
<li>Inakalant</li>
<li><a href="Kaliotoxin" title="Kaliotoxin">Kaliotoxin</a></li>
<li><a href="Linopirdine" title="Linopirdine">Linopirdine</a></li>
<li><a href="Lolitrem_B" title="Lolitrem B">Lolitrem B</a></li>
<li><a href="Maurotoxin" title="Maurotoxin">Maurotoxin</a></li>
<li><a href="Nifekalant" title="Nifekalant">Nifekalant</a></li>
<li>Notoxin</li>
<li><a href="Paxilline" title="Paxilline">Paxilline</a></li>
<li>Pinokalant</li>
<li><a href="Quinidine" title="Quinidine">Quinidine</a></li>
<li>ShK-186</li>
<li><a href="Sotalol" title="Sotalol">Sotalol</a></li>
<li><a href="Tedisamil" title="Tedisamil">Tedisamil</a></li>
<li>Terikalant</li>
<li><a href="Tetraethylammonium" title="Tetraethylammonium">Tetraethylammonium</a></li>
<li><a href="Vernakalant" title="Vernakalant">Vernakalant</a></li></ul>
<ul><li><b><a href="HERG" class="mw-redirect" title="HERG">hERG</a> (KCNH2, K<sub>v</sub>11.1)-specific:</b> <a href="Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="AmmTX3" title="AmmTX3">AmmTX3</a></li>
<li><a href="Astemizole" title="Astemizole">Astemizole</a></li>
<li><a href="Azaspiracid" title="Azaspiracid">Azaspiracid</a></li>
<li><a href="AZD1305" title="AZD1305">AZD1305</a></li>
<li><a href="Azimilide" title="Azimilide">Azimilide</a></li>
<li><a href="Bedaquiline" title="Bedaquiline">Bedaquiline</a></li>
<li><a href="BeKm-1_toxin" title="BeKm-1 toxin">BeKm-1</a></li>
<li><a href="BmTx3" title="BmTx3">BmTx3</a></li>
<li><a href="BRL-32872" title="BRL-32872">BRL-32872</a></li>
<li><a href="Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Cisapride" title="Cisapride">Cisapride</a></li>
<li><a href="Clarithromycin" title="Clarithromycin">Clarithromycin</a></li>
<li><a href="Darifenacin" title="Darifenacin">Darifenacin</a></li>
<li><a href="Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a></li>
<li><a href="Diallyl_trisulfide" title="Diallyl trisulfide">Diallyl trisulfide</a></li>
<li><a href="Domperidone" title="Domperidone">Domperidone</a></li>
<li><a href="E-4031" title="E-4031">E-4031</a></li>
<li><a href="Ergtoxin" title="Ergtoxin">Ergtoxins</a></li>
<li><a href="Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li><a href="Gigactonine" title="Gigactonine">Gigactonine</a></li>
<li><a href="Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><a href="Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Norpropoxyphene" title="Norpropoxyphene">Norpropoxyphene</a></li>
<li><a href="Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="Pimozide" title="Pimozide">Pimozide</a></li>
<li><a href="PNU-282%2C987" title="PNU-282,987">PNU-282,987</a></li>
<li><a href="Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Ranolazine" title="Ranolazine">Ranolazine</a></li>
<li><a href="Roxithromycin" title="Roxithromycin">Roxithromycin</a></li>
<li><a href="Sertindole" title="Sertindole">Sertindole</a></li>
<li><a href="Solifenacin" title="Solifenacin">Solifenacin</a></li>
<li><a href="Tamulotoxin" title="Tamulotoxin">Tamulotoxin</a></li>
<li><a href="Terodiline" title="Terodiline">Terodiline</a></li>
<li><a href="Terfenadine" title="Terfenadine">Terfenadine</a></li>
<li><a href="Thioridazine" title="Thioridazine">Thioridazine</a></li>
<li><a href="Tolterodine" title="Tolterodine">Tolterodine</a></li>
<li><a href="Vanoxerine" title="Vanoxerine">Vanoxerine</a></li>
<li><a href="Vernakalant" title="Vernakalant">Vernakalant</a></li></ul>
<ul><li><b><a href="KCNQ" title="KCNQ">KCNQ (K<sub>v</sub>7)</a>-specific:</b> <a href="Linopirdine" title="Linopirdine">Linopirdine</a></li>
<li>XE-991</li>
<li><a href="Ssm_spooky_toxin" title="Ssm spooky toxin">Spooky toxin (SsTx)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_opener" title="Potassium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="KCNQ" title="KCNQ">KCNQ (K<sub>v</sub>7)</a>-specific:</b> <a href="Flupirtine" title="Flupirtine">Flupirtine</a></li>
<li><a href="Retigabine" title="Retigabine">Retigabine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Inwardly_rectifying_potassium_channel" class="mw-redirect" title="Inwardly rectifying potassium channel"><abbr title="Inwardly rectifying potassium channel">IRKs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Inwardly rectifying potassium channel</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_blocker" title="Potassium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="ATP-sensitive_potassium_channel" title="ATP-sensitive potassium channel"><abbr title="ATP-sensitive potassium channel">K<sub>ATP</sub></abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip ATP-sensitive potassium channel</span>-specific:</b> <a href="Acetohexamide" title="Acetohexamide">Acetohexamide</a></li>
<li><a href="Carbutamide" title="Carbutamide">Carbutamide</a></li>
<li><a href="Chlorpropamide" title="Chlorpropamide">Chlorpropamide</a></li>
<li><a href="Glibenclamide" title="Glibenclamide">Glibenclamide (glyburide)</a></li>
<li><a href="Glibornuride" title="Glibornuride">Glibornuride</a></li>
<li><a href="Glicaramide" title="Glicaramide">Glicaramide</a></li>
<li><a href="Gliclazide" title="Gliclazide">Gliclazide</a></li>
<li><a href="Glimepiride" title="Glimepiride">Glimepiride</a></li>
<li><a href="Glipizide" title="Glipizide">Glipizide</a></li>
<li><a href="Gliquidone" title="Gliquidone">Gliquidone</a></li>
<li><a href="Glisoxepide" title="Glisoxepide">Glisoxepide</a></li>
<li><a href="Glyclopyramide" title="Glyclopyramide">Glyclopyramide</a></li>
<li>Glycyclamide</li>
<li><a href="Metahexamide" title="Metahexamide">Metahexamide</a></li>
<li><a href="Mitiglinide" title="Mitiglinide">Mitiglinide</a></li>
<li><a href="Nateglinide" title="Nateglinide">Nateglinide</a></li>
<li><a href="Repaglinide" title="Repaglinide">Repaglinide</a></li>
<li><a href="Tolazamide" title="Tolazamide">Tolazamide</a></li>
<li><a href="Tolbutamide" title="Tolbutamide">Tolbutamide</a></li></ul>
<ul><li><b><a href="G_protein-coupled_inwardly_rectifying_potassium_channel" title="G protein-coupled inwardly rectifying potassium channel"><abbr title="G protein-coupled inwardly rectifying potassium channel">GIRK</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip G protein-coupled inwardly rectifying potassium channel</span>-specific:</b> <a href="Barium" title="Barium">Barium</a></li>
<li><a href="Caramiphen" title="Caramiphen">Caramiphen</a></li>
<li><a href="Cloperastine" title="Cloperastine">Cloperastine</a></li>
<li><a href="Clozapine" title="Clozapine">Clozapine</a></li>
<li><a href="Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li><a href="Ethosuximide" title="Ethosuximide">Ethosuximide</a></li>
<li><a href="Ifenprodil" title="Ifenprodil">Ifenprodil</a></li>
<li><a href="Tertiapin" title="Tertiapin">Tertiapin</a></li>
<li><a href="Tipepidine" title="Tipepidine">Tipepidine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_opener" title="Potassium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="ATP-sensitive_potassium_channel" title="ATP-sensitive potassium channel"><abbr title="ATP-sensitive potassium channel">K<sub>ATP</sub></abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip ATP-sensitive potassium channel</span>-specific:</b> Aprikalim</li>
<li><a href="Bimakalim" title="Bimakalim">Bimakalim</a></li>
<li><a href="Cromakalim" title="Cromakalim">Cromakalim</a></li>
<li><a href="Diazoxide" title="Diazoxide">Diazoxide</a></li>
<li>Emakalim</li>
<li><a href="Levcromakalim" class="mw-redirect" title="Levcromakalim">Levcromakalim</a></li>
<li>Mazokalim</li>
<li><a href="Minoxidil" title="Minoxidil">Minoxidil</a></li>
<li><a href="Minoxidil_sulfate" title="Minoxidil sulfate">Minoxidil sulfate</a></li>
<li><a href="Naminidil" title="Naminidil">Naminidil</a></li>
<li><a href="Nicorandil" title="Nicorandil">Nicorandil</a></li>
<li><a href="Pinacidil" title="Pinacidil">Pinacidil</a></li>
<li>Rilmakalim</li>
<li>Sarakalim</li></ul>
<ul><li><b><a href="G_protein-coupled_inwardly_rectifying_potassium_channel" title="G protein-coupled inwardly rectifying potassium channel"><abbr title="G protein-coupled inwardly rectifying potassium channel">GIRK</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip G protein-coupled inwardly rectifying potassium channel</span>-specific:</b> ML-297 (VU0456810)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Calcium-activated_potassium_channel" title="Calcium-activated potassium channel"><abbr title="Calcium-activated potassium channel">K<sub>Ca</sub></abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Calcium-activated potassium channel</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_blocker" title="Potassium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="BK_channel" title="BK channel">BK<sub>Ca</sub></a>-specific:</b> <a href="Alcohol_(drug)" title="Alcohol (drug)">Ethanol (alcohol)</a></li>
<li><a href="GAL-021" class="mw-redirect" title="GAL-021">GAL-021</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_opener" title="Potassium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><b><a href="BK_channel" title="BK channel">BK<sub>Ca</sub></a>-specific:</b> <a href="Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><a href="Nimesulide" title="Nimesulide">Nimesulide</a></li>
<li><a href="Rottlerin" title="Rottlerin">Rottlerin (mallotoxin)</a></li>
<li><a href="Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Tandem_pore_domain_potassium_channel" class="mw-redirect" title="Tandem pore domain potassium channel"><abbr title="Tandem pore domain potassium channel">K2Ps</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Tandem pore domain potassium channel</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_blocker" title="Potassium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="12-O-Tetradecanoylphorbol-13-acetate" title="12-O-Tetradecanoylphorbol-13-acetate">12-O-Tetradecanoylphorbol-13-acetate</a></li>
<li><a href="Arachidonic_acid" title="Arachidonic acid">Arachidonic acid</a></li>
<li><a href="Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Norfluoxetine" class="mw-redirect" title="Norfluoxetine">Norfluoxetine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Potassium_channel_opener" title="Potassium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Riluzole" title="Riluzole">Riluzole</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Sodium_channel" title="Sodium channel">Sodium</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Voltage-gated_sodium_channels" class="mw-redirect" title="Voltage-gated sodium channels"><abbr title="Voltage-gated sodium channels">VGSCs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Voltage-gated sodium channels</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Sodium_channel_blocker" title="Sodium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><i>Antianginals:</i> <a href="Ranolazine" title="Ranolazine">Ranolazine</a></li></ul>
<ul><li><i>Antiarrhythmics (class I):</i> <a href="Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Aprindine" title="Aprindine">Aprindine</a></li>
<li><a href="Disopyramide" title="Disopyramide">Disopyramide</a></li>
<li><a href="Dronedarone" title="Dronedarone">Dronedarone</a></li>
<li><a href="Encainide" title="Encainide">Encainide</a></li>
<li><a href="Flecainide" title="Flecainide">Flecainide</a></li>
<li><a href="Lidocaine" title="Lidocaine">Lidocaine</a></li>
<li><a href="Lorajmine" title="Lorajmine">Lorajmine</a></li>
<li><a href="Lorcainide" title="Lorcainide">Lorcainide</a></li>
<li><a href="Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li><a href="Moracizine" title="Moracizine">Moricizine</a></li>
<li><a href="Pilsicainide" title="Pilsicainide">Pilsicainide</a></li>
<li><a href="Prajmaline" title="Prajmaline">Prajmaline</a></li>
<li><a href="Procainamide" title="Procainamide">Procainamide</a></li>
<li><a href="Propafenone" title="Propafenone">Propafenone</a></li>
<li><a href="Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Sparteine" title="Sparteine">Sparteine</a></li>
<li><a href="Tocainide" title="Tocainide">Tocainide</a></li></ul>
<ul><li><i>Anticonvulsants:</i> Acetylpheneturide</li>
<li><a href="Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="Cenobamate" title="Cenobamate">Cenobamate</a></li>
<li><a href="Chlorphenacemide" title="Chlorphenacemide">Chlorphenacemide</a></li>
<li>Elpetrigine</li>
<li><a href="Eslicarbazepine_acetate" title="Eslicarbazepine acetate">Eslicarbazepine acetate</a></li>
<li><a href="Ethotoin" title="Ethotoin">Ethotoin</a></li>
<li><a href="Fosphenytoin" title="Fosphenytoin">Fosphenytoin</a></li>
<li><a href="Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Lacosamide" title="Lacosamide">Lacosamide</a></li>
<li><a href="Licarbazepine" title="Licarbazepine">Licarbazepine</a></li>
<li><a href="Mephenytoin" title="Mephenytoin">Mephenytoin</a></li>
<li><a href="Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a></li>
<li><a href="Oxitriptyline" title="Oxitriptyline">Oxitriptyline</a></li>
<li><a href="Phenacemide" title="Phenacemide">Phenacemide</a></li>
<li><a href="Pheneturide" title="Pheneturide">Pheneturide</a></li>
<li><a href="Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li><a href="Rufinamide" title="Rufinamide">Rufinamide</a></li>
<li>Sipatrigine</li>
<li><a href="Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Sodium_valproate" class="mw-redirect" title="Sodium valproate">Sodium valproate</a></li>
<li><a href="Valnoctamide" title="Valnoctamide">Valnoctamide</a></li>
<li><a href="Valproate_pivoxil" title="Valproate pivoxil">Valproate pivoxil</a></li>
<li><a href="Valproate_semisodium" class="mw-redirect" title="Valproate semisodium">Valproate semisodium</a></li>
<li><a href="Valproic_acid" class="mw-redirect" title="Valproic acid">Valproic acid</a></li>
<li><a href="Valpromide" title="Valpromide">Valpromide</a></li>
<li><a href="Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>
<ul><li><i>Local anesthetics:</i> <a href="3-(p-Fluorobenzoyloxy)tropane" title="3-(p-Fluorobenzoyloxy)tropane"><i>p</i>FBT</a></li>
<li><a href="Amylocaine" title="Amylocaine">Amylocaine</a></li>
<li><a href="Articaine" title="Articaine">Articaine</a></li>
<li><a href="Benzocaine" title="Benzocaine">Benzocaine</a></li>
<li><a href="Bupivacaine" title="Bupivacaine">Bupivacaine</a> (<a href="Levobupivacaine" title="Levobupivacaine">Levobupivacaine</a>, <a href="Ropivacaine" title="Ropivacaine">Ropivacaine</a>)</li>
<li><a href="Butacaine" title="Butacaine">Butacaine</a></li>
<li><a href="Butamben" title="Butamben">Butamben</a></li>
<li><a href="Chloroprocaine" title="Chloroprocaine">Chloroprocaine</a></li>
<li><a href="Cinchocaine" title="Cinchocaine">Cinchocaine</a></li>
<li><a href="Cocaine" title="Cocaine">Cocaine</a></li>
<li><a href="Cyclomethycaine" title="Cyclomethycaine">Cyclomethycaine</a></li>
<li><a href="Dimethocaine" title="Dimethocaine">Dimethocaine</a></li>
<li><a href="Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="Etidocaine" title="Etidocaine">Etidocaine</a></li>
<li><a href="Hexylcaine" title="Hexylcaine">Hexylcaine</a></li>
<li><a href="Iontocaine" title="Iontocaine">Iontocaine</a></li>
<li><a href="Lidocaine" title="Lidocaine">Lidocaine</a></li>
<li><a href="Mepivacaine" title="Mepivacaine">Mepivacaine</a></li>
<li><a href="Meprylcaine" title="Meprylcaine">Meprylcaine</a></li>
<li><a href="Metabutoxycaine" title="Metabutoxycaine">Metabutoxycaine</a></li>
<li><a href="Orthocaine" title="Orthocaine">Orthocaine</a></li>
<li><a href="Piperocaine" title="Piperocaine">Piperocaine</a></li>
<li><a href="Prilocaine" title="Prilocaine">Prilocaine</a></li>
<li><a href="Procaine" title="Procaine">Procaine</a></li>
<li><a href="Propoxycaine" title="Propoxycaine">Propoxycaine</a></li>
<li><a href="Proxymetacaine" title="Proxymetacaine">Proxymetacaine</a></li>
<li><a href="Risocaine" title="Risocaine">Risocaine</a></li>
<li><a href="Tetracaine" title="Tetracaine">Tetracaine</a></li>
<li><a href="Trimecaine" title="Trimecaine">Trimecaine</a></li></ul>
<ul><li><i>Analgesics:</i> AZD-3161</li>
<li><a href="DSP-2230" title="DSP-2230">DSP-2230</a></li>
<li><a href="Funapide" title="Funapide">Funapide</a></li>
<li>GDC-0276</li>
<li>NKTR-171</li>
<li>PF-04531083</li>
<li><a href="PF-05089771" title="PF-05089771">PF-05089771</a></li>
<li><a href="Ralfinamide" title="Ralfinamide">Ralfinamide</a></li>
<li><a href="Raxatrigine" class="mw-redirect" title="Raxatrigine">Raxatrigine</a></li>
<li>RG7893 (GDC-0287)</li>
<li><a href="Suzetrigine" title="Suzetrigine">Suzetrigine</a></li></ul>
<ul><li><i>Toxins:</i> <a href="Conotoxin" title="Conotoxin">Conotoxins</a></li>
<li><a href="Neosaxitoxin" title="Neosaxitoxin">Neosaxitoxin</a></li>
<li><a href="Saxitoxin" title="Saxitoxin">Saxitoxin</a></li>
<li><a href="Tetrodotoxin" title="Tetrodotoxin">Tetrodotoxin</a></li>
<li><a href="Zetekitoxin_AB" title="Zetekitoxin AB">Zetekitoxin AB</a></li></ul>
<ul><li><i>Others:</i> <a href="Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li><a href="Evenamide" title="Evenamide">Evenamide</a></li>
<li><a href="Menthol" title="Menthol">Menthol</a> (<a href="Mentha" title="Mentha">mint</a>)</li>
<li><a href="Safinamide" title="Safinamide">Safinamide</a></li>
<li><a href="Tricyclic_antidepressant" title="Tricyclic antidepressant">Tricyclic antidepressants</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Sodium_channel_opener" title="Sodium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Aconitine" title="Aconitine">Aconitine</a></li>
<li>Atracotoxins (<a href="Omega-Atracotoxin" title="Omega-Atracotoxin">ω-Atracotoxin</a>, <a href="Robustoxin" class="mw-redirect" title="Robustoxin">Robustoxin</a>, <a href="Versutoxin" title="Versutoxin">Versutoxin</a>)</li>
<li><a href="Batrachotoxin" title="Batrachotoxin">Batrachotoxin</a></li>
<li><a href="Ciguatoxin" title="Ciguatoxin">Ciguatoxins</a></li>
<li><a href="Grayanotoxin" title="Grayanotoxin">Grayanotoxins</a></li>
<li><a href="Poneratoxin" title="Poneratoxin">Poneratoxin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Epithelial_sodium_channel" title="Epithelial sodium channel"><abbr title="Epithelial sodium channel">ENaC</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Epithelial sodium channel</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Sodium_channel_blocker" title="Sodium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Amiloride" title="Amiloride">Amiloride</a></li>
<li><a href="Benzamil" title="Benzamil">Benzamil</a></li>
<li><a href="Triamterene" title="Triamterene">Triamterene</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Sodium_channel_opener" title="Sodium channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li>Solnatide</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Acid-sensing_ion_channel" title="Acid-sensing ion channel"><abbr title="Acid-sensing ion channel">ASICs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Acid-sensing ion channel</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Sodium_channel_blocker" title="Sodium channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li>A-317567</li>
<li><a href="Amiloride" title="Amiloride">Amiloride</a></li>
<li><a href="Aspirin" title="Aspirin">Aspirin</a></li>
<li><a href="Ibuprofen" title="Ibuprofen">Ibuprofen</a></li>
<li>PcTX1</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="Chloride_channel" title="Chloride channel">Chloride</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Calcium-activated_chloride_channel" class="mw-redirect" title="Calcium-activated chloride channel"><abbr title="Calcium-activated chloride channel">CaCCs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Calcium-activated chloride channel</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Chloride_channel_blocker" title="Chloride channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Crofelemer" title="Crofelemer">Crofelemer</a></li>
<li><a href="DIDS" title="DIDS">DIDS</a></li>
<li><a href="Ethacrynic_acid" class="mw-redirect" title="Ethacrynic acid">Ethacrynic acid</a></li>
<li><a href="Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Furosemide" title="Furosemide">Furosemide</a></li>
<li><a href="Glibenclamide" title="Glibenclamide">Glibenclamide</a></li>
<li><a href="Mefloquine" title="Mefloquine">Mefloquine</a></li>
<li><a href="Mibefradil" title="Mibefradil">Mibefradil</a></li>
<li><a href="Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Chloride_channel_opener" title="Chloride channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Carbachol" title="Carbachol">Carbachol</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Cystic_fibrosis_transmembrane_conductance_regulator" title="Cystic fibrosis transmembrane conductance regulator"><abbr title="Cystic fibrosis transmembrane conductance regulator">CFTR</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Cystic fibrosis transmembrane conductance regulator</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Chloride_channel_blocker" title="Chloride channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Glibenclamide" title="Glibenclamide">Glibenclamide</a></li>
<li><a href="Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li><a href="Piretanide" title="Piretanide">Piretanide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Chloride_channel_opener" title="Chloride channel opener">Activators</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li>1,7-Phenanthroline</li>
<li><a href="1%2C10-Phenanthroline" title="1,10-Phenanthroline">1,10-Phenanthroline</a></li>
<li>4,7-Phenanthroline</li>
<li>7,8-Benzoquinoline</li>
<li><a href="Ivacaftor" title="Ivacaftor">Ivacaftor</a></li>
<li><a href="Phenanthridine" title="Phenanthridine">Phenanthridine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Unsorted</th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Chloride_channel_blocker" title="Chloride channel blocker">Blockers</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li><a href="Bumetanide" title="Bumetanide">Bumetanide</a></li>
<li><a href="Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Mefenamic_acid" title="Mefenamic acid">Mefenamic acid</a></li>
<li><a href="Mepacrine" title="Mepacrine">Mepacrine</a></li>
<li><a href="Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li>Talniflumate</li>
<li><a href="Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li>
<li><a href="Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Transient_receptor_potential_channels" class="mw-redirect" title="Transient receptor potential channels"><abbr title="Transient receptor potential channels">TRPs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Transient receptor potential channels</span></th><td class="navbox-list-with-group navbox-list navbox-odd" style="padding:0"><div style="padding:0 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><a href="Ligand_gated_ion_channels" class="mw-redirect" title="Ligand gated ion channels"><abbr title="Ligand gated ion channels">LGICs</abbr></a><span class="sr-only" style="border: 0; clip: rect(0, 0, 0, 0); clip-path: polygon(0px 0px, 0px 0px, 0px 0px); height: 1px; margin: -1px; overflow: hidden; padding: 0; position: absolute; width: 1px; white-space: nowrap;">Tooltip Ligand gated ion channels</span></th><td class="navbox-list-with-group navbox-list navbox-even" style="padding:0"><div style="padding:0 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Transient receptor potential channel modulators</i></div></td></tr></tbody></table></div>
<style data-mw-deduplicate="TemplateStyles:r1130092004">
/* start https://en.wikipedia.org/ */


.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-related{font-size:100%;justify-content:flex-start}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;flex:0 0 auto;min-height:24px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;flex:0 1 auto;padding:0.15em 0;column-gap:1em;align-items:baseline;margin:0;list-style:none}.mw-parser-output .portal-bar-content-related{margin:0;list-style:none}.mw-parser-output .portal-bar-item{display:inline-block;margin:0.15em 0.2em;min-height:24px;line-height:24px}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap;align-items:baseline}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-related{font-size:100%;align-items:flex-start}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:center;flex:0;column-gap:1em;border-top:1px solid #a2a9b1;margin:0 auto;list-style:none}.mw-parser-output .portal-bar-content-related{border-top:none;margin:0;list-style:none}}.mw-parser-output .navbox+link+.portal-bar,.mw-parser-output .navbox+style+.portal-bar,.mw-parser-output .navbox+link+.portal-bar-bordered,.mw-parser-output .navbox+style+.portal-bar-bordered,.mw-parser-output .sister-bar+link+.portal-bar,.mw-parser-output .sister-bar+style+.portal-bar,.mw-parser-output .portal-bar+.navbox-styles+.navbox,.mw-parser-output .portal-bar+.navbox-styles+.sister-bar{margin-top:-1px}


/* end https://en.wikipedia.org/ */
</style>
<div class="navbox-styles"></div><div role="navigation" class="navbox authority-control" aria-label="Navbox507" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Authority control databases: National </th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/sh2011002275">United States</a></span></li><li><span class="uid"><a rel="nofollow" class="external text" href="https://www.nli.org.il/en/authorities/987007597633105171">Israel</a></span></li></ul></div></td></tr></tbody></table></div></div><!--htdig_noindex--><div><div class="zim-footer">
This article is issued from <a class="external text" title="Last edited on 2025-07-25" href="https://en.wikipedia.org/wiki/?title=Pregabalin&amp;oldid=1302493025">Wikipedia</a>. The text is available under <a class="external text" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">Creative Commons Attribution-Share Alike 4.0</a> unless otherwise noted. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
</div>
</main>
</div>
</div>
</div>

</body></html>